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      For complex human diseases, identifying the underlying genetic factors 
has previously primarily relied on either genome-wide linkage scans to narrow 
down the chromosomal regions that are linked to disease-causing genes or the 
candidate gene approach based on known mechanisms of disease 
pathogenesis. During the past few years, genome-wide association studies 
have emerged as popular tools to identify genetic variants underlying common 
and complex diseases, greatly advancing our understanding of the genetic 
architecture of human diseases.  
      Refractive errors are complex ocular disorders, as the underlying causes 
are both genetic and environmental in origin. The need for continued research 
into the genetic aetiology of refractive errors is considerable, especially 
considering a mismatch between high heritability in twin studies and the 
paucity of evidence for associated genetic variation. This thesis seeks to 
address the potential roles of genetic factors involved in refractive errors. 
Through a meta-analysis of three genome-wide association scans on ocular 
biometry of axial length in Asians, we have determined that a genetic locus on 
chromosome 1q41 is associated with axial length and high myopia. In 
addition, our meta-analysis in five genome-wide association studies in Asians 
has revealed that genetic variants on chromosome 4q12 are associated with 
corneal astigmatism, exhibiting strong and consistent effects over Chinese, 
Malays and Indians. 
      Inter-population variation in patterns of linkage disequilibrium, largely 
shaped by underlying homologous recombination, influences the 
transferability of genetic risk loci across different populations. Understanding 
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the recombination variation provides the insight into fine-mapping of the 
functional polymorphisms by leveraging on the genetic diversity of different 
populations. This motivates an attempt to quantify the recombination 
variations between populations. For this purpose, a quantitative measure 
(varRecM) is proposed to evaluate the extent of inter-population differences in 
recombination rates. Our findings suggest that significant fine-scale 
differences exist in the recombination profiles of Europeans, Africans and East 
Asians. Regions that emerged with the strongest evidence harbour candidate 
genes for population-specific positive selection, and for genetic syndromes. 
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1 Chapter 1   Introduction 
 
      In this Chapter, I will initially introduce the genome-wide association 
studies (GWAS) and the GWAS meta-analysis, and also highlight the 
statistical challenges for paired-eye data. Subsequently, I will provide the 
background and motivation of the study in inter-population recombination 
variations. The last section will include a literature review on the aetiology of 
refractive errors, particularly myopia. 
 
1.1 Statistical analysis of genome-wide association studies 
1.1.1 Linkage disequilibrium based association mapping 
      Mapping disease genes primarily depends on linkage studies and 
association mapping. The former exploits within-family correlations between 
the disease and the genetic markers (i.e. microsatellite) linked to disease-
related genes by calculating the logarithm of odds (LOD) scores1. Mutations 
for more than 1,600 Mendelian diseases have been discovered by linkage 
studies; however, it is less successful for complex (polygenic) disorders.      
      The genome-wide design is proposed as a powerful means to identify 
common variants that underlie complex human traits2,3. GWAS typically 
survey between 500,000 to 1,000,000 single nucleotide polymorphisms 
(SNPs) across the entire human genome simultaneously4. Such a dense set of 
SNPs (known as tag SNPs) across the genome is chosen based on the linkage 
disequilibrium (LD) pattern of genotyped SNPs within a particular 
chromosomal region in HapMap reference samples, thanks to the launch of the 
international HapMap project5. In the simple scenario, an association study 
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compares the frequency of alleles or genotypes for a particular variant 
between the cases and controls. The current design of GWAS relies on genetic 
correlations between the genotyped markers and underlying functional 
polymorphisms, named LD-mapping. LD is the non-random association of 
alleles at two or more loci. The amount of LD depends on the difference 
between observed and expected (which is assumed randomly distributed) 
allelic frequencies. SNPs in high LD are likely to transmit to the same 
offspring in subsequent generations. It is hoped that a true causal SNP not 
genotyped in a study would be captured through a minimal level of LD with 
an informative nearby genotyped SNP exhibiting significant association with 
the disease.  
 
1.1.2 Study design and analytical strategy 
1.1.2.1 Data quality control 
      GWAS rely on commercial SNP chips, predominantly by Illumina 
(http://www.illumina.com/) and Affymetrix (http://www.affymetrix.com/). 
Regardless of the type of SNP chips used, a rigorous quality control (QC) 
procedure is very important to ensure the success of the study. While both 
Affymetrix and Illumina have their own genotype-calling algorithms for raw 
data analysis, one should make sure that the best practice of genotype calling 
protocol is applied. Several QC check points are often examined in a GWAS 
including the sample call rate, Hardy-Weinberg equilibrium (HWE), the minor 
allele frequency (MAF), genotype missingness per marker, and population 
structure6. Although there is no gold standard for these QC check points, 
examples of thresholds that we would recommend are: excluding samples with 
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call rates <95%, and excluding SNPs which are out of HWE (p< 10-6) in 
control samples, MAF < 0.01, or genotype missingness >10%. Population 
structure is another important QC task to investigate and will be described in 
the next section. 
1.1.2.2 Population structure 
      Early views of the role of population structure in genetic association 
studies of unrelated individuals focused on the concern that cryptic population 
substructure would raise the false-positive rate of statistical tests above their 
nominal level. For instance, in a case-control dataset, we assume that there are 
two underlying subpopulations with different allele frequencies at the SNP 
and that the number of cases is disproportionally high in one subpopulation 
(Figure 1). Although genotype frequencies are identical in the cases and 
controls within a population 1 or population 2, it appears there are dramatic 
differences in CC and TT genotypes among cases and controls in the 
combined data. Under this scenario, the failure to account for population 
stratification, a confounding factor of allele frequency differences, could result 





Figure 1. Impact of population stratification on genotype frequencies in the 
case-control association study. The percentages of individuals carrying different 
genotypes in cases in the population 1, combined populations and population 2 
respectively are on top panel; analogously for controls in bottom panel. Cases are 
overrepresented in population 1.  
       Price and colleagues proposed a computational feasible approach to detect 
and correct population stratification7. In their approach, principal components 
analysis (PCA) was used to model ancestry differences between cases and 
controls. The EIGENSTRAT approach identifies ancestry differences among 
samples along eigenvectors of a covariates matrix. The ancestry outliers will 
be excluded from further association analyses. In addition to excluding these 
samples, the EIGENSTRAT approach is used to adjust the amounts 
attributable to ancestry for the top eigenvectors 
(http://genepath.med.harvard.edu/~reich /Software.htm). Patterson and 
colleagues pointed out that top eigenvectors could be caused by a large set of 
markers in a high (or complete) LD block8. Hence they recommended pruning 
the markers in tight LD before performing PCA.  
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1.1.2.3 Study design 
      Case-control or cross-sectional study designs are widely adopted to 
evaluate the association between the disease and multiple SNPs. The statistical 
approach to analyse GWAS data is similar to traditional epidemiology studies, 
except the same test is repeated for each SNP. Cochran-Armitage’s trend test, 
χ2 test and logistical regression model are largely utilised in the case-control 
design to study the overrepresentation of the mutated allele in cases versus 
controls9.  
      Although most GWAS phenotype data, employing the existing 
epidemiology cohorts, are collected longitudinally, they are usually analysed 
in a case-control fashion. The incorporation of longitudinal information such 
as modelling time to event and repeated measurements will add merit to 
GWAS10. Analysing the longitudinal data of repeated measurements is 
however computational intensive, and lacks efficient software. An alternative 
way is to use the aggregate outcome of interest, i.e. changes in the outcome 
over time, but the use of limited or partial data can compromise the statistical 
power11.  
      For a family-based GWAS, the transmission disequilibrium test (TDT) is 
used to measure the excessive-transmission of an allele from heterozygous 
parents to the affected offspring under the condition of Mendel’s law12. TDT 
has been generalised for multiple sibling using family based association tests 
(FBATs)13. Such tests are extended to quantitative traits, named quantitative 
transmission disequilibrium test (QTDT) and family-based association tests 
for quantitative traits (QFAM), and both are implemented in the QTDT 
software package (http://www.sph.umich.edu/csg/abecasis/QTDT/). 
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Compared to the population-based case-control design, family-based 
association study in the use of trios of families is robust against the population 
stratification14.  However, the recruitment of parents-offsprings usually 
requires more research resources than that of unrelated subjects in population-
based study, particularly posing challenges for late-onset diseases. 
Furthermore, to obtain the similar statistical power, costs increase in 
genotyping trios to that of genotyping two individuals in the case-control 
study 15. These factors might explain the popularity of population-based 
design in current GWAS.   
1.1.2.4 Multiple testing 
      Testing multiple hypotheses simultaneously to draw the correct statistical 
inference is the most challenging aspect of a GWAS. It is now common to 
assay one million variants in a GWAS, and this effectively constitutes 
1,000,000 hypothesis tests. A conventional significance threshold of 5% is 
thus expected to artificially identify 5,000 markers that are “correlated” to the 
trait. To address this issue of multiple testing, geneticists have adopted a 
stringent statistical significance level of 5.0 × 10-8, commonly defined as 
attaining genome-wide significance, as the benchmark for evaluating the 
fidelity of the association signal at each marker9.  Notably, the Bonferroni 
correction is simple but conservative, as assuming the independence of one 
million genetic variants and all tests conducted without considering the inter-
marker correlation. Replication is thus considered as the gold standard for 
GWAS publications16. Currently, the identification of candidate genetic loci 
for replication is mainly driven by the level of statistical evidence from single-
18 
 
marker association tests (either the p-value or the Bayes factor) for further 
downstream functional evaluation.  
1.1.3 Phenotype classification 
1.1.3.1 Binary/quantitative traits 
      In gene mapping, ocular phenotypes are usually classified into two broad 
types: qualitative (or binary) and quantitative (or continuous) traits. 
Dichotomous traits have been featured in GWAS for age-related macular 
degeneration (AMD)17,18, primary open-angle glaucoma (POAG)19,20, 
cataract21 and high myopia22,23. The affected individuals are usually classified 
on the basis of diagnosis from the worse eye or both eyes, while controls 
exhibit no sign of syndrome for both eyes. Although assessing the binary 
outcome is more directly relevant to clinical application, quantitative traits 
(endophenotypes or intermediate traits) underlying diseases are also valuable 
in the dissection of the genetic architecture, as they take the full-spectrum 
measures into account. For instance, central corneal thickness (CCT) and cup-
to-disc ratio (CDR) are presented as quantitative endophenotypes of open-
angle glaucoma (OPRG)24. Mapping genes for CCT25-27 and CDR28,29 in the 
GWAS would shed light on the joint genetic aetiology of OPRG. 
      A “myopia” gene may be practically relevant to the hyperopic defocus 
whereas quantitative trait locus (QTL) for refractive error affecting ocular 
component growth is responsible for the entire phenotypic spectrum. It is 
possible that genes involved in a quantitative trait (refractive error) also play a 
role in the extreme forms of the trait (high myopia)30.  
19 
 
1.1.3.2 Paired eye measurements  
      Often, the primary interest in ophthalmological genetic studies is to locate 
shared quantitative genetic loci (QTL) that exert effects on both eyes31-33, as 
the physiological mechanism underlying inter-eye difference of phenotypic 
abnormalities remains elusive and inadequately understood. Therefore, for 
quantitative traits collected from both eyes, an immediate question is whether 
the analyses should be performed on data from one eye or two eyes. In seven 
GWAS papers on eye-related QTL that have been published 
(http://www.genome.gov/gwastudies), the analytic strategies varied from the 
use of right eye26,27,29 or a randomly chosen eye28 to the averaged 
measurement from two eyes25,34,35. Conducting analysis on one eye alone is a 
simple approach to avoid the statistical model complexity. However, using 
partial data of one eye only might be statistically inefficient. Averaging ocular 
measurements between two eyes has been suggested to yield higher 
heterogeneity estimates than using information from one eye only; therefore 
this tends to have more power in genetic studies36. Using averaged ocular 
measurements therefore has been the convention in QTL linkage studies in the 
myopia genetics research community37-40. However, in a few scenarios the 
traits might be moderately or weakly correlated between two eyes41. Neither 
the use of data from one eye nor an average from both eyes is appropriate due 
to the negligence of phenotypic dissimilarity.  
      A wide array of statistical approaches has emerged recently for the 
detection of the pleiotropic genetic factors contributing to multiple correlated 
traits, which could also be applied to two-eye data (see Table 1). The 
simultaneous consideration of all correlated phenotypes has been shown to be 
20 
 
statistically powered to exploit pleiotropic genetic effects over univariate 
analysis42-45. The first approach is to combine dependent test statistics or 
estimators from the univariate analyses for a global assessment on 
association42,46-48. In brief, GWAS tests are conducted for two eyes separately. 
The two test statistics from both eyes (for example, z scores) are combined 
subsequently in a linear form weighted by the covariance matrix estimates42,48. 
Correcting for twice the number of markers is not relevant here since for each 
marker only one global test is performed using the combined statistics. This 
simple approach does not rely on any complicated model assumption as well. 
The second approach is to transform multiple traits to an optimal single 
phenotype with enhanced heritability, and one such example is principle 
component analysis43,49. This dimension reduction technique involves 
intensive computation, thus the application in two-eye data might not be 
straightforward. The third one is model-based joint analysis of bivariate traits, 
including generalized estimating equations (GEE)44,50-52, the mixed-effect 
model45,53 and tree-based regression model54, etc. Among these, the GEE 
model is most statistically efficient to perform bivariate association tests44,52. 
To date, few statistical software packages incorporating model-based joint 
analyses on bivariate traits are available55, and much more effort should be 
devoted to this area.  
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Table 1. Summary of analytic approaches for quantitative trait two-eye 
data in genome-wide association studies 
 
Approaches Comments 
Data from One eye  
    -either eye or a 
randomized eye 
Simple; less powerful if the correlation between the two 
traits is low  
Data from  Both Eyes  
Transform bivariate traits 
to one trait 
 
    -average measurements  Simple and efficient; statistically less efficient if the 
correlation between bivariate traits is low and missing 
data are present on either eye.  
    -principle components 
analysis43,49     
Statistically powerful; complex; reduce the phenotypes 
to a single trait; computationally intensive 
Combining univariate test 
statistics 
Simple and powerful; capable of handling paired-eye 
traits not highly correlated; robust for partially missing 
trait values 
Model-based approaches  
    -GEE44,50-52 Statistically powerful; robust for various correlation 
structures; efficient on both normal and nonnormal traits; 
complex 
    -mixed-effect model50  Statistically powerful; complex; robust for various 
correlation structures of multiple traits; computationally 
intensive 
    -tree-based regression54 Analytically complex; capable of assessing multiloci 





1.1.4 Meta-analysis of genome-wide association studies 
    Accumulated evidence suggests that most of the GWAS are underpowered 
for the variants with small effect sizes (ORs of 1.0 ~ 1.5), and the associated 
SNPs generally explain a small fraction of the genetic risk56. Meta-analysis 
provides a robust approach to enhance statistical power and effective sample 
size by pooling evidence from multiple independent association studies57,58. 
The application of meta-analysis in ophthalmology has become a standard 
practice to identify genes that are associated with eye disorders26-29,34,35.   
1.1.4.1 Imputation on genotyped data 
      If the individual GWAS is conducted with different genotyping platforms 
(Illumina or Affymetrix), the meta-analysis strategy could only utilise a small 
subset of overlapped markers. In addition, if the causal polymorphism is a 
common untyped SNP and in varying degrees of LD with the genotyped SNP 
nearby in different populations, the meta-analysis also has limited power to 
detect true association in the combined data. One way to address these issues 
is to perform imputation using the HapMap reference panels, which provide a 
powerful framework for the assessment of the complete array of genetic 
variants (most of which are un-typed). Step-by-step guidelines and techniques 
for performing imputation-based genome-wide meta-analysis was reviewed by 
de Bakker and colleagues58. The development of several imputation methods 
for inferring the genotypes of untyped markers has provided a solution for this 
problem (for a review, see59). The basic idea behind imputation is to utilise the 
correlation among untyped and typed markers to infer the genotypes of 
untyped markers in each dataset. With the imputation programs becoming 
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available, we now can impute untyped markers at the first stage to allow 
assessing multiple datasets for the same set of SNPs.  
      The accuracy of imputation largely depends on two factors. First, the 
overall level of LD reflects the distance over which the genotypic correlations 
permit imputation to extend, so the imputation is more accurate in high-LD 
regions60. Second, the level of genetic similarity of the study population to the 
reference panels affects the utility of the haplotypes copied from the reference 
samples in imputing genotypes in the study populations. Imputation accuracy 
based on HapMap reference panels is highest in European populations, which 
are closely related to the HapMap CEU panel, and lowest in Africans with a 
diverse genetic background. If GWAS are conducted in populations which are 
not represented by the available high density reference panels in HapMap 
data, for example, Malays and Indians, mixtures of reference panels are 
recommended to maximize imputation accuracy61 .      
      In addition, it should be noted that imputation is generally computational 
intensive. IMPUT60,62, MACH62, and BEAGLE63 are the frequently used 
programs. Each has different strengths and weaknesses, but none of them is 
optimal for all situations64.  
1.1.4.2  Statistics in the meta-analysis  
      Meta-analysis in the setting of genetic studies refers to combining 
summary statistics of overlapping SNPs from multiple genetic association 
studies. Since combining raw individual genotype and phenotype data across 
studies to perform pooled analysis is difficult in general, the meta-analysis 
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based on the summary results is a surrogate to assess the association tests 
across all datasets. Here, we describe a few meta-analysis methods in GWAS.   
      First, the simplest meta-analysis method is Fisher's methods Tfisher = -2 * ∑ 
log(pi), where pi is p value of study i, i=1, …, k.  Tfisher follows a χ2 
distribution of 2k degrees of freedom where k is the total number of datasets. 
Since Fisher’s method takes only information from the p-values, it is 
important to keep in mind that it should be applied to the markers with the 
same direction of the effect to the susceptibility of the disease.  
      Second, Mantel-Haenszel methods are commonly used for dichotomous 
traits if the information for a 2 × 2 contingency table can be recovered from 
each study65. In combining odds ratio, weight is usually given proportionally 
to the precision of the results in each study.  
      Third, if a 2 × 2 table is not available in each study, such as if p-values 
were obtained from logistical regression framework in order to adjust for 
potential confounding covariates, using z-score statistics to compute the meta-
p values is the best option. The z-score statistics are wildly used in practice for 
meta-analysis since a z-score could be easily converted in each study and the 
direction of effect is manifested in itself58. For quantitative traits, the pooled 
weighted effect size is commonly calculated as the sum of the individual 
effect size using inverse variance of each study as weight. Such an approach is 
also known as a fixed-effect model under an assumption of the same expected 
effect size between studies. Combined effect size is calculated as:  
                                            Tmeta = ∑Tiwi,  
 where Ti is the effect size of study i and wi is the inverse variance of effect 
size of study i. The pooled standard error of Tmeta is: 
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                                    SEmeta= �
1
∑𝑤𝑖
   
Then a pooled z-score is obtained as  
                                    zmeta = 
𝑇𝑚𝑒𝑡𝑎   𝑆𝐸𝑚𝑒𝑡𝑎 , which follows a chi-square distribution 
with 1 degree of freedom. In cases where the variance is not given in the 
summary statistics or standard error is not on the same unit (for example, the 
quantitative trait is not measure on the same unit), a z-score can then be 
summed across multiple studies weighting them by study sample size:  
                                     𝑍𝑚𝑒𝑡𝑎 = ∑ 𝛽𝑖𝑆𝐸𝑖 𝑤𝑖,  where wi =� 𝑁𝑖𝑁𝑡𝑜𝑡𝑎𝑙. 
      It is unlikely that every dataset for a meta-analysis is derived from a single 
homogenous population with the same genetic effect. Therefore, it is 
important to access the heterogeneity across datasets. A commonly used 
method to assess between-study heterogeneity is called Cochran’s Q statistic, 
for which the large values of Cochran’s Q favour the alternative hypothesis of 
heterogeneity. For datasets i = 1, … , k, T1, … , Tk is the study-specific effect 
size. The Cochran’s Q statistic is computed by:  
                                 𝑄 = ∑ 𝑤𝑖(𝑇𝑖 − 𝑇),  where 𝑇 = ∑ 𝑤𝑖𝑇𝑖𝑘𝑖=1∑ 𝑤𝑖𝑘𝑖=1𝑘𝑖=1    
and wi is the inverse of the estimated variance in dataset i. Q is distributed as a 
chi-square distribution with k-1 degrees of freedom. An alternative form, 
statistic I2 (inconsistency), derived from Q, 100% × (Q-degree of freedom), is 
a measure of the percentage of heterogeneity versus total variation across 
studies. Values of I2 over 50% indicate the presence of heterogeneity. If 
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evidence of heterogeneity is demonstrated, measures to identify its possible 
cause are needed before drawing any explicit conclusion.  
      Finally, given the presence of inter-study heterogeneity, a random-effect 
model in the meta-analysis makes an assumption that individual studies are 
sampled from populations that may have different true effect sizes. 
Differences in observed effect sizes arise from two resources: random errors 
and true variations in expected effect sizes. In practice, the meta-analysis is 
conducted in diverse populations using different study design, sample 
ascertainment and phenotype definition. More advanced statistical analyses 
are expected to accommodate these issues in the trans-ethnic mapping66-68. No 
matter what statistical strategies are adopted in such scenarios, additional 
cohorts for replication or fine-mapping approaches are required to further 
investigate on the true genetic variants of interest.  
1.1.4.3 Statistical challenges in analyzing multi-ethnic populations 
      A meta-analysis of GWAS across multi-ethnic groups enables us to 
uncover the shared genetic variants underlying susceptibility to diseases, an 
essential component of the next phase of GWAS to gain a broader view of 
disease aetiology69. Heterogeneity, where the genetic effect exits but the effect 
sizes vary in different populations, poses a major challenge in the multi-ethnic 
meta-analysis. One example is the ε4 allele of the apolipoprotein E gene 
(APOE), which is associated with Alzheimer’s disease in Caucasians of per-
allele odds ratio above 2, but not significantly associated in African 
Americans70. Therefore, the association signals at APOE are expected to dilate 
in the pooled data comprising both Caucasians and Africans. 
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      The ethnic-specific genetic risk offers a clue to understand the interaction 
of the identified genetic locus with the undetermined environmental or genetic 
variables that influence diseases. The gene-gene (epistatic) or gene-
environmental interactions occur when the effect of a causal variant manifests 
under a certain genetic or environmental background71. Environment can have 
a substantial role to influence the effect sizes at a given susceptibility locus. 
However, the detection of gene-gene or gene-environmental interaction is a 
daunting task. Little robust evidence has been provided for ocular diseases. 
      Heterogeneity can also occur when the genetic association between the 
causal variant and the genotyped SNPs varies in different ethnic groups, or in 
different samples but the same population (due to the sampling error). The 
different LD pattern can generate spurious associations in terms of both size 
and direction of effects at the genotyped SNPs, confounding the underlying 
true effect of the casual variant72.   
      Allele frequency also has an impact on effect sizes of the risk allele. It has 
been noted that wide variation in allele frequencies at susceptibility loci to the 
complex diseases across populations. One such example is rs19061170 in the 
complement factor H gene, which has a large effect size with age-related 
macular degeneration in Caucasians that is much smaller in East Asian 
populations; the risk allele is found at low frequencies in East Asians (5%), 
but at moderate frequencies in Caucasians (35%)73.  
      Allelic heterogeneity (or population-specific causal variants) is also 
noteworthy, where the causal variants reside at different loci but likely in the 
same functional unit across different populations. However, current meta-
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analysis approaches for the combination of genetic association results in the 
presence of allelic heterogeneity are underpowered74. Allelic heterogeneity is 
believed to be enriched for rare variants, and gene-based or regional-based 
meta-analysis is expected in exploring sequencing or exome sequencing data 
targeting rare variants75.  
      
1.2 Recombination variation between populations 
1.2.1 Recombination and genetic diversity 
      Homologous recombination is one of the key evolutionary determinants of 
genomic diversity through the introduction of new haplotypes that alter the 
extent and pattern of linkage disequilibrium (LD)76. The most striking feature 
of recombination in human is the tendency to cluster in highly localized 
regions named ‘hotspots’ in the human genome of typical 1 to 2 kb in 
width77,78. Extensive heterogeneity in recombination rates has been catalogued 
between species79-81. In the comparison between the genomes of human and 
chimpanzee, where even though 99% of the genomes were conserved, 
remarkable differences in recombination and LD patterns were observed82,83. 
Meiotic recombination landscape is transient over evolutionary time84,85 and 
highly variable between individuals78,86. 
      Homologous recombination is an important evolutionary determinant of 
genomic diversity by producing novel combination of alleles, resulting in 
selection for or against new haplotypes, and linkage disequilibrium (LD) 
decay76. LD mapping is one of the key features to permit the success of 
genome-wide assessment by linking the untyped functional polymorphism and 
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surrounding assayed markers87,88. Recombination rate has also been widely 
used as a surrogate for LD in SNP imputation algorithms60. As such, 
understanding recombination variation does not only provides insight into the 
genome evolutionary process that has shaped the genetic diversity along the 
human history, but also builds a foundation for genetic studies to disentangle 
the genes that are associated with common diseases89. 
 
1.2.2 Variation in inter-population recombination 
      Within the human species, our understanding of fine-scale differences in 
rates of recombination between human populations remains relatively limited.  
Studies have shown that, on a broad scale, recombination rates generally 
remain evolutionarily conserved in the entire genome90-92. Of the 
approximately 30,000 potential recombination hotspots estimated from 
European, African and Han Chinese ancestries, only half are common to three 
populations, and the remaining are population-specific93. Significant variation 
in recombination rates have been documented mostly in regions containing 
polymorphic inversions90,94,95, although these comparisons have mainly been 
performed at a broad scale across regions stretching megabases in lengths. At 
a finer scale comparison across kilobases of the genome, population-specific 
spikes or peaks in rates have similarly been reported92,96,97. Recently, Hinch 
and colleagues have inferred that 2,500 recombination hotspots, defined as 
localized regions of elevated recombination, are active in West Africans but 
not Europeans, and that there appears to be a scarcity of hotspots that are 
unique to the people of European ancestry98. This observation, along with 
findings from the sequenced genes by the Seattle SNPs program96,97, suggests 
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that the intensity and location of recombination hotspots can differ 
substantially across different populations. The International HapMap 
Consortium5,99 provided the first large-scale database with sufficiently dense 
genotyping across the human genome in multiple populations for investigating 
recombination. However, there is no study to-date that systematically 
interrogates the whole genome for evidence of inter-population variation in 
recombination rates.  
      Such inter-population differences in recombination patterns can provide 
vital opportunities in fine-mapping the functional polymorphisms that 
underpin the association signals from large-scale genetic studies, through 
leveraging on different patterns of LD in multiple populations. Understanding 
the similarities in recombination rates across multiple populations is also 
important in bioinformatic analyses that depend on recombination rates, such 
as in genotype imputation and in surveying the human genome for signatures 
of positive natural selection. Variation in recombination, particularly at 
disease-associated regions, is likely to have important consequences to genetic 
association studies.   
 
1.2.3 Current approaches of quantifying recombination differences 
       Comparing recombination differences at a fine scale relies on the 
availability of genetic maps at a high resolution. However, generating a 
precise genome-wide map of recombination via direct experimental mapping 
of hotspots is not feasible. Genetic maps of recombination commonly 
employed in genotype imputation and population selection surveys, such as 
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those from the International HapMap Project5 or from the Singapore Genome 
Variation Project100, are usually probabilistically inferred from genotype data 
across at least tens of samples from a particular population by correlating 
recombination events with the breakdown of linkage disequilibrium (LD) 
observed across the population samples based on population coalescent 
theory101. The resolution of these maps thus depends on the density of the 
SNPs in these databases, and typically yields a resolution in the order of 
kilobases. Such LD-based estimates of recombination rate are sex-averaged 
over tens of thousands of generations, and are likely to be influenced by the 
locus-specific demographic forces102,103. Despite the potential limitations, 
these estimated rates of recombination have yielded remarkable insights into 
the process of human evolution, leading to the identification of 13-basepair 
motifs that are enriched in hotspots104 and the discovery of the PRDM9 gene 
as a genetic modifier of recombination activity105. 
        Current metrics that prioritise genomic regions exhibiting differences in 
recombination profiles or differential presence of recombination hotspots tend 
to rely on ad-hoc thresholds, such as: (i) searching for recombination rates 
exceeding 5 cM/Mb over 2 kb in one population but yet less than 1 cM/Mb in 
the other population98; (ii) possessing a standardized rate of 10 over a 10kb 
region in one population but less than 3 or 1 in the second population106; (iii) a 
five-fold increase in the mean recombination rate in only one population107;  
or (iv) spanning a genetic distance of more than 0.01cM within a physical 
distance of less than 100kb in only one population but not the other108. Using 
different definitions can alter the number and positions of the detected 
32 
 
hotspots, and simply querying whether hotspots overlap between populations 
may neglect vital information on the local recombination profile. 
 
1.3 Refractive errors and the aetiology of myopia 
      Refractive errors broadly comprise two types of ocular abnormalities: 
spherical errors and cylindrical errors. Spherical errors include myopia 
(commonly known as nearsightedness) and hyperopia (farsightedness), while 
the condition of cylindrical errors is usually called astigmatism.  
      Myopia, a multifactorial disorder, represents one of the most common 
refractive errors. It is most often associated with subsequent long-term 
pathological outcomes. Myopia is caused by a variety of ocular, optical or 
functional difficulties manifested while visually interacting with the external 
environment109. Environmental factors such as the extent of near work, level 
of educational attainment and amount of outdoor activities have been 
documented to affect myopia development110. On the other hand, compelling 
evidence points to the genetic basis of myopia and more than twenty myopic 
loci have been reported from genome-wide linkage studies, some of which 
show evidence of replication in the independent studies33. In the last five 
years, genome-wide association studies have suggested that several genes are 
associated with myopia, which are currently awaiting further confirmation and 
the assessment of their biological function. 
      In contrast to myopia, very little data is currently available with regard to 
elucidating the aetiology of astigmatism. No environmental factors have been 
recognised to influence the development of astigmatism. Although 
33 
 
astigmatism is a heritable trait, no prior study has reported any genes 
associated with astigmatism. 
  
1.3.1 Types of refractive errors 
1.3.1.1 Myopia, hyperopia and ocular biometrics  
      When light rays are focused in front of the retina, leading to blurred vision 
on far objects, myopia occurs (Figure 2A). Similarly, when light rays are 
focused behind the retina, it is called hyperopia, as the near objects are 
blurred. 
      Myopia poses a considerable public health burden. It is highly prevalent, 
especially in urban areas of East and Southeast Asia, where 80% of children 
completing high school have myopia109. Myopia-associated pathological 
complications could lead to degenerative changes in the retina and the 
choroid, which are not prevented by optical correction. This subsequently 
increases the risk of visual impairment through myopic maculopathy, 
choroidal neovascularisation and retinal detachment111,112.   
      Spherical refractive errors are measured on a continuous dioptric scale, an 
optical power of lens in diopters (D) that is necessary to correct the myopic or 
hyperopic eye, and are generally quantified using the spherical equivalent (SE; 
the algebraic sum of the value of the sphere and half the cylindrical value). 
Various categorisations have been applied when describing different refractive 
states. By convention, an eye presenting with an SE beyond 0.5 D is referred 
to as being hyperopic; a value between -0.5 and 0.5 D is referred to as being 
emmetropic. Myopia is defined of the SE at least -1.00 or -0.50 D, and can be 
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further divided into mild (-3.0 < SE ≤ -0.5), moderate (-6.0 < SE ≤ - 3.0) and 
high myopia (SE ≤ -6.0).  
      The spherical refractive error status is contributed by the underlying ocular 
biometrics: the optical power of the cornea and lens, and the axial length (AL) 
of the eyeball (Figure 2A). AL is composed of the anterior chamber depth 
(ACD), lens thickness and vitreous chamber depth (VCD)113. Particularly, 
myopic subjects are more likely to have a longer axial length. A 1mm increase 
in AL, mainly through the elongation of the vitreous chamber, is equivalent to 
a myopic shift of -2.00 to -3.00 D without corresponding changes in the 
optical power of the cornea and lens. In contrast, the differences in lens 
thickness and corneal curvature (CC) by comparing myopic to emmetropic 
subjects are minimal114. Therefore, the control of the AL and excessive 
elongation of the eyes is crucial for achieving normal vision in humans.     
 
 
Figure 2. Cross-sectional view of the human eye structure.  A) myopic eye; B) 
astigmatic eye. 
1.3.1.2 Astigmatism  
      Cylindrical refractive errors commonly refer to astigmatism, where the 









(Figure 2B). While astigmatism comprises corneal and non-corneal 
components, it typically results from the unequal curvature of two principle 
meridians in the anterior surface of the cornea, which is known as corneal 
astigmatism115,116.  
      The presence of a high degree of astigmatism during early development is 
believed to be associated with refractive amblyopia117-119, as evidenced by 
decreased best-corrected visual acuity which cannot be remedied by external 
corrective lenses. Early abnormal visual input caused by uncorrected 
astigmatism can lead to orientation-dependent visual deficits, despite optical 
correction of visual acuity later in life120. In addition, it has been suggested 
that optical blurring by astigmatism may predispose the development of 
myopia121-124. Astigmatism is highly prevalent across most populations, with 
at least 1 in 3 adults above 30 years of age suffering from astigmatism of 0.5 
D or greater125. 
 
1.3.2 Experimental animal myopia models 
1.3.2.1 Deprivation myopia and inducing myopia  
      Deprivation myopia occurs when the eyesight is deprived by limited 
illumination and degraded vision image, e.g. as a result of wearing a diffusing 
goggle (form deprivation myopia), or a negative/positive spectacle lens 
(induced myopia) in front of the eye. Such a phenomenon has been observed 
in a wide range of species including the chicken, fish, tree shrew, rhesus 
monkey, guinea pig and mouse126. A negative lens in front of the eye induces 
hyperopic defocus (image behind the retina photoreceptors) that results in the 
elongation of the eyeball to compensate for the optical effects of the lens. 
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Therefore the eye becomes myopic because of the excessive elongated axial 
length. Analogously, a positive lens causes the image to form in front of the 
retina (myopic defocus) and reduces the ocular growth rate. Nevertheless, 
findings related to its association with hyperopia are less consistent in 
primates as compared to chicks and mice. It is noteworthy to mention that, in 
the animal model, such induced myopia or hyperopia generally shows a 
significant degree of recovery after lens removal127.  
      Myopia induction in animals following alteration of the visual input 
requires the eye or brain to be able to distinguish myopic defocus from 
hyperopic defocus. Although the retina produces biochemical signals which 
control eye growth in response to local defocus, it has become clear that both 
retinal and central elements play roles in the emmetropisation process, with 
the central nervous system exhibiting fine-tuning128. Of particular interest are 
genes that express in the opposite direction in ocular tissues when subjects 
alternately wear negative and positive lenses. The transcription factor ZENK, a 
so-called ‘STOP” sign for myopia, is found expressed differently within 
glucagonergic amacrine cells in myopia- versus hyperopia-induced mouse 
models129. Dopamine has been shown to be involved in the optical regulation 
of eye growth in myopia-induced animal model, while its gene expression is 
also mainly restricted to the amacrine cells in the retina130. Muscarinic 
receptors are known to regulate several important physiologic processes in eye 
growth, and antagonists to these receptors, such as atropine and pirenzepine, 
are effective in stopping the excessive ocular growth that results in myopia131. 
However, the primary mechanism of genes as well as the pathway used by the 
eye to detect the direction of defocus remains unclear.    
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1.3.2.2 Emmetropisation and the role of scleral changes in eye growth 
      The endogenous process in matching axial length to the focal place in the 
eye growth is called emmetropisation. This biological mechanism involves the 
detection of myopic or hyperopic defocus at the retina, signal transmission 
across the retinal pigment epithelium and choroid, and alteration of the scleral 
matrix132. In myopic human eyes, it is speculated that the emmetropisation 
mechanism is defective, with a loss of ability to use myopia defocus to slow 
the growth of the eyes. In this case, eyes will gradually become more myopic. 
This diminished emmetropisation was also observed in an animal study 
showing that wearing positive lens in myopic-induced older tree shrews had 
less of an effect; most of the eyes remained myopic while wearing the lens in 
older tree shrews, which was in contrast to what was found in infant tree 
shrews133.       
      A larger body of evidence shows that the changes in refraction in animal 
models are primarily due to changes in AL, rather than in corneal or lens 
parameters. In the process of AL elongation, scleral remodelling plays a 
pivotal role in eye size regulation, with sclera thinning and changes in 
collagen fibril architecture through the turnover of extra-cellular matrix 
(ECM) materials; this is evident in mammals134.  
1.3.2.3 Peripheral refraction 
      There is a growing interest in understanding the role of peripheral 
refraction in controlling eye growth. The visual optical device implemented in 
the animal model that affects the entire field of view can alter the pattern of 
peripheral refraction as well. Emerging evidence in animal studies suggests 
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that the peripheral retinal signals can dominate axial growth and central 
refractive development when there are conflicting visual signals in the central 
and peripheral retina135. Smith and colleagues found that infant monkeys with 
peripheral form deprivation but intact central vision were significantly less 
hyperopic or more myopic compared to the age-matched controls, suggesting 
that the peripheral retina contributes to emmetropising responses136. A recent 
study in monkeys also showed that foveal ablation by itself did not produce 
alterations in either the central or peripheral refractive errors of treated eyes 
137. However, emmetropisation appears not to be affected by changes in 
peripheral refraction in chicks, possibly due to different patterns in the 
distribution of photoreceptors on the retina in chicks and primates138.  
 
1.3.3 Roles of environmental factors in controlling human refraction 
      Numerous studies support factors such as the level of educational 
attainment, near work and outdoor activities having an effect on myopia onset 
or progression. Evidence has also recently emerged to support a potential role 
of peripheral refractive errors in myopia development. 
      Level of education has been consistently associated with myopia across 
different ethnic groups in a large number of epidemiological studies, where 
higher academic achievements appear to be positively correlated with 
myopia139-141. Education level usually correlates with the time spent on 
reading and writing, so this can be treated as a surrogate of near work. 
      Near work has long been regarded as an important factor for the 
development of myopia. Under the accommodation theory, the eye increases 
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its optical power to maintain a clear visual image when reviewing a near 
object. The active accommodation to a near target is the driver to move the 
retina toward the conjugate point, resulting in axial eye elongation142. In 
humans, clinical evidence has showed that atropine, a potent cycloplegic, 
inhibits myopic progression under the non-accommodative mechanism143. The 
important role of near work may also be implicated from the fact that more 
intensive near work concurs with the increased prevalence of myopia seen in 
the past few decades. In a longitudinal cohort study in school children aged 7 
to 9 years (Singapore cohort study for risk factors of myopia; SCORM), 
students who read more than two books per week were three times more likely 
to have higher myopia compared to those who read less than two books per 
week144. In a population-based sample of 12-year-old Australian 
schoolchildren recruited in the Sydney Myopia Study (SMS), the positive 
association between the time of continuously reading (>30 min)/reading 
distance (<30cm) and myopia was maintained145. It is noteworthy that the 
association between near work and myopia assessed so far is probably not 
very precise, partially because of the inaccuracy of the questionnaire in 
measuring the amount of near work. Although it remains to be elucidated 
whether the total amount of time of near work, or the modifiable reading habit 
(i.e. intensity of reading, reading posture, or proper lighting), is associated 
with myopia, most ophthalmologists recommend taking breaks during periods 
of high-intensity near work to prevent the onset of myopia.  
      A recent study reported that the number of sports and hours of outdoor 
activity, rather than the number of reading hours per week, was significantly 
associated with myopia in children aged 8 to 13 years in the U.S146. Similarly, 
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students in Australia who had performed high levels of outdoor activity were 
found to be more hyperopic than those involved in a low amount of outdoor 
activity147, where the protective effect of outdoor activities appeared to be 
associated with the total time spent outdoors, rather than sports per se. The 
biological basis however remains unclear. The authors postulated that high 
light intensity promotes the retinal transmitter dopamine, which can inhibit 
eye elongation147,148. Recent animal experiments suggested that the bright light 
level could significantly retard the development of form-deprivation 
myopia149. An alternative possibility is the greater depth of three-dimensional 
structures from a large outdoor field, which could impact the patterns of 
defocus on the retina150. 
      Studies in primates have shown that hyperopic defocus in the retinal 
periphery could stimulate foveal myopic progression135. In humans, myopes 
tend to show less myopic off-axis (periphery hyperiopia) because of their 
relatively less oblate ocular shape, while hyperopic eyes tend to show less 
hyperopic off-axis (periphery myopia)151,152. In a longitudinal cohort of about 
1,000 children aged between 6 and 14 years in the Collaborative Longitudinal 
Evaluation of Ethnicity and Refractive Error (CLEERE) study in the U.S., 
children who became myopic were more hyperopic relative peripheral 
refractive errors than emmetropes from 2 years before the onset through to 5 
years after the onset of myopia153. Following 2,043 non-myopic third-grade 
children for five years, Mutti and colleagues recently found that the 
association between hyperopic peripheral defocus and myopia onset was 
inconsistent across different ethnic groups, as the highest risk for myopia was 
noted in Asian children154. Myopia progression was greater per diopter of 
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more hyperopic relative peripheral refractive error, but only by a small amount 
(−0.024 D per year).  
      Other environmental factors such as higher glycaemic index diets, body 
mass index, and early exposure to night lights or depth of the field have also 
been postulated for myopia development155. Collectively, the environmental 
factors account for a small proportion of the variation in myopia156.   
 
1.3.4 Genetic basis of myopia  
      Evidence from family and twin studies has supported a substantial genetic 
component in myopia, astigmatism and underlying ocular parameters156-163. 
The following section mainly highlights the findings for myopia, and relevant 
ocular biometrics. The genetic basis for corneal astigmatism will be addressed 
in Chapter 4.  
      Syndromic myopia refers to the condition where high myopia is one of the 
symptoms of a Mendelian disorder, such as connective tissue disorders 
(Marfan and Sticker syndromes). In the following section, I will focus on 
simple non-syndromic myopia rather than degenerated syndromic myopia. 
1.3.4.1 Familial aggregation and segregation  
      Familial aggregation represents a scenario where relatives with the same 
genes and/or shared environmental factors are more phenotypically similar 
than unrelated individuals. The recurrence risk (λ) refers to the risk of being 
affected given an affected sibling, relative to the risk of being affected in the 
overall population. The study of familial aggregation is a central theme in 
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genetic field in order to evaluate the relevant genetic and environmental 
effects.  
      Ample evidence shows the clustering of myopia within a family. The Old 
Order Amish (OOA) is an isolated population with homogeneous agrarian 
lifestyle, representing an ideal population to investigate the genetic heritability 
and familial aggregation of refractive errors. In 967 siblings in 269 OOA 
families, λs were estimated at 2.36 (95% CI: 1.65-3.19) and 4.52 (95% CI: 
2.27 – 8.38) for mild (SE ≤ -0.5 D) and moderate myopia (SE ≤ -2.5 D), 
respectively164. In 296 siblings in a cohort from the United Kingdom, λs were 
approximately 5 to 20 for high myopia (SE ≤ - 6.0 D), and 1.5 to 3 for 
moderate myopia (-3.0 D ≤ SE ≤ -1.0 D)165. Similarly, in 1,259 nuclear 
families of Tehran, for myopia at threshold of SE at -0.5 D or -2.0 D, λs 
ranged from 2.09 to 3.86 in siblings and 1.82 to 3.81 among parent-offspring 
pairs166. Strong familial aggregation for myopia was also observed in 759 
siblings in 241 families recruited from the Salisbury Eye Evaluation Study in 
Maryland167, where the odds ratios of myopia (SE ≤ -0.5 D) or moderate 
myopia (SE ≤ - 2.0 D) were greater than 2 for an individual having a myopic 
sibling relative to non-myopic sibling. Interestingly, in the Framingham Eye 
Study cohort, the estimated odds ratio of myopia (SE ≤ -1.0 D) was 5 for an 
age difference of 2 years, while it was reduced to half that for an age 
difference of 10 years, showing a pattern of the decrease in the strength of the 
between-sibling association for myopia with increasing between-sibling age 
differences168.       
      Eye size has also been shown to vary in children according to the parental 
history of myopia. A cross-sectional study of 716 schoolchildren (aged 6 to 14 
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years) demonstrated that children with two myopic parents had longer eyes 
and less hyperopic refractive error than children with only one myopic parent 
or no myopic parents169. A one-year follow-up study in 4,468 Hong Kong 
Chinese children aged 5 to 16 years showed more rapid changes in AL growth 
and myopia progression among children with a stronger parental history of 
myopia170. In SCORM, parental myopia was significantly associated with the 
3 year change in AL after adjustment for school, age, sex, race, and reading in 
books per week114. As a contrast, in a longitudinal cohort of the Beaver Dam 
Eye study, although strong familial aggregation was evident for a sibling to be 
myopic (λ = 4.18), no statistically significant correlation between siblings in 
changes of refraction, cylinder power or astigmatism were seen171.    
      Based on the evidence illustrated from familial aggregation studies, 
segregation analysis has been further adopted to elucidate the inheritance 
mode for myopia: a single gene of a large effect (monogenetic) versus 
multiple genes of small or modest effects (polygenetic). Through the complex 
segregation analysis, a study conducted in nuclear families of both Japanese 
and European ancestries has failed to support the influence of a single major 
gene on refraction172. Furthermore, Klein and colleagues showed that the 
heritance mode of refection was polygenic, rather than showing single–gene 
Mendelian inheritance, in 620 extended pedigrees of 2138 Caucasians from 
the Beaver Dam Eye Study40.   
1.3.4.2 Estimates of heritability 
       Heritability is the proportion of phenotypic variation that is attributable to 
genetic variation among subjects. Both twin studies and families data are 
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utilised to estimate the heritability of the trait of interest. In the simplest 
scenario, twin studies examine whether the identical monozygotic (MZ) twins 
raised together are more similar to each other for a given phenotype than 
dizygotic (DZ) twins, who share half of their genes. The correlation between 
MZ twins is expected to be twice that of DZ twins under the assumption of 
additive genetic effects. The heritability (h2) is thus approximately twice of the 
difference in the correlation of MZ and DZ twin pairs: 
                              h2 = 2(rMZ – rDZ) where r = inter-pair correlation  
      Since the similarity of the phenotype for MZ twins in contrast to DZ twins 
could also be due to shared environment factors, the underlying Equal 
Environment Assumption (EEA) in the heritability estimation for MZ and DZ 
twin is assumed to hold in the heritability studies. 
      Family studies are also adopted to estimate heritability in a more 
complicated familial relationship. Provided the genetic covariance between 
individuals of differing degree of relatedness, the Structure Equation 
Modelling (SEM) method is widely used in the heritability estimation for twin 
and family data, by solving a series of linear equations simultaneously and 
permitting the joint estimation of the parameters.   
      The heritability estimate was 61% (95% CI: 34% - 88%) for ocular 
refractive error (SE) in 759 siblings of 241 families residing in Maryland167. 
Similarly, the estimation was 69% (95% CI: 58%–85%) in the OOA 
population164,173. Twin studies have yielded higher heritability for refractive 
errors, with 83% (95% CI: 77% - 87%) for 90 MZ and 86 DZ female twins in 
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Finland, and 85% in 226 MZ and 280 DZ twin pairs aged 49 to 79 years from 
the United Kingdom using a model with additive genetic and environmental 
components157. Recently, a large twin study comprising of 1,152 MZ and 
1,149 DZ twin pairs yielded similar results (heritability for SE =0.77; 95% CI: 
0.68-0.84)162. However, interpreting results from twin studies should be 
performed with caution. The heritability calculation might be overestimated as 
the excess correlation in MZ twins compared to DZ twins might be also due 
the larger shared environmental exposure within MZ twins.   
      Ample evidence supports an underlying genetic basis, not only for 
refractive error but also for underlying ocular dimensions. The majority of 
heritability estimates for ocular parameters are found to be greater than 0.5. 
For instance, in 2,375 participants in a population-based family cohort from 
the Beaver Dam Eye Study, Klein and colleagues reported that the adjusted 
heritability estimates were 0.58 ± 0.13 for SE, 0.67 ± 0.14 for AL, 0.78 ± 0.14 
for ACD, and 0.95 ± 0.11 for CC159. In 723 participants from 132 pedigrees in 
Australia in the Gene in Myopia (GEM) family study, similar adjusted 
heritability estimates were reported for SE at 0.50 ± 0.05, 0.73 ± 0.04 for AL, 
0.78 ± 0.04 for ACD, and 0.16 ± 0.06 for CC156. In 345 MZ and 267 DZ twin 
pairs between the ages of 18 and 88 years in Austria, the heritability was 
estimated in the men and women separately. The heritability values were 
found 0.88 and 0.75 in the men and woman for SE, 0.94 and 0.92 for AL, and 
0.51 and 0.78 for ACD, respectively158. For a comprehensive review on the 




1.3.5 Genetic loci associated with or linked to refractive errors 
      Genetic variants that predispose an individual to an increased risk of 
developing myopia have been studied for several decades. The majority of 
near-sighted individuals develop juvenile onset myopia (or school myopia), 
with a peak incidence between 10 and 16 years of age33. A more severe form 
of pathological myopia is contrasted with juvenile-onset myopia by its earlier 
age of onset, the greater amount of myopia (≤ -6.0 D), and a higher frequency 
of fundus abnormalities. As a result, the following questions may arise: what 
are the genetic variants involved in various level of myopia?  Are the genetic 
factors for pathologic myopia (or early-onset myopia) similar to those for 
common and moderate myopia (juvenile-onset myopia)?  
 
1.3.5.1 Myopic loci identified from genome-wide linkage studies 
      More than 20 putative myopia loci have been implicated in the last two 
decades through genome-wide linkage studies (Table 2). Typically, most 
studies utilised families with a history of high myopia, and a severe form of 
myopia usually defined as SE ≤  -6.00 D; as a result, a number of genetic loci 
have been reported to link to high myopia. The list includes genetic loci on 
chromosome 2p37.1175, 4p22-q27176, 5p15.33-15.2177, 5p15.1-13.1178, 7p15179, 
7p36180, 10q21.1181, 12q21-23182, 14q22.1 – 14q24.2183, 17q21-22184, 
18p11.31185, Xq23-27.2186 and Xq28187. Of these implicated loci predisposed 
to high myopia, several loci have been replicated in independent samples. For 
instance, chromosome 7p15 (MYP17) and 7p36 (MYP4) were subsequently 
replicated for quantitative refraction in American pedigrees188. The 
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chromosomal locus 12q21-23 (MYP3) was found to associate with high 
myopia in an independent Caucasian samples from Europe189. The genetic 
locus 18p11.31 (MYP2) identified from Chinese and American multi-
generation families showed significant association in 15 Chinese families190. 
Further sequencing of these linkage peaks within MYP2, however, failed to 
establish any genes involved in myopia development in the Caucasian 
population191. A locus on chromosome Xq23-27.2 (MYP13) was replicated in 
an independent Chinese family study192, adjacent to MYP1 (Xq28). Although 
a few genetic regions, i.e. loci at 7p15 (MYP17) and 7p36 (MYP4), have 
shown association to quantitative refraction in replication studies, others, 
including 18p (MYP2) and 12q (MYP3), do not appear to play a similar role 
in moderate or mild myopia193,194.  
      A study on a milder form of myopia as affected samples defined as SE ≤ -
1.00 D pointed to a myopia locus to chromosome 22q12 (MYP6) in a large 
sample set of Ashkenazi Jewish individuals195. MYP6 was replicated in two 
studies using either the same definition for myopia196 or quantitative trait of 
refraction197.  
      A few genome-wide linkage studies have been conducted for quantitative 
refraction. The implicated genetic regions pinpointed to chromosome loci 
3q26, 4q12, 8p23 and 11p13 in 221 dizygotic twins39 and 1p36 in 49 
multigenerational Ashkenazi Jewish families198. Hammon and colleagues 
identified the strongest linkage signal on chromosome 11p13 (MYP7), which 
contains the biologically relevant candidate paired box gene 6 (PAX6)39. 
Chromosome 8p23 (MYP10) was further replicated in an OOA population for 
mild myopia199. 3q26 (MYP8) was also mapped to quantitative refraction and 
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hyperopia via a linkage scan188. Wojciechowski and colleagues performed a 
genome-wide linkage meta-analysis for refractive error in pooled samples of 
Caucasians, OOAs, African Americans and Ashkenazi Jewish subjects, but 
chromosome 1q36 (MYP14) showed no significant association200. In an 
international collaborative effort combining 254 pedigrees of Caucasian 
families for quantitative refraction, the MYP14 genetic locus was replicated 
with multipoint linkage scores above 1.5201. 
      Although twenty regions in the human genome susceptible to refractive 
error and myopia have been implicated, no myopia genes have been 
consistently identified from these regions by fine-mapping or deep-
sequencing. In addition, it is still an open question whether there is any 
overlap between genes that might be responsible for both the rarer forms of 
high myopia and the more common, less severe juvenile-onset myopia. This 
scenario reflects the complexity in the disease architecture of myopia 
pathogenesis.  
      AL is the most important endophenotype of myopia. Presently there have 
been only two genome-wide linkage studies performed in European descent 
populations that suggested the presence of AL quantitative trait loci (QTLs) on 
chromosomes 2p24202 and 5q (at 98 centimorgans) along with two classical 
genetic loci (MYP3 at 12q21 and MYP9 at 4q12)203, but there are no reports 












Affected status  AAO 
(yrs) 
LOD Ref 
1p36 MYP14 Ashkenazi 
Jewish 
QTL SE ≤ -1.00; 
mean SE -3.46  
na 9.54 198 
  Caucasian QTL mean SE −5.74  na 1.5 201 
2q37.1 MYP12 Caucasian AD SE ≤ -7.25; mean 
SE -14.46 
<12 4.75 175 
3q26 MYP8 English QTL mean SE < 0  
[-12.12, 7.25] 
na 3.7 39 
  English AD mean SE -0.55 na  204 
  American  QTL  Mean SE  0.44  
[-12.12, 8.38] 
na P=5.34×10-4 188 
3q28  MYP 
unknown 
Caucasian AD SE ≤ -5.00 
 [-5,-18] 
na 11.5 205 
4q12 MYP9 UK QTL mean SE < 0 
 [-12.12, 7.25] 
na 3.3 39 
4p22 - q27 MYP11 Han Chinese  AD SE [-5 ,-20] <6 3.11 176 
5p15.33 -p15.2 MYP16 Han Chinese AD SE ≤ -6.00  
Mean SE -11.59 
na 4.81 177 
5p15.1 -p13.3 MYP19 Han Chinese AD SE ≤ -6.00 & AL 
>26  
<12 3.02 178 
7p15 MYP17 French and 
Algerian 
AD SE ≤ -6.00  na 4.07 179 
  African 
American 
QTL SE: 2.87 ± 3.58 na 5.87 38 
  American  QTL Mean SE: 0.44  
[-12.12, 8.38] 
na P=9.43 ×10-4 188 
7q36 MYP4 French and 
Algerian 
AD SE ≤ -6.00 na 2.81 180 
  American QTL Mean SE:0.44  
[-12.12 , 8.38] 
na P=2.32 ×10-3 188 
8p23 MYP10 UK QTL -12.12 ≤ SE ≤  
7.25 
na 4.1 39 
  Old Order 
Amish 
AD SE ≤ -1.00  na 2.03 199 
10q21.1 MYP15 Caucasian AD SE ≤ -6.00 na 3.22 181 
11p13 MYP7 UK QTL SE [-12.12, 7.25] na 6.1 39 
  Ashkenazi 
Jewish 
AD SE ≤ -1.00 na >2 206 
12q21-23 MYP3 German/Italian AD SE ≤ -6.00 5.9 3.85 182 
  UK AD SE ≤ -6.00 na 2.54 189 
14q22.1- q24.2 MYP18 Chinese AR SE ≤ -6.00 na 2.19 183 
17q21-22 MYP5 English/Canadi
an 
AD SE ≤ -6.00, mean 
SE -13.95 
8.9 3.17 184 
18p11.31 MYP2 American &  
Chinese 
AD SE ≤ -6.00 6.8 9.59 185 
  Hong Kong 
Chinese 
 SE ≤ -6.00 na 2.1 207 
22q12 MYP6 American 
families of 
Jewish descent 
AD SE ≤ -1.00 na 3.54 195 
  Jewish descent AD SE ≤ -1.00 na 4.73 196 
  American  QTL Mean SE 0.44  
[-12.12 , 8.38] 
na P=0.0033 188,1
97 
Xq23 - 25 MYP13 Han Chinese XR SE ≤ -6.00 <6 2.75 186 
Xq23 – 27.2  Han Chinese XR SE ≤ -6.00 na 2.79   192 
Xq28 MYP1 Danish  XR SE ≤ -6.00   1.5-5 4.8   187 
  Asian Indian  XR SE ≤ -6.00    na 5.3   208 
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SE – spherical equivalent in diopters; AL – axial length in mm; LOD-logarithm of 
odds;  AAO – age at onset of myopia;  na- not available. 
 
1.3.5.2 Candidate gene studies 
      A number of candidate genes have been queried in genetic studies of 
refractive errors based on their potential biological function, differential gene 
expression in animal models, or until recently, their physical locations residing 
in known myopia loci identified from the linkage studies or genome-wide 
association studies. Table 3 summarises the candidate genes studied for 
myopia at the time of writing this thesis.   
      Sclera thinning is an important process involved in the development of 
myopia. 90% of the human sclera is composed of ECM collagen fibrils. The 
mutation in collagen genes causes autosomal dominant syndromes, such as 
osteogenesis imperfecta, Ehlers-Danlos syndrome (collage, type 1, COL1A1) 
and Stickler’s syndrome (collagen, type 2, COL2A1). A positive association 
with COL1A1 was observed, but only in a Japanese study209. In contrast, two 
studies supported the role of COL2A1 in the pathogenesis of myopia in 123 
nuclear families of mixed ethnicities (62% Caucasian)210 and in a Duke-
Cardiff cohort totalling 276 families of Caucasians211. The SNP identified in 
these two cohorts was rs1635529. However, the assessment of rs1635529 or 
other investigated SNPs in COL2A1 for high myopia has failed to show 
significance in the Chinese population212,213.   
      The structural organisation of the ECM also largely depends on the 
cellular activity of fibroblasts, which is partially regulated by members of a 
major family of zinc- and calcium-dependent endopeptidases: the matrix 
metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases 
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(TIMP)214. In a family-based study, Wojciechowski and colleagues found 
positive associations for rs1939008 (MMP1) and rs9928731 (MMP2) with 
quantitative refraction in OOA families, but not Ashkenazi Jewish (ASHK) 
families215. The authors speculated that strong environmental exposure may 
mask the effect in ASHK society where much a more rigorous schooling 
system was implemented. Significant association of MMP3 and MMP9 for 
low myopia in the Caucasian population has also been observed216. However, 
MMP isoforms 1, 2 and 3 do not appear to play critical roles in the 
development of high myopia in the Japanese population217. The MMP3 and 
TIMP1 genes also showed no significant association for high myopia in 
Taiwanese men218. 
      Hepatocyte growth factor (HGF) and its receptor, cMET, which modulates 
the MMP and TIMP pathways, have been proposed to play an active role in 
the scleral remodelling. The association of rs373350 in HGF with myopia was 
first reported in 128 families with severe myopic sibs defined as SE ≤ -10.0 
D219. For the Caucasian population, the same SNP was found to be associated 
with HGF in 146 multiplex Caucasian families for moderate myopia220, but a 
different set of SNPs within HGF showed significant association221. The 
association of cMET with high myopia was noted in school children in 
Singapore (Khor, et al., 2009), but these findings need further assessment in 
other studies.   
      Transforming growth factor-β (TGF-β) is known to initiate myofibroblast 
formation and fibrosis as well as the production of collagen222. Although five 
members of the TGF-β family have currently been identified, only TGF-β 
isoforms 1, 2, and 3 are detected in eyes, and TGF-β2 is the predominant 
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form. The mRNA levels of TGF-β are significantly reduced in retina, choroid 
and sclera in correlation with axial elongation of myopia (Liu et al., 1996). 
The activation of TGFB1 expression in ocular tissues mediated by 
transcription factor EGR1 (early growth response type 1 gene) is thought to 
influence ocular elongation. The SNP rs1800470 in TGFB1, which is 
associated with high myopia, was first reported in Taiwanese individuals (201 
cases and 86 controls)223. Another SNP (rs4803455) in TGFB1 also showed a 
significant association with high myopia in two Chinese studies224,225. With 
regard to TGFB2, emerging evidence suggests its role in the development of 
myopia, as rs7550232 in the promoter region in TGFβ2 was implicated with 
high myopia226. 
      Insulin-like growth factor 1 (IGF-1) lies within the MYP3 loci and plays 
an important role in cell proliferation, differentiation and apoptosis. It has 
been speculated that high-glycaemic load carbohydrate diets may contribute to 
the development and progression of myopia, perhaps by affecting sensitivity 
to insulin or increasing free-circulating IGF-1 levels227. The role of the IGF-1 
gene in association with human myopia was first examined in 265 multiplex 
families with 1,391 Caucasians, revealing significant associations between 
SNP rs6214 with both high and mild myopia228. The association of IGF1 gene 
with myopia was replicated in several Chinese populations229,230.   
      Trabecular-meshwork-inducible glucocorticoid response (TIGR) gene 
encodes myocillin (MYOC). The expression of MYOC in the trabecular 
meshwork is affected by TGFB and mechanical stretching. In addition, the 
ECM components comprise small leucine-rich proteins/proteoglycans 
(SLRPs) to regulate collagen fibril diameter, including lumican (LUM), 
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fibromodulin (FMOD), prolargin (PRELP) and opticin (OPTC)231. Given their 
roles in ECM assembly and expression in the eye, these candidates are likely 
to regulate the shape and size of eyes. However, there has been no data so far 
to support the roles of TIGR, MYOC and SLRPs in myopia development. 
      In addition to the growth factors and extracellular matrix components, a 
‘major’ gene controlling the activity of many ‘myopia genes’ is also proposed 
to be involved in eye growth. For example, paired box (PAX) genes encode 
tissue-specific transcription factors and, among those, the PAX6 gene is 
involved in oculogenesis and ocular growth. The correct dosage of PAX6 is 
crucial for normal eye development: over-expression of Pax6 in mice results 
in microphthalmia, retinal dysplasia and defective retinal ganglion cell axon 
guidance232. Interestingly, despite a lack of evidence in the Caucasian 
population, three positive association studies in Chinese individuals suggest 





Table 3 Candidate genes studied for myopia. 
Chr Gene Ref Phenotype Study population (sample 
sizes) 
Chosen criteria Significant 
SNPs 
1 FMOD 226 High myopia Chinese  
(195 cases, 94 controls) 
ECM  ns (rs7543418) 
1 TGFB2  226 High myopia Chinese  
(195 cases, 94 controls) 




235 High myopia Chinese  
(70 cases, 69 controls) 
MYP2 ns 
  236 High myopia Chinese  
(162 families) 
 rs235858,  
rs2421853 
  237 High myopia Caucasian  
(164  Cardiff and 87 Duke 
families ) 
 ns 
3 SOX2 238 Low/moderate Caucasian  
(n=596) 
Eye growth ns 
3 LEPREL1 205 High myopia Caucasian  
( a pedigree) 
Linkage study c.1523 G>F 
4 FGF2 210 Low/moderate 
myopia 
American  





  226 High myopia Chinese  
(195 cases, 94 controls) 
 ns(rs308395, 
rs41348645) 
  239 High myopia Chinese  
(1064 cases, 1001 controls) 
 ns 
5 CTNND2 240 High myopia Chinese  
(287 cases, 673 controls) 
MYP16/ GWAS rs6885224  
7 cMET 220 All Caucasian  
(146 multiplex families) 
ECM ns 
  241 Moderate 
myopia  
Chinese  (n=650)  rs2073560 
  242 Low/moderate, 
hypermetropric 
Caucasian (n=818 )  ns 
7 HGF 219 High myopia 
(SE ≤ -10.0 ) 
Han Chinese  
(128 families) 
ECM rs3735520 
  243 High myopia Chinese  
(288 cases, 208 controls) 
 ns 
  220 All Caucasian  
(146 multiplex families) 
 rs3735520  
rs2286194  
 






  244 VCD Chinese (n=814)  rs3735520 
11 BDNF 210 Low/moderate 
myopia 
American  
(62% Caucasian, 123 
families) 
Function  ns 
11 CHRM1 245 High myopia Chinese  




11 MMP1 216 Low myopia 






  215 SPH (spherical 
component of 
refraction) 




  217 High myopia 
(SE ≤ -6.0 & AL 
≥ 26) 
Japanese  
(case 725, controls 546) 
 ns 
11 MMP3 218 High myopia  Taiwanese  




  216 Low myopia 
(SE ≤ -1.0)  
Caucasian (n=366)   -1612 5A/6A 
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  217 High myopia 
(SE ≤ -6.0 & AL 
≥ 26) 
Japanese  
(case 725, controls 546) 
 ns 
11 PAX6 39 Low/moderate 
myopia 
UK (221 dizygotic twin) MYP7 ns 
  210 Low myopia 
(SE ≤ -0.75) 
American  
(62% Caucasian, 123 
families) 
 ns 
  238 Low/moderate 
myopia 
Caucasian (n=596)  ns 
  233 High myopia  Chinese 
 (188 cases, 85 controls) 
 rs667773  
  234 High myopia  Chinese (164 families with 
170 highly myopic offspring) 
 rs3026393 
  232 High myopia ( 
SE ≤ -8.0) 
Chinese  





12 COL2A1 210 Low myopia 
(SE ≤ -0.75) 
USA  
(62% Caucasian, 123 
families) 
ECM rs1635529 
  211 High myopia 
(SE ≤ -5.0) 
English/Welsh  








  212 High myopia  Chinese  
(697 cases, 762 controls) 
 ns  
  213 High myopia Chinese  
(581 cases, 384 controls) 
 ns  
12 DCN 246 High myopia Taiwanese   
(120 cases, 137 controls) 
ECM ns 
  247 High myopia Taiwanese  
 (120 cases, 137 controls) 
 ns 
12 DSPG3 247 High myopia Taiwanese   
(120 cases, 137 controls) 
 ns 
12 LUM 246 High myopia Taiwanese   
(120 cases, 137 controls) 
ECM rs3759223 
  243 High myopia  Chinese  
(288 cases and 208 controls) 
 ns 
  248 High myopia English and  Finnish  
(125 cases, 308 controls) 
 n/a 
  249 High myopia Chinese  
( 201 cases, 86 controls) 
 c1567 
  247 High myopia Taiwanese  
 (120 cases, 137 controls) 
 rs3759223, 
rs3741834 




  250 High myopia Polish (42 multiplex families)  ns 
  230 High myopia Chinese  
(421 cases, 401 controls) 
 rs12423791 
  244 Lens thickness Chinese (n=814)  rs6214 
  229 High myopia Chinese  





15 GJD2 251 High myopia Japanese  
(1125 cases, 929 controls) 
GWAS r634990,  rs524952 
  244 Ocular 
biometrics 
Chinese (n=814)  ns 
15 RASGRF1  252 High myopia Chinese  




  251 High myopia Japanese  
(1125 cases, 929 controls) 
 rs8027441 





 ASHK (n=535) 
  217 High myopia 
(SE ≤ -6.0 &AL 
>=26) 
Japanese  
(case 725, controls 546) 
 ns  
17 COL1A1 253 High myopia Taiwanese  
(471 cases, 623 controls) 
MYP5 ns 
  209 High myopia 
(SE ≤ -9.25) 
Japanese  
(330 cases, 330 controls) 
 rs2075555,  
rs2269336 
  254 High myopia 
(SE ≤ -6.0 and 
AL ≥ 26) 
Japanese  
(427 cases, 420 controls) 
 ns  
  211 High myopia 
(SE ≤ -5.0) 
English/Welsh (146 Duke and 
130 Cardiff families) 
 ns 
  212 High myopia 
(SE ≤ -6.0 and 
AL ≥ 26) 
Chinese  
(697 cases, 762 controls)  
 ns  
17 RARA 255 Low/moderate, 
hyperopic 
Caucasian (n=802) Gene expression ns 
18 TGIF 190 High myopia Chinese  
(71 cases, 105 controls) 
MYP2  657 (T - > G) 
  256 High myopia Caucasian  (n=21, 
sequencing) 
 ns 
  257 High myopia 
(SE ≤ -9.0) 
Japanese  
(330 cases, 330 controls) 
 ns 




(257 cases, 294 controls) 
 rs8082866, 
rs2020436 
ns after multiple 
testing 
  243 High myopia Chinese  
(288 cases, 208 controls) 
 ns   
19 TGFB1 223 High myopia  Taiwanese 




  259 High myopia 
(SE ≤ -9.25 ) 
Japanese  
(300 cases, 300 controls) 
 ns 
  243 High myopia Chinese  
(288 cases, 208 controls) 
 ns 
  224 High myopia 
(SE ≤ -10.0) 
Chinese 




  225 High myopia Singapore Chinese  rs4803455 
20 BMP2 260 High myopia Chinese (201 cases, 86 
controls) 
Gene expression rs2288255 
20 MMP9 216 Low myopia 
(SE ≤ -1.0)  
Caucasian (n=366) ECM/ Gene 
expression 
Exon 6 
(Arg- > Gln) 
21 COL18A1 210 Low myopia 
(SE ≤ -0.75) 
American 
 (62% Caucasian, 123 
families) 
Function ns 
21 UMODL1 261 High myopia Japanese 
 (520 cases, 520 controls) 
Linkage study rs2839471 
23 TIMP1 218 High myopia Taiwanese  
(216 cases, 474 controls) 
Gene expression  
SE – Spherical equivalent in diopters;  AL – Axial length in mm; VCD -  Vitreous chamber 
depth; ns - not significant; ECM – Extracellular matrix;  High myopia is defined as SE ≤ -6.0 
D unless otherwise indicated in the parentheses. Controls are non-myopic controls.   
BDNF - brain-derived neurotrophic factor; BMP2 –bone morphogenetic protein 2; COL18A1-
collagen, type XVIII, alpha 1; COL2A1 – collagen, type II, alpha 1;  COL1A1 – collagen, type 
1, alpha 1; CTNND2 – catenin (cadherin – associated protein); cMET – growth factor receptor 
c-met; DCN – decorin; DSPG3 - dermatan sulfate proteoglycan 3; FMOD - fibromodulin ; 
FGF2 - fibroblast growth factor 2; FMOD – fibromodulin; GJD2 – gap junction protein, delta 
2; HGF - hepatocyte growth factor; IGF1 – Insulin-like Growth factor-1; LEPREL1 – 
leprecan-like 1; LUM – Lumican;  MMP-matrix metallopeptidase;  PAX6 –paired box gene 6; 
RASGRF1 – RAS protein-specific guanine nucleotide –releasing factor 1. RARA – retinoic 
acid receptor, alpha;  SOX2 – sex determining region Y –box 2;  TIGR/MYOC – myocilin; 
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TGFB1 - transforming growth factor-beta1; TGIF - Transforming growth beta-induced factor; 
TGFB2 - transforming growth factor-beta2;  TIMP1 – tissue inhibitor of metalloproteinase 
metallopeptidase inhibitor 1; UMODL1 – uromodulin –like 1.  
 
1.3.5.3 Genome-wide association studies 
      In the past several years, with the advent of cheap and high-density array-
based DNA marker technologies, genome-wide scale assessments of the 
genetic effect for each typed marker have become common practice87,88. 
GWAS have transformed population-based epidemiology studies into 
repertoires for further genetic exploration. The ophthalmology genetic 
community has started to benefit from the convergence of population-based 
epidemiological studies and genetic assays to identify genes involved in 
susceptibility to eye disorders, including refractive errors17-21,23,34,35,73,262. 
Table 4 lists the recent GWAS findings for refractive errors or myopia and the 
subsequent replication results.  
     Two companion GWAS pinpointed genetic susceptibility variants for 
quantitative refraction at 15q1434 and 15q2535 in Caucasian populations. A 
locus in the region 15q14 was further successfully replicated for SE in a large-
scale meta-analysis study composed of 42,848 Caucasians and 12,332 
Asians263 and in a Japanese cohort for high myopia251, whereas the association 
at the 15q25 region was mixed in the pooled data. For chromosome loci 
15q14, the implicated polymorphisms are in a putative regulatory region near 
the genes GJD2 and ACTC1. GJD2 encodes a neuron-specific protein 
(connexin36) in retinal photoreceptors, amacrine and bipolar cells, implying 
an important modulator of retinal signal transmission. ACTC1 encodes the 42-
kDa alpha cardiac muscle actin 1, with the function in eyes being largely 
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unknown. The gene closest to chromosome 15q25 is RASGRF1, which is 
highly expressed in human retina and known to be functionally involved in 
eye development. RASGRF1 is regulated by muscarinic receptor and retinoic 
acid, both of which are postulated in the biological mechanisms for refractive 
controls.  
      In a meta-analysis of two GWAS in Chinese adults and children, our group 
identified that minor allele of rs6885224 in CTNND2 at chromosome 5 was 
associated with an elevated risk of high myopia (Pmeta = 7.84 × 10-6) 22. 
CTNND2 is known to play a crucial role in retinal morphogenesis, adhesion, 
and retinal cell architectural integrity via the regulation of adhesion molecules. 
Interestingly, the most prominent SNP rs6885224 was subsequently found to 
be associated with high myopia (n=1203) and moderate myopia (n=615) 
versus emmetropia (n=955) in an independent Chinese sample set, but with a 
protective effect for the same minor allele240. 
      Nakanishi and colleagues reported the first GWAS for pathological 
myopia (defined as AL ≥ 26mm on both eyes) and detected a novel 
susceptibility locus at chromosome 11q24.1 in a Japanese cohort23. The 
adjacent BLID gene discovered in this study along with the gene PSARL 
identified from another genome-wide linkage study204 are both involved in 
mitochondrial apoptosis. However, the association with BLID was not 
replicated in 1,818 high myopia cases (SE ≤ -10.0 D) and 1,052 controls in the 
Chinese population264.  
      In a case-control data comprising 500 high myopia cases (SE ≤ -6.0 D and 
AL ≥ 26 mm on either eye) and 500 emmetropic controls in South China, Shi 
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and colleagues reported a strong association for high myopia at gene MIPEP 
on chromosome 13q12.12 in a GWAS, which encodes proteins targeting to the 
mitochondrial matrix, suggesting a potential novel pathway leading to 
myopia265. The associated gene MIPEP for high myopia was also noted in our 
GWAS data (p < 0.05). Using a much smaller sample size for high myopia, Li 
and colleagues identified chromosome locus 4q25 associated with high 
myopia across older Chinese and much younger cohorts266.    
Table 4 Genetic loci identified from genome-wide association studies 
Locus (gene) Ethnics Most significant SNP Phenotype Sample size Ref 
11q24.1 (BLID) Japanese rs577948 High myopia 830/934 23 
 Chinese ns(rs577948,rs11218544, 
rs2839471) 
High myopia  




European rs634990 SE 15,608 34 
15q25 
(RASGRF1) 
European rs8027411 SE 17,685 35 
 Japanese 15q14: rs634990,rs524952 
15q25: rs8027411,rs17175798  
High myopia 1125/366 (929) 251 
 Chinese ns (GJD2) Ocular biometrics  244 
5q15 (CTNND2) Chinese rs6885224  High myopia 1,246/2,584 22 




4q25 (intergenic) Chinese rs10034228 High myopia 2,993/10,406 266 
 Chinese rs10034228/rs2218817/ 
rs1585471/rs6837348 
High myopia 1,052/1255 252 
13q12.12(MIPEP) Chinese rs9318086 High myopia 3,222/6,341 265 
SE – Spherical equivalent; high myopia is defined as either SE ≤ -6.0 D or axial 
length ≥ 26 mm, unless otherwise specified 
 
      The first genome-wide exome sequencing study is worthy of note. Shi and 
colleagues identified the association of zinc finger protein 644 isoform 
1 (ZNF644) sequence variants with susceptibility to high myopia in two 
affected individuals in a large Han Chinese family and the findings were 
confirmed in 600 Chinese adults of high myopia cases (both SE < -6.0 D) 
and 600 normal controls267. In a multi-ethnic case-control study, primarily 
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comprised of Caucasians, the rare variants in ZNF644 screened by deep-
sequencing were also observed to be significantly enriched in 131 high 
myopia cases compared to 672 controls268. ZNF644 belongs to the C2H2-type 
zinc-finger protein family, which contains seven C2H2-type zinc fingers and 
is predicted to be a transcription factor in gene expression regulation in the 
retina and retinal pigment epithelium (RPE). 
      The sequence variants identified thus far from standard GWAS approaches 
exhibit very modest effect sizes on myopia risk (per-allele odds ratio ≤ 1.5). 
This observation reflects the complexity in the disease architecture of myopia 
pathogenesis. The implicated genes for myopia identified through candidate 
gene studies, GWAS or exome sequencing fall into three categories as shown 
in Figure 3: 1) The majority are known to be involved in the process of sclera 
remodelling, for example COL2A1, COL2A2, HGF, TGFB1, TGFB2 etc.; 2) 
Photoreceptor-related genes, like GJD2 for retinal signal transmission on 
RPE; and 3) Genes hypothesised to regulate the ‘myopia important genes’ at 
the transcriptional level, such as ZNF644. Interestingly, none of the genes 
involved in sclera remodelling in the ECM pathway (Category 1) reached 




Figure 3. The implicated genes likely to be involved in the visual signal 
transmission and scleral remodeling.  
COL2A1 – collagen, type II, alpha 1;  COL1A1 – collagen, type 1, alpha 1; CTNND2 
– catenin (cadherin – associated protein);  cMET – growth factor receptor c-met; 
GJD2 – gap junction protein, delta 2; HGF - hepatocyte growth factor; IGF1 – 
Insulin-like Growth factor-1;  LUM – Lumican;  MMP-matrix metallopeptidase;  
PAX6 –paired box gene 6; RASGRF1 – RAS protein-specific guanine nucleotide –
releasing factor 1.  TGFB - transforming growth factor-beta 1; TGIF - Transforming 
growth beta-induced factor; TGFB2 - transforming growth factor-beta2; UMODL1 – 
uromodulin –like 1; ZNF644 – zinc finger protein 644 isoform 1.  
 
1.3.6 Intervention to slow myopia progression 
      Different aetiological factors have been proposed for myopia onset and 
progression, such as anomalous accommodative activity and defocus of the 
retinal image. Depending on the implicated mechanism, different clinical 
approaches have been developed. The effectiveness of current strategies to 
control the progression of myopia in children has been reviewed 
extensively269,270.  
      Using single vision lenses (SVLs) is the most common routine to correct 
vision, although it does not retard the progression of myopia. Myopic 
individuals exhibit a greater accommodative lag (poor focusing accuracy 
while looking at near work) than emmetropes. Accommodative lag results in 
Neurotransmission in the retina : GJD2, RASGRF1
Scleral remodeling: COL2A1, COL1A1, HGF, cMET, 
MMP1, MMP2, MMP3, MMP9, MMP13, LUM, PAX6, TGFB1, 




Signaling cascade  Regulate transcription levels: ZNF644, PAX6





light being focused behind the retina during near work, which may stimulate 
the eye growth progressively after myopia onset. It is thus proposed that the 
reduction in accommodative lag (or load) in reviewing a near object with 
bifocal or multifocal spectacles should reduce myopic progression in already 
myopic children. In the Correction of Myopia Evaluation Trial (COMET), 
however, children wearing progression additional lenses (PALS) were found 
to have a small slowing of myopia progression compared to those wearing 
SVLs, with negligible clinical significance271. Similar findings were noted in 
several other trails as systematically reviewed by Walline and colleagues269. 
Interestingly, a subset of myopic children - for example, esophores at near 
with high accommodative lag - showed a larger treatment effect142, suggesting 
that accommodation lag may be a potential indicator for some individuals who 
could actually benefit from the treatment.  
      The uncorrected myopia decreases the need for accurate accommodation 
and poses the question of whether myopia progression can be reduced by 
diminishing accommodation by reading without spectacles or wearing under-
corrected spectacles. In a three-year perspective study in myopic school 
children aged 9 to 11 years, the myopia progression was not correlated with 
full-time spectacle wearing, limited-time wearing for distance vision only or 
bifocal lenses272. The most interesting finding in this study, however, was that 
the shorter the average reading distance in the follow-up time, the faster the 
myopic progression was. In a randomised trial, Chung and colleagues found 
that the myopic progression was significantly accelerated in the under-
corrected myopic children as compared to the full-time fully corrected group, 
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suggesting that the presence of blurred vision at any distance may stimulate 
the progression of myopia regardless of the sign of defocus in the susceptible 
eyes273. However, the findings have been criticised for not accounting for 
‘running period’ at the onset of experiment. 
      One treatment modality is the use of overnight rigid gas permeable (RGP) 
contact lens to reshape the corneal surface. It has been shown that RGP lenses 
effectively reduce the degree of hyperopic field curvature in myopic eyes274. 
Experimental studies support the concept that the peripheral hyperopic 
defocus promotes axial myopia135. It has been shown that the rigid contact lens 
corrected not only the central refractive error but also induced a myopic 
change in relative peripheral refractive error, while the latter could be 
effective for controlling eye growth in myopic children275. Two recent 
randomised clinical trials reported significant changes in axial length in the 
corneal reshaping group compared to those wearing spectacles276,277 or soft 
contact lenses278. Nevertheless, an early trial over 24-months in children aged 
6 to 12 years in Singapore showed a statistically insignificant reduction in 
myopia in the participants wearing rigid contact lenses during the daytime 
when compared with the spectacle-corrected group279. Notably, there are 
number of risks with overnight contact lens wearing, including corneal 
infection and scarring, and the potentially-related microbial keratitis280.      
      The positive effects for slowing myopia progression have been exhibited 
by cycloplegic agents centred on atropine and pirenzepine. Such types of 
medicines are thought to reduce myopic progression by eliminating 
accommodation. Several studies have reported that children receiving 
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pirenzepine gel, cyclopentolate eye drops, or atropine eye drops showed 
significantly less myopic progression compared with children receiving 
placebo281,282. However, many ophthalmologists do not embrace this treatment 
option due to concern over the atropine toxicity, photophobia, and significant 








2 Chapter 2 Study Aims 
Study 1: Genetic Variants on Chromosome 1q41 Influence ocular Axial 
Length and High Myopia (Chapter 3) 
      As a highly heritable ocular biometry of refractive errors, identification of 
quantitative trait loci influencing axial length (AL) variation would be 
valuable in informing the biological aetiology of myopia. This is the first 
study using GWAS approach to investigate genes susceptibility to AL. The 
aims of this study are to 
1) discover genetic variants associated with AL  in Asian populations   
2) provide evidence of association for myopia at the implicated genetic 
locus  
 
Study 2: Genome-wide Meta-Analysis of Five Asian Cohorts Identifies 
PDGFRA as a Susceptibility Locus for Corneal Astigmatism (Chapter 4) 
     Corneal astigmatism is associated with reduced visual acuity and is highly 
heritable, but currently there is a paucity of research to investigate the genetic 
aetiology of corneal astigmatism. This study aims to  
1) identify genetic variants associated with corneal astigmatism in Asians 
2) explore the transferability of the implicated loci in multiple Asian 
populations  
 
Study 3: Genome-wide Comparison of Estimated Recombination Rates 
between Populations (Chapter 5) 
      Homologous recombination is the only force which breaks down  linkage 
disequilibrium (LD), where the inter-population pattern of  LD is a 
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fundamental basis on the transferability of genome-wide associated genetic 
loci. Inter-population differences in recombination patterns yield important 
insights into trans-ethnic fine-mapping as well as recent human evolution. Ad-
hoc thresholds have been previously used to identify genomic regions 
exhibiting either concurring or differential evidence of hotspot differences . 
No formal statistical matrix has been applied to quantify the inter-population 
recombination rate variation based on estimated rates. This study aims to 
1) introduce a novel strategy to evaluate the inter-population genetic 
recombination differences 





3 Chapter 3   Genetic Variants on Chromosome 1q41 
Influence Ocular Axial Length and High Myopia 
This Chapter is a slightly modified version of the paper published in PLoS 
Genet 2012, 8(6): e1002753. doi:10.1371/journal.pgen.1002753 
3.1 Abstract 
      As one of the leading causes of visual impairment and blindness, myopia 
poses a significant public health burden in Asia. The primary determinant of 
myopia is an elongated ocular axial length (AL). Here we report a meta-
analysis of three genome-wide association studies on AL conducted in 1,860 
Chinese adults, 929 Chinese children and 2,155 Malay adults respectively. We 
identified a genetic locus on chromosome 1q41 harbouring the zinc-finger 
11B pseudogene ZC3H11B showing genome-wide significant association with 
AL variation (rs4373767, β = -0.16 mm per minor allele, Pmeta = 2.69 × 10-10). 
The minor C allele of rs4373767 was also observed to significantly associate 
with decreased susceptibility to high myopia (per-allele odds ratio (OR) = 
0.75, 95% CI: 0.68 – 0.84, Pmeta = 4.38 × 10-7) in 1,118 highly myopic cases 
and 5,433 controls. ZC3H11B and two neighboring genes SLC30A10 and 
LYPLAL1 were expressed in the human neural retina, retinal pigment 
epithelium and sclera. In an experimental myopia mouse model, we observed 
significant alterations to gene and protein expression in the retina and sclera of 
the unilateral induced myopic eyes for the murine genes ZC3H11A, SLC30A10 
and LYPLAL1. This supports the likely role of genetic variants at chromosome 





      Myopia increases the risk of visual morbidity and poses a considerable 
public health and economic burden globally, especially in Asia, where the 
prevalence is significantly higher than other parts of the world 283. Human 
myopia primarily results from an abnormal increase in ocular axial length 
(AL), the distance between the anterior and posterior poles of the eye globe, 
whereas the role of corneal curvature and lens thickness is minimal 114. A 1 
millimeter (mm) increase in AL is equivalent to a myopic shift of -2.00 to -
3.00 diopters (D) with no corresponding changes in the optical power of the 
cornea and lens. High myopia, often defined as ocular spherical equivalent  
(SE) refraction below -6.00 D, is associated with an abnormally long AL, and 
this affects between 1% to 10% of the general population284. The degenerative 
changes in the retina and the choroid due to the excessive elongation of the 
globe are not prevented by optical correction and this subsequently increases 
the risk of visual morbidity through myopic maculopathy, choroidal 
neovascularization, retinal detachment and macular holes111. The active 
remodelling of the sclera, mediated by the signaling cascade initiated in the 
retina under visual input, has also been found to be critical in determining 
axial growth, and thus the refractive state of the eye285. 
      It is well documented that near work, educational attainment and outdoor 
activities are environmental factors contributing to myopia286. Evidence from 
family and twin studies has also supported a substantial genetic component in 
spherical refractive error and AL157,159,160. The heritability of the quantitative 
trait AL has been estimated to be as high as 94% comparable to that for SE 
(for a review, see174). Although linkage scans on pedigrees (myopia loci 
69 
 
MYP1 to MYP18; see http://www.omim.org) and genome-wide association 
studies (GWAS)22,23,34,35,265,266 have implicated several regions in the human 
genome as being significant for refractive error and myopia, no myopia genes 
have been consistently identified within or across different population groups. 
This scenario reflects the complexity in the disease architecture of myopia 
pathogenesis. 
      Genetic factors influencing AL and refraction appear to be at least partly 
shared, given previous literature from twin studies illustrating that at least half 
of the covariance between AL and refraction are due to common genetic 
factors287. The measurement of AL is more precise and less prone to errors 
compared to cycloplegic or non-cycloplegic assessments of refraction. As AL 
is an endophenotype for spherical refractive error, identifying genes that are 
responsible for AL variation provides insight into myopia predisposition and 
development. Presently there are only two genome-wide linkage studies 
performed in European descent populations that suggest the presence of AL 
quantitative trait loci (QTLs) on chromosomes 2p24202 and 5q (at 98 
centimorgans) along with two classical myopia loci (MYP3 at 12q21 and 
MYP9 at 4q12)203, and there are no reports of any genes that are indisputably 
confirmed to be associated with AL.  
      We thus performed a meta-analysis of three genome-wide surveys of AL 
in a total of 4,944 individuals in Asian populations comprising (i) Chinese 
adults from the Singapore Chinese Eye Study (SCES); (ii) Chinese children 
from the Singapore cohort Study of the Risk factors for Myopia (SCORM); 
and (iii)  Malay adults from the Singapore Malay Eye Study (SiMES). SNPs 
that have been identified from this meta-analysis to be significantly associated 
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with AL were further assessed for association with high myopia in an 
additional two independent case-control studies from Japan. We also 
examined the expression patterns of the candidate genes located in the vicinity 
of the identified SNPs in human ocular tissues and in the eyes of myopic mice.  
 
3.3 Methods 
3.3.1 Study cohorts 
Discovery cohorts 
      Singapore Chinese Eye Study (SCES). SCES is an ongoing population-
based cross-sectional survey of eye diseases in Chinese adults aged 40 to 80 
years residing in the Southwestern part of Singapore. The study began in 2007 
and a detailed description was published elsewhere288. In brief, a total of 2,226 
residents in the Southwestern area of Singapore completed comprehensive 
ophthalmologic examinations, including visual acuity assessments, refraction, 
lens and retinal imaging, and slit lamp examinations. Genome-wide 
genotyping was performed in 1,952 individuals. Completed post quality 
control (QC) data for GWAS were available for 1,860 adults with AL 
measurements.  
      Singapore Cohort study of the Risk factors for Myopia (SCORM). A 
total of 1,979 children in grades 1, 2, and 3 from three schools in Singapore 
were recruited from 1999 to 2001289.  The children were examined on their 
respective school premises annually by a team of eye care professionals. The 
GWAS was conducted in a subset of 1,116 Chinese children22,290. The 
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phenotype used in this study was based on the AL measured on the 4th annual 
examination of the study (children at age 10 to 12 years). Complete post-
filtering data on AL measurements and SNP data were available in 929 
children.  
      Singapore Malay Eye Study (SiMES).  SiMES is a population-based 
cross-sectional survey of eye diseases in Malay adults aged 40 to 80 years 
living in Singapore. It was conducted between August of 2004 and June of 
2006291.  A total of 4,168 Malay residents in the Southwestern area of 
Singapore were identified and invited for a detailed ocular examination where 
3,280 (78.7%) participated. Genome-wide genotyping was performed in 3,072 
individuals26,29. Complete post-filtering data for GWAS with AL 
measurements were available for 2,155 subjects.  
 
Validation cohorts for high myopia 
      Japan dataset 1. The Japan dataset 1 consisted of 483 high myopia cases 
and 1,194 general healthy population controls. High myopia status was 
determined primarily on the basis of AL ≥ 28 mm for both eyes, which 
corresponded to the spherical equivalent (SE) cut-off of at least -9.00 D292. 
Cases were recruited at the Center for Macular Disease of Kyoto University 
Hospital, the High Myopia Clinic of Tokyo Medical and Dental University, 
and the Fukushima Medical University Hospital. Details of the data have been 
reported elsewhere 23. The population controls were recruited at the Aichi 
Cancer Center Research Institute. 
      Japan dataset 2.  The Japan dataset 2 was comprised of 504 high myopia 
cases (SE ≤ -9.00 D in either eye) and 550 non-highly myopic controls (SE ≥ -
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3.00 D in both eyes). Less stringent thresholds were adopted for controls for 
the purpose of ease of recruitment from the clinics. Given the large phenotypic 
separation between the cases and controls, and assumption of 
homoscedasticity across genotype categories, such a study design using the 
extreme on one end (i.e. SE ≤ -9.00 D) but sampling less extreme controls (i.e. 
SE ≥ -3.00 D) still provides sufficient statistical power to detect the true 
positive signals in the association study293. Cases were recruited at the 
Yokohama City University and Okada Eye Clinic. Controls were obtained 
from the Yokohama City University and Tokai University Hospital.  
 
Measurements of AL, refractive error and covariates 
      All the studies used a similar protocol for ocular phenotype measurements. 
For subjects in SCES and SiMES, AL for both eyes were measured using 
optical laser interferometry (IOLMaster V3.01, Carl Zeiss; Meditec AG Jena, 
Germany)288,291. Children in the SCORM study underwent AL measurements 
using the A-scan ultrasound biometry machine (Echoscan US-800; Nidek Co, 
Tokyo, Japan)289. For subjects in the Japan dataset 1, applanation A-scan 
ultrasongraphy (UD-6000, Tomey, Nagoya, Japan) or partial coherence 
interferometry (IOLMaster, Carl Zeiss Meditec, Dublin, CA) were used to 
measure AL. AL was assessed using a portable A-scan Biometer/pachymeter 
(AL-2000, Tomey, Negoya, Japan) for the participants in the Japan dataset 2.   
      Non-cycloplegic refraction in SCES and SiMES as well as cycloplegic 
refraction in SCORM (three drops of 1% cyclopentolate at 5 minutes apart) 
were measured by autorefractor (Canon RK-5, Tokyo, Japan)294. For subjects 
in the Japan dataset 2, refraction was measured using auto-refraction ARK-
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730A (NIDEK), ARK-700A (NIDEK) and KR-8100P (TOPCON). SE was 
calculated as the sphere power plus half of the cylinder power for each eye.  
      To perform the genetic association of high myopia in SCES and SiMES, 
we used the definition adopted by the Japan case-control studies and defined 
high myopia cases as subjects having SE ≤ -9.0 D in at least one eye, and non 
high-myopia controls as samples with SE ≥ -3.0 D in both eyes. For children 
from SCORM aged 10 to 12 years, cases were defined as SE ≤ -6.0 D for at 
least one eye, while controls were defined as SE ≥ -1.0 D for both eyes; this is 
approximately equivalent to the projected SE of -9.0 and -3.0 respectively at 
university age based on the estimated annual progression rate in SE of -0.6 D 
for Chinese myopic children and -0.3 D in the controls295. Given the small 
sample sizes of high myopia cases identified in our population-based cohorts, 
in the supplementary analysis, we further applied the commonly adopted 
criteria of SE≤ -6.0 D in either eye as cases. Controls were defined as SE ≥ -
1.0 D in both eyes. For SCORM children, we retained the same criteria in both 
analyses.  
      Age, gender, height and level of education were obtained from all 
Singapore participants who underwent ophthalmologic examination. 
Education was measured on an ordinal scale from no formal education to the 
highest educational level. For participants in SCORM, the education of the 
child was defined by the level of educational attainment of the father, as a 




3.3.2 Data quality control 
Discovery cohorts  
      For SCES, a total of 1,952 venous blood-derived samples were genotyped 
using Illumina Human 610 Quad Beadchips (Illumina Inc., San Diego, US) 
according to the manufacturer’s protocols. Samples which failed genotyping 
or with low call rate (< 95%, n = 11), with excessive heterozygosity (defined 
as sample heterozygosity exceeding 3 standard deviations from the mean 
sample heterogzygosity; n = 3), with gender discrepancies (n = 2) were 
excluded, as were cryptically related samples identified by the identity-by-
state (IBS) (n = 41) and population structure in the principal components 
analyses (PCA) (n = 6). The criteria to define cryptically related samples and 
outliers with population structure in the discovery cohorts are described in the 
following paragraph. After the removal of the samples, SNP quality control 
(QC) was then applied on a total of 579,999 autosomal SNPs for the 1,889 
post-QC samples. SNPs were excluded based on (i) high rates of missingness 
(> 5%) (n = 26,437); (ii) monomorphism or minor allele frequency (MAF) < 
1% (n = 59,633); or (iii) genotype frequencies deviating from Hardy-
Weinberg Equilibrium (HWE) defined as HWE P-value < 10-6 (n = 1,821). 
This yielded 492,108 autosomal SNPs. Those individuals with missing data on 
phenotypes were further removed (n = 29).  Finally, 492,108 SNPs in 1,860 
samples were available for analyses. 
      For SCORM, 1,116 DNA samples (1,037 from buccal swab and 79 from 
saliva) were genotyped on the Illumina HumanHap 550 Beadchips and 550 
Duo Beadarrays. A total of 108 samples were excluded, comprising (i) 70 
samples with call rates below 98%; (ii) 6 with poor genotyping quality; (iii) 11 
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samples identified from sib-ships; (iv) 18 with inconsistent gender 
information; and (v) 3 due to population structure. This left a total of 1,008 
samples for further SNP QC. Based on 514,849 autosomal SNPs, we excluded 
32,669 markers if they had missing genotype calls > 5%, MAF < 1%, or 
significantly deviated from HWE (P < 10-6) 22. A final set of 929 samples with 
482,180 post-QC SNPs and completed AL measurement were included in 
analyses.       
      For SiMES, 3,072 DNA samples were genotyped using the Illumina 
Human 610 Quad Beadchips. The detailed QC procedures were provided 
elsewhere296. In brief, we omitted a total of 530 individuals due to: (i) 
subpopulation structure (n = 170); (ii) cryptic relatedness (n = 279); (iii) 
excessive heterozygosity or high missingness rate > 5% (n = 37); and (iv) 
gender discrepancy (n = 44). After the removal of the samples, SNP QC was 
then applied on a total of 579,999 autosomal SNPs for the 2,542 post-QC 
samples. SNPs were excluded based on: (i) high rates of missingness ( > 5%) 
(n = 26,343); (ii) monomorphism or MAF < 1% (n = 34,891); or (iii) genotype 
frequencies deviating from HWE (P < 10-6) (n = 3,645). This yielded 515,120 
SNPs after the same SNP QC criteria. Individuals without valid measurements 
for AL were further removed (n = 387). After the above filtering criteria, 
515,120 SNPs in 2,155 samples were available for association analyses. 
      In our discovery cohorts, IBS was estimated with the genome-wide SNP 
data using PLINK software to assess the degree of recent shared ancestry for a 
pair of individuals297. For a pair of putatively-related samples defined as an 
identity by descent (IBD) value greater than 0.1856, we removed one 
individual from each pair of monzygotic twins/duplicates, parent-offspring or 
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full-siblings etc. Population structure was ascertained using PCA with the 
EIGENSTRAT program and genetic outliers were defined as individuals 
whose ancestry was at least 6 standard deviations from the mean on one of the 
top ten inferred axes of variation7.  
      For SiMES Malays, we also excluded the samples falling in the main 
clusters of PCA plots of the Chinese and Indians ethnic groups, as described in 
the previous study296. In SiMES, we noticed some degree of admixture in 
genetic ancestry of Malays and thus adjusted for ancestry along the top five 
axes of variation, as the spread of principal component scores was greater for 
the top five eigenvectors in the bivariate plots of PCA (Figure 4), The top ten 
principal components explained a small percentage of the global genetic 
variability of 1.3% while top five explained 1.0%, suggesting, all together, 
they had minimal effects on our association analyses.   
 
Validation cohorts for high myopia 
      High myopia cases in the Japan dataset 1 were genotyped using Illumina 
Human-Hap550 and 660 chips23, while controls in the Japan dataset 1 were 
genotyped on Illumina Human-Hap610 chips. Subjects in the Japan dataset 2 
were genotyped on the Affymetrix GeneChip Human Mapping 500K Array 
Set (Affymetrix Inc., Santa Clara, US). For SNPs not available on the 
Affymetric chips (rs43737678, rs10779363 and rs7544369), genotyping was 
performed with TaqMan 5′ exonuclease assays using primers supplied by 
Applied Biosystems (Foster City, US). The probe fluorescence signal was 
detected using the TaqMan Assay for Real-Time PCR (7500 Fast Real-Time 




3.3.3 Statistical methods 
      The primary analysis was performed on the AL quantitative trait. As a 
strong correlation exists in AL measurements from both eyes (r > 0.9), we 
used the mean AL across both eyes in the GWAS analysis, as was 
recommended in a review298. Linear regression was used to interrogate the 
association of each SNP with AL after adjusting for age, gender, height and 
level of education, under the assumption of an additive genetic effect where 
the genotypes of each SNP are coded numerically as 0, 1 and 2 for the number 
of minor alleles carried. In addition, for SiMES, the top five principal 
components of genetic ancestry from the EIGENSTRAT PCA were also 
included as covariates to account for the effects of population substructure as 
described in genotype QC section290. Association tests between each genetic 
marker and phenotype were carried out using PLINK software297 (version 
1.07). Analyses were also repeated without adjustment for education level or 
height for the purpose of comparison.  
      In the discovery phase, we conducted a meta-analysis of GWAS results 
from 3 cohorts for AL using a weighted-inverse variance approach by fixed-
effect modelling in METAL (http://www.sph.umich.edu/csg/abecasis/metal).  
In the secondary analyses, SNPs that have been identified from the primary 
analyses were tested for association with high myopia onset (as a binary trait) 
and SE (as a quantitative trait). For Singapore cohorts, the association analyses 
adjusted for the same covariates as the primary analyses within a linear 
regression and logistic regression framework respectively. For Japan case-
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control datasets, only age and gender were included as covariates in the model 
for high myopia, as the other covariates were not available.   
      The regional association plots were constructed by SNAP 
(http://www.broadinstitute.org/mpg /snap ). Haploview 4.1 
(http://www.broad.mit.edu/mpg/ haploview) was used to visualize the LD of 
the genomic regions. Genotyping quality of all reported SNPs has been 
visually evaluated by the intensity clusterplots. The coordinates reported in 
this paper are on NCB136 (hg18).   
      For functional studies in the myopic mouse model, gene expression of all 
three identified genes in control and experimental groups was quantified using 
the 2-∆∆Ct method299. The standard student’s t-test was performed to determine 
the significance of the relative fold change of mRNA between the myopic 
eyes of the experimental mice with the independent age-matched controls. 
 
3.3.4 Functional studies 
3.3.4.1 Gene expression in human  
      Genes ZC3H11B , SLC30A10 and LYLPLAL1, adjacent to the top 
associated SNPs, as well as GAPDH (house keeping gene) were run using 
10ul reactions with Qiagen’s PCR products consisting of 1.26 ul H2O, 1.0 ul 
10X buffer, 1.0 ul dNTPs, 0.3 ul MgCl, 2.0 ul Q- Solution, 0.06 ul taq 
polymerase, 1.0 ul forward primer, 1.0 ul reverse primer and 1.5.0 ul cDNA.  
The reactions were run on a Eppendorf Mastercycler Pro S thermocycler with 
touchdown PCR ramping down 1°C per cycle from 72°C to 55°C followed by 
50 cycles of 94°C for 0:30, 55°C for 0:30 and 72°C for 0:30 with a final 
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elongation of 7:00 at 72°C. All primer sets were designed using Primer3300. 
The gel electrophoresis was run on a 2% agarose gel at 70 volts for 35 
minutes. The primers from a custom tissue panel including Clontech’s Human 
MTC Panel I, Fetal MTC Panel I and an ocular tissue panel were used to 
amplify the relevant transcripts. The adult ocular samples were obtained from 
normal eyes of an 82-year-old Caucasian female from the North Carolina Eye 
Bank, Winston-Salem, North Carolina, USA. The fetal ocular samples were 
from 24-week fetal eyes obtained by Advanced Bioscience Resources Inc., 
Alameda, California, USA. All adult ocular samples were stored in Qiagen’s 
RNAlater within 6.5 hours of collection and shipped on ice overnight to the 
lab. Fetal eyes were preserved in RNAlater within minutes of harvesting and 
shipped over night on ice. Whole globes were dissected on the arrival day. 
Isolated tissues were snap-frozen and stored at -80°C until RNA extraction. 
RNA was extracted from each tissue sample independently using the Ambion 
mirVana  total RNA extraction kit. The tissue samples were homogenized in 
Ambion lysis buffer using an Omni Bead Ruptor Tissue Homogenizer per 
protocol. Reverse transcription reactions were performed with Invitrogen 
SuperScript III First-Strand Synthesis kit. 
 
3.3.4.2 Myopia-induced mouse model 
Gene expression in a mouse model of myopia 
      Experimental myopia was induced in B6 wild-type (WT) mice (n = 36) by 
applying a -15.00 D spectacle lens on the right eye (experimental eye) for 6 
weeks since post-natal day 10. The left eyes were uncovered and served as 
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contra-lateral fellow eyes. Age matched naive mice eyes were used as 
independent control eyes (n = 36). Each eye was refracted weekly using the 
automated infrared photorefractor as described previously301. AL was 
measured by AC- Master, Optic low coherence interferometry (Carl-Zeiss), in-
vivo at 2, 4 and 6 weeks after the induction of myopia302. The minus-lens-
induced eyes after six weeks were significantly associated with increased AL 
and myopic shift in refraction of < -5.00 D as compared to independent 
control eyes (n = 36, P = 3.00 × 10-6 for AL, and 2.05 x 10-4 for refraction). 
Eye tissues were collected at 6 weeks post myopia induction for further 
analyses. 
      Total RNA was isolated from pooled cryogenically ground mouse neural 
retina (retina), retinal pigment epithelium (RPE) and sclera for three batches 
using TRIzol Reagent (Invitrogen, Carlsbad, CA) with each batch (n = 6) 
comprising the myopic eye, fellow eye and control eye. RNA concentration 
and quality were assessed by the absorbance at 260 nm and the ratio of 
absorbance ratio at 260 and 280nm respectively, using Nanodrop® ND-1000 
Spectrophotometer (Nanodrop Technologies, Wilmington, DE). RNA was 
purified using the RNeasy® Mini kit (Qiagen, GmbH).  
      500 ng of purifed RNA was reverse-transcribed into cDNA using random 
primers and reagents from iScriptTM select cDNA synthesis kit (Bio-rad 
Laboratories, Hercules, CA). The pseudogene ZC3H11B (zinc finger CCCH 
type containing 11B) is not characterized in the mouse genome, therefore we 
examined a similar gene ZC3H11A (zinc finger CCCH type containing 11A) 
in mice. ZC3H11A in mice and ZC3H11B in humans are highly conserved 
with 79% nucleotide similarity by BLAST alignment analysis 
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(http://blast.ncbi.nlm.nih.gov). We used quantitative Real-Time PCR (qRT-
PCR) to validate the gene expression. qRT-PCR primers were designed using 
ProbeFinder 2.45 (Roche Applied Science, Indianapolis, IN) and this was 
performed using a Lightcycler 480 Probe Master (Roche Applied Science, 
Indianapolis, IN). The reaction was run in a Lightcycler 480 for 45 cycles 
under the following conditions: 95˚C for 10s, 56˚C for 10s and 72˚C for 30s. 
Gene expressions in the retina, RPE and sclera after six weeks of myopic eyes 
and the fellow eyes were compared to the control eyes. Glyceraldehyde 3-




      Whole mouse eyes (6 weeks minus lens treated myopic, contra-lateral 
fellow and independent control eyes, n = 6 per type) were embedded in frozen 
tissue matrix compound at -20°C for 1 hour. Prepared tissue blocks were 
sectioned with a cryostat at 6 microns thicknesses and collected on clean 
polysine™ glass slides. Slides with the sections were air dried at room 
temperature (RT) for 1 hour and fixed with 4% para-formaldehyde for 10 min. 
After washing 3X with 1x PBS for 5 minutes, 4% bovine serum albumin 
(BSA) diluted with 1x PBS was added as a blocking buffer. The slides were 
then covered and incubated for 1 hour at RT in a humid chamber. After rinsing 
with 1x PBS, a specific primary antibody raised in rabbit against ZC3H11A, 
SLC30A10 and raised in goat against LYPLAL1 (Abcam, Cambridge, UK) 
diluted (1:200) with 4% BSA was added and incubated further at 4°C in a 
humid chamber overnight. After washing 3X with 1x PBS for 10 min, 
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fluorescein-labeled goat anti-rabbit secondary antibody (1:800, Invitrogen-
Molecular Probes, Eugene, OR) and fluorescein-labeled rabbit anti-goat 
secondary antibody (1:800, Santa Cruz Biotechnology, Inc. CA, USA) was 
applied respectively and incubated for 90 min at RT. After washing and air-
drying, slides were mounted with antifade medium containing DAPI (4,6-
diamidino-2-phenylindole; Vectashield, Vector Laboratories, Burlingame, 
CA) to visualize the cell nuclei. Sections incubated with 4% BSA and omitted 
primary antibody were used as a negative control. A fluorescence microscope 
(Axioplan 2; Carl Zeiss Meditec GmbH, Oberkochen, Germany) was used to 
examine the slides and capture images. Experiments were repeated in 
duplicates from three different samples. 
 
3.4 Results 
3.4.1 Datasets after quality control  
      A genome-wide meta-analysis of three GWAS on AL was performed in 
the post quality control samples from SCES (n = 1,860), SCORM (n = 929) 
and SiMES (n = 2,155). Principal component analysis (PCA) of these samples 
with reference to the HapMap Phase 2 individuals showed that the two 
Chinese cohorts (SCES and SCORM) are indistinguishable with respect to 
samples of Han Chinese descent, and the differentiation from samples of 
Japanese descent is evident only on the fourth principal component (Figure 
5). The SiMES Malays are genetically similar to the Chinese-descent samples 
relative to individuals with European or African ancestries. The distributions 
of AL measurements in the three cohorts were approximately Gaussian and 
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the baseline characteristics are summarised in Table 5. The mean AL were 
23.98 mm (SD = 1.39 mm), 24.10 mm (SD = 1.18 mm) and 23.57 mm (SD = 
1.04 mm) for SCES, SCORM and SiMES respectively. Moderate to high 
correlations between AL and SE were observed (SCES/SCORM/ SiMES; 
Pearson correlation coefficient r = -0.75, -0.76 and -0.62 respectively).  
3.4.2 Locus at chromosome 1q41 achieved genome-wide significance 
      The meta-analysis was performed on 456,634 SNPs present in all three 
studies, and the quantile-quantile (QQ) plots of the P-values showed only 
modest inflation of the test statistics in SCES and in the meta-analysis 
(genomic control inflation factor: λmeta = 1.03; λSCES = 1.05; λSCORM = 1.00; 
λSiMES = 1.00, Figure 6).        
      A cluster of four SNPs on chromosome 1q41 (rs4373767, rs10779363, 
rs7544369 and rs4428898) attained genome-wide significance on meta-
analysis for AL, adjusting for age, gender, height and education level (Figure 
7). Analyses conducted without adjustment for height or education level 
yielded the same pattern of results. The most significant SNP rs4373767 (Pmeta 
= 2.69 × 10-10) explained 0.98% of AL variance in SCES, 0.86% in SCORM 
and 0.73% in SiMES, and each copy of the minor allele (cytosine) decreased 
AL by 0.16mm on average (Table 6). These top associated SNPs at 
chromosome 1q41 remained significant after adjustment for genomic control 
(Pmeta ≤ 1.85 × 10-8). Table 6 also lists three genetic loci at chromosome 
2p13.1 (SEMA4F), 2p21 (SPTBN1) and 5q11.1 (PARP8) exhibiting suggestive 
evidence of association with AL that were seen in at least one SNP with P-
values < 1 ×10-5.   
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3.4.3 Association with high myopia on the identified SNPs 
      To assess whether these four SNPs at chromosome 1q41 have any role in 
high myopia predisposition, we performed association testing of these SNPs 
with high myopia in two independent case-control studies from Japan 
consisting of 987 high myopes and 1,744 controls. High myopes were defined 
as individuals with SE ≤ -9.00 D or AL ≥ 28 mm. All four SNPs exhibited 
consistent evidence of association (P < 0.05) in both Japanese studies, 
suggesting a potential role of these SNPs for high myopia (Table 7).  
      We further dichotomized the quantitative refraction from our three 
population-based studies (SCORM, SCES, and SIMES) to define samples as 
high myopes and controls according to similar criteria from the Japanese 
datasets. High myopes in SCES and SiMES were younger and more highly 
educated than controls. While the case-control associations of these 4 SNPs 
with high myopia did not achieve statistical significance in SCES and SiMES, 
this is likely a consequence of the small sample sizes since the direction and 
magnitude of the odds ratios were highly similar across all cohorts. The meta-
analysis of 1,118 high myopia cases and 5,433 controls from all the five 
cohorts yielded strong evidence of association with high myopia at these SNPs 
(Pmeta between 1.45 × 10-6 to 7.86 × 10-8, Table 7), with no evidence of inter-
study heterogeneity (P ≥ 0.75 for heterogeneity). The minor allele cytosine at 
rs4373767 lowered the odds of high myopia by 25% with respect to the 
thymidine allele (ORmeta = 0.75, 95% CI: 0.68 – 0.84, Pmeta = 4.38 × 10-7). The 
stringent definition of high myopia (SE ≤ -9.00D) used here only considered 
between 1.0% to 2.4% of our samples as cases, and relaxing this criterion to 
the commonly adopted threshold of SE ≤ -6.00D identified more myopia cases 
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and increased the statistical support of all four SNPs (Pmeta between 1.47 × 10-
7 to 9.13 × 10-9). 
      This associated interval spans approximately 70kb in the extended linkage 
disequilibrium (LD) block within an intergenic region on chromosome 1q41 
(pairwise r2 > 0.5 with the most significant SNP rs4373767, Figure 8A). Zinc 
finger family CCCH-type 11B pseudogene ZC3H11B (RefSeq NG_007367.2) 
is embedded between the associated top SNPs rs4373767 and rs10779363 
(Figure 8B). The most significant SNP rs4373767 is located 223kb 
downstream from SLC30A10 (RefSeq NM_018713.2), which is a member of 
solute carrier family 30, and 354kb downstream of LYPLAL1 (RefSeq 
NM_138794.3), encoding a lysophospholipase-like protein.  
 
3.4.4 Gene expression 
       The mRNA expression levels of ZC3H11B, SLC30A10 and LYPLAL1 
were surveyed in 24-week human fetal and adult tissues using reverse-
transcriptase polymerase chain reaction (RT-PCR). Whilst ZC3H11B and 
LYPLAL1 were found to be expressed across all the tissues including brain, 
placenta, neural retina, retina pigment epithelium (RPE) and sclera, the 
expression of ZC3H11B was more abundant compared to LYPLAL1 (Figure 
9). SLC30A10 was expressed in all tissues but the adult sclera, analogous to 
observations made in other zinc transporters303.  
      Gene expressions for ZC3H11A, SLC30A10 and LYPLAL1 from the tissues 
of myopic (with SE < -5.0 D) and fellow non-occluded eyes of the 
experimental mice were compared with age-matched control tissues (Figure 
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10). The mRNA levels of ZC3H11A, a gene that is conserved with respect to 
ZC3H11B in human, were significantly down-regulated in myopic eyes 
compared to naive controls (retina/ RPE/sclera, Fold change = -2.88 , -3.24 
and -2.07; P = 2.60 × 10-5, 2.62 × 10-6 and 1.08 × 10-4, respectively). At the 
neighboring gene SLC30A10, there was a similarly significant reduction in the 
expression of mRNA in the retina tissue of myopic eyes in contrast to 
independent controls (retina/RPE, Fold change = -2.02, -2.69; P = 2.00 × 10-4, 
2.00 × 10-4, respectively), with elevated expression in the sclera (Fold change 
= 4.58; P = 4.02 × 10-4). Another neighboring gene LYPLAL1 exhibited up-
regulation of transcription levels in retina tissue but was down-regulated in the 
sclera (retina/ RPE/sclera, Fold change = 2.71, 3.45 and -2.36; P = 1.50 × 10-4, 
1.50 × 10-4 and 1.54 × 10-4, respectively).   
      Immunohistochemical results confirmed the localization of ZC3H11A, 
SLC30A10 and LYPLAL1 proteins in the neural retina, RPE and sclera (Figure 
11). For ZC3H11A, positive immunostaining intensity was reduced 
significantly in the myopic tissues of experimental mice compared to the non-
myopic independent controls (Figures 10A). This is consistent with the 
differential expression patterns at the transcription level. For SLC30A10 and 
LYPLAL1, there were also similarly noticeable changes in the expression of 
proteins to that of their mRNA levels (Figures 10B and 10C). 
 
3.5 Discussion 
      We report that the chromosome 1q41 locus (most significant SNP 
rs4373767) is associated with AL in a meta-analysis of three GWAS 
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performed in the study cohorts consisting of Chinese adults, Chinese children, 
and Malay adults. The discovery of chromosome 1q41 as a locus for high 
myopia in our data is further supported by validation in two independent 
Japanese cohorts, and the observed genetic effects are highly consistent across 
all five studies. The pseudogene ZC3H11B and two nearby genes SLC30A10 
and LYPLAL1 were found to be expressed in the human retina and sclera. The 
potential roles in regulating myopia at three candidate genes were further 
implicated by the concordant changes in the pattern of transcription and 
protein expression in the mouse model.  
      The ZC3H11B pseudogene belongs to the CCCH-type zinc finger family, 
whereas such type of zinc finger protein has been shown as a RNA-binding 
motif to facilitate the mRNA processing at transcription 304. Emerging 
evidence suggests that pseudogenes, resembling known genes but not 
producing proteins, play a significant role in pathological conditions by 
competing for binding sites to regulate the transcription of its protein-coding 
counterpart 305-307. Although the function of the ZC3H11B in humans is 
presently unknown, the implicated role of the murine gene ZC3H11A 
(conserved gene of ZC3H11B in mouse) in myopia development is in keeping 
with previous findings that several zinc finger proteins are involved in myopia 
308,309. Given their role as transcription factors 310, zinc finger protein ZENK  
has been proposed to function as a messenger in modulating the visual 
signaling cascade in the chicken retina, where the expression of the ZENK was 
suppressed by the condition of minus defocus (induced myopic eye growth) 
and enhanced by positive defocus (induced hyperopic eye growth)311-313. 
Similarly, it has been reported that ZENK knockout mice had elongated AL 
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and a myopic shift in refraction309. Moreover, early growth response gene 
type1 EGR-1 (the human homologue of ZENK) has been shown to activate 
transforming growth factor beta 1 gene TGFB1 by binding its promoter314,315, 
a gene that is implicated to be associated with myopia224,225. Another zinc 
protein finger protein 644 isoform ZNF644 has recently been identified to be 
responsible for high myopia using whole genome exome sequencing in a Han 
Chinese family308, whereas its influence on “myopia genes” remains to be 
elucidated. In light of this, the observation that ZC3H11B is abundantly 
expressed in retina and sclera, together with the significant down-regulation of 
the coding counterpart ZC3H11A in myopic mice eyes, suggests it may 
promote or inhibit the transcription of ocular growth genes vital in myopia 
development.  
      One of the two neighboring genes SLC30A10 is an efflux transporter that 
reduces cytoplasmic zinc concentrations316. The SLC30 zinc transporters are 
expressed abundantly in human RPE cells, and the retina has been observed to 
possess the highest concentration of zinc in the human body303. Zinc 
deficiency in the intracellular retina has thus been implicated in the 
pathogenesis of age-related macular degeneration (AMD)317,318, and in RPE-
photoreceptor complex deficits, which can affect visual signal transduction 
from retina to sclera and lead to visual impairment319. LYPLAL1 functions as a 
triglyceride lipase and this gene has been shown to be up-regulated in 
subcutaneous adipose tissue in obese individuals320-322. While the relationship 
between LYPLAL1 and myopia is unknown, elevated saturated-fat intake has 
been proposed to influence myopia development through the retinoid receptor 
pathway227,323,324. Interestingly, the SNPs pinpointing chromosome 1q41 in 
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our study are 1Mb away from the transforming growth factor beta 2 gene 
(TGFβ2) which has been implicated in the down-regulation of mRNA levels 
in myopia progression of an induced tree shrew myopia model325. None of 
these nearby genes, however, are within the LD block containing our 
identified SNPs. 
      Chromosome 1q41 is a previously reported locus for refraction from a 
linkage analysis of 486 pedigrees in the Beaver Dam Eye Study, US197. Using 
microsatellite markers, Klein et al identified novel regions of linkage to SE on 
chromosome 1q41, whereas the peak spanned a broad region near Marker 
D1S2141 (multipoint  P < 1.9 × 10-4). This result however was not replicated 
in a subsequent genome-wide linkage scan for SE with denser SNP markers, 
partially due to varying information of linkage conveyed by SNPs versus 
microsatellites188. The identified variants at chromosome 1q41 in our study 
were noted to exhibit weaker, albeit still significant, association with SE in 
SCES and SCORM (rs4373767, SCES/SCORM: P = 3.54 × 10-3, 3.49 × 10-2, 
respectively), but not in SiMES (3.51 × 10-1 ), which is consistent with the 
lower correlation of AL and SE seen in the SiMES data, partially from 
increasing lens opalescence in the Malay population326,327.   
      Our data have shown that genetic variants on chromosome 1q41 influence 
the physiological attribute of AL and are also associated with high myopia. 
Elongation of AL is the major underlying structural determinant of high 
myopia, mostly accompanied with prolate eyeballs and thinning of the sclera, 
macula and retina111. Thus, high myopia is also defined as AL of >26 mm in 
some studies23,328. It is possible that genes involved in a quantitative trait 
(refraction or underlying AL) also play a role in the extreme forms of the trait 
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(high myopia)30. Two recent GWAS performed in general Caucasians 
population have identified genetic variants for quantitative refraction at 
chromosome 15q1434 and 15q2535, of which the locus on 15q14 was 
subsequently confirmed to be associated with high myopia in the Japanese251. 
Our GWAS results herein highlight AL QTLs’ relevance for high myopia 
predisposition, which advances our understanding of the genetic aetiology of 
myopia at different levels of severity. 
      The meta-analysis of three GWAS in our discovery suggests that the 
quantitative trait locus at chromosome 1q41 accounts for variation in AL in 
both school children and adults, regardless of age differences. Notably, the 
early-onset of myopia in childhood may continuously progress toward high 
myopia in later life, while adult-onset of myopia is usually in the low or 
moderate form329,330. The significant association on chromosome 1q41 for 
high myopia in adults and children thus also implicates this locus identified 
for AL is likely to be associated with early-onset myopia. 
      The prevalence of myopia among Asian population is considerably higher 
than in Caucasians 283. Although distinct genetic mechanisms governing 
myopia may exist for populations with different genetic backgrounds, we 
believe there are polymorphisms involved in refractive variation that are 
shared across populations. However, the allele frequencies of these identified 
SNPs vary across populations. For instance, the minor C allele of rs4373767 
was a major allele in the HapMap Africans and Europeans with frequency of 
0.92 and 0.62 respectively. The effect size of the top SNPs on AL was found 
greatly attenuated in Singapore Indian samples (rs4373767; β = -0.04 mm per 
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minor allele C, P = 0.151, MAF = 0.48; details of Indian cohort in Chapter 4).  
In addition, we note that the variability in refraction attributed to AL may vary 
in different ethnic groups. For example, AL has been reported to account for a 
larger proportion of the variation in refraction in East-Asian children 
compared to their Caucasian counterparts 331, therefore the increased power of 
refraction may reflect more variation in factors other than pure elongation of 
AL in certain ethnic groups. Such heterogeneity may confer different 
statistical power and large sample sizes will be required to study the 
transferability of the same variants in Caucasian populations 332,333. Recent 
largest GWAS conducted by the international Consortium for refractive Error 
and Myopia has confirmed 1q41 locus influencing axial length across 
Europeans (data has not published yet), which will be discussed in the Chapter 
6.            
       In conclusion, our findings suggest that common variants at chromosome 
1q41 are associated with AL and high myopia in a pediatric and an adult 
cohort, the latter incorporating Chinese, Malay and Japanese populations. 
Further evaluation of causal variants and underlying pathway mechanisms 
may contribute to early identification of children at highest risk of developing 
myopia, and eventually lead to appropriate interventions to retard the 
progression of myopia.  
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Table 5: Characteristics of study participants in the five Asian cohorts. 
Characteristics SCESc SCORMc SiMESc Japan Dataset 1d Japan Dataset 2e 
    High myopia Controls High myopia Controls 
Individuals (n) 1,860 929 2,155 483 1,194 504 550 
Male (%) 51.5 51.7 49.3 33.7 41.3 43.3 49.5 
Age a (yrs) 58.4 (9.5) 10.8 (0.8) 57.7 (13.9) 58.8 (13.2) 50.3 
(15.9) 
37.8 (11.9) 39.7 
(12.6) 
Range of age [44, 85] [10, 12] [40, 80] [14, 91] [20, 79] [12, 76] [21, 75] 
Height a (cm)        
      Male 168.5 (6.3) 144.8 (8.7) 165.5 (6.4) NAf NA NA NA 
      Female 156.7 (5.5) 145.5 (8.9) 152.3 (6.2) NA NA NA NA 
Average ALa (mm) 23.97 (1.39) 24.13 (1.18) 23.57 (1.04) 30.08 (1.38) NA 27.83 (1.28) NA 
Range of AL [20.64, 33.36] [21.05,28.20] [20.48, 31.11] [28.00, 38.03] NA [24.25, 34.74] NA 
Average SEa (diopter) -0.77 (2.64) -2.02 (2.26) -0.05 (1.90) -14.86 (4.28) NA -11.61 (2.22) NA 
Range of SE [-15.40, 6.25] [-11.09, 3.78] [-17.46, 8.56] [-42.00, -2.50] NA [-23.00, -9.25] ≥ -3.0 
a Data presented are means ( standard deviation). AL, ocular axial length; SE, spherical equivalent.  
b The education levels of the children in SOCRM was presented by the level of educational attainment of the father, as   
cGWAS cohorts. SCES, Singapore Chinese Eye Study; SCORM, Singapore Cohort study of the Risk factors for Myopia; SiMES, 
Singapore Malay Eye Study. 
dFor the Japan dataset 1, high myopia, AL ≥ 28mm for both eyes; controls, general healthy population.  
e For the Japan dataset 2, high myopia, SE ≤ -9.0 D for either eye; controls, SE ≥ -3.0 D for both eyes.  





Table 6. Top SNPs (Pmeta-value  ≤ 1 × 10-5) associated with AL from the meta-analysis in the three Asian cohorts.  
 
     
SCESc  
(n = 1,860)  
SCORMc 
(n = 929)  
SiMESc  
(n = 2,155) 
Meta-analysis 
(n =  4,944) 
SNP 
Nearest 
Gene CHR BP MAa MAFb 
βd 
(s.e) P MAF 
β  




(s.e.) Pmeta Phete 
rs4373767 ZC3H11B 1 217826305 C 0.30 -0.21 
(0.05) 
2.55 ×10-6 0.32 -0.16 
(0.05) 
1.80 ×10-3 0.24 -0.12 
(0.04) 
1.22 ×10-3 -0.16 
(0.02) 
2.69 ×10-10 0.23 
rs10779363 ZC3H11B 1 217853513 C 0.29 -0.21 
(0.05) 
5.27 ×10-6 0.31 -0.17 
(0.05) 
1.63 ×10-3 0.24 -0.11 
(0.04) 
1.70 ×10-3 -0.15 
(0.02) 
7.83 ×10-10 0.23 
rs7544369 ZC3H11B 1 217856085 T 0.29 -0.21 
(0.05) 
7.17 ×10-6 0.31 -0.16 
(0.05) 
2.56 ×10-3 0.24 -0.12 
(0.04) 
1.45 ×10-3 -0.15 
(0.03) 
1.10 ×10-9 0.29 
rs4428898 ZC3H11B 1 217806589 G 0.30 -0.21 
(0.05) 
4.49 ×10-6 0.31 -0.14 
(0.05) 
7.46 ×10-3 0.22 -0.10 
(0.04) 
4.79 ×10-3 -0.14 
(0.02) 
9.07 ×10-9 0.19 
rs4557020 SPTBN1 2 54571685 T 0.37 -0.11 
(0.04) 
9.08 ×10-3 0.37 -0.15 
(0.05) 
2.81 ×10-3 0.31 -0.11 
(0.03) 
8.10 ×10-4 -0.12 
(0.02) 
2.61 ×10-7 0.76 
rs282544 PARP8 5 50062222 C 0.35 -0.10 
(0.04) 
2.38 ×10-2 0.33 -0.14 
(0.05) 
6.13 ×10-3 0.40 -0.09 
(0.03) 
2.40 ×10-3 -0.10 
(0.02) 
4.15 ×10-6 0.70 
rs1137 SEMA4F 2 74792684 C 0.16 -0.01 
(0.06) 
8.68 ×10-1 0.18 0.22 (0.06) 5.97 ×10-4 0.26 0.14 
(0.03) 
3.01 ×10-5 0.12 
(0.03) 
4.26 ×10-6 0.02 
rs2404958 PARP8 5 50098792 T 0.35 -0.10 
(0.04) 
2.91 ×10-2 0.33 -0.15 
(0.05) 
5.32 ×10-3 0.40 -0.09 
(0.03) 
2.46 ×10-3 -0.10 
(0.02) 
4.72 ×10-6 0.66 
rs10735496 ZC3H11B 1 217790029 C 0.29 -0.14 
(0.05) 
1.95 ×10-3 0.30 -0.09 
(0.05) 
7.61 ×10-2 0.26 -0.10 
(0.03) 
3.66 ×10-3 -0.11 
(0.02) 
5.75 ×10-6 0.71 
rs4671938 SPTBN1 2 54546708 G 0.35 -0.08 
(0.04) 
5.85 ×10-2 0.34 -0.12 
(0.05) 
1.61 ×10-2 0.33 -0.11 
(0.03) 
8.92 ×10-4 -0.10 
(0.02) 
7.46 ×10-6 0.82 
rs32396 PARP8 5 50142196 A 0.35 -0.09 
(0.04) 
3.78 ×10-2 0.33 -0.14 
(0.05) 
6.98 ×10-3 0.40 -0.09 
(0.03) 
2.57 ×10-3 -0.10 
(0.02) 
7.73 ×10-6 0.69 
rs12055210 PARP8 5 50025458 A 0.35 -0.10 
(0.04) 
2.38 ×10-2 0.33 -0.14 
(0.05) 
8.39 ×10-3 0.40 -0.09 
(0.03) 
4.01 ×10-3 -0.10 
(0.02) 
9.11 ×10-6 0.70 
rs11954386 PARP8 5 50021409 A 0.35 -0.10 
(0.04) 
2.17 ×10-2 0.33 -0.14 
(0.05) 
6.34 ×10-3 0.40 -0.09 
(0.03) 
5.35 ×10-3 -0.10 
(0.02) 
9.44 ×10-6 0.63 
aMA, minor allele. 
bMAF, minor allele frequency in each cohort. 
cGWAS cohorts. SCES - Singapore Chinese Eye Study; SCORM - Singapore Cohort study of the Risk factors for Myopia; SiMES - 
Singapore Malay Eye Study. 
dβ, coefficient of linear regression; s.e., standard error for coefficient β. Association between each genetic marker and AL was examined 
using linear regression, adjusted for age, gender, height and level of education. The effect sizes denote changes in millimeter of AL 
per each additional copy of the minor allele. 





Table 7. Association between genetic variants at chromosome 1q41 and high myopia in the five Asian cohorts. 
 
   Japan Dataset 1 
(483/1,194)c 
























Pmeta Phet e 
rs4428898 217806589 G 0.74  
(0.64, 0.87) 
2.33 ×10-4 0.76  
(0.64, 0.91) 
2.15 ×10-3 0.73  
(0.45, 1.19) 
2.06 ×10-1 0.63 
 (0.40, 0.99) 
4.89 ×10-2 0.72  
(0.32, 1.64) 
4.37 ×10-1 0.74  
(0.66, 0.83) 
7.86 ×10-8 0.96 
rs4373767 217826305 C 0.74  
(0.63, 0.86) 
1.44 ×10-4 0.81  
(0.68, 0.96) 
1.80 ×10-2 0.73  
(0.44, 1.18) 
1.99 ×10-1 0.59  
(0.38, 0.94) 
2.59 ×10-2 0.77 
(0.35, 1.69) 
5.16 ×10-1 0.75  
(0.68, 0.84) 
4.38 ×10-7 0.75 
rs10779363 217853513 C 0.74  
(0.63, 0.87) 
2.11 ×10-4 0.81  
(0.68, 0.96) 
1.41 ×10-2 0.68  
(0.41, 1.13) 
1.35 ×10-1 0.62  
(0.39, 0.98) 
4.13 ×10-2 0.76  
(0.34, 1.68) 
4.96 ×10-1 0.76  
(0.68, 0.85) 
7.81 ×10-7 0.82 
rs7544369 217856085 T 0.75  
(0.64, 0.88) 
3.05 ×10-4 0.82  
(0.69, 0.97) 
2.32 ×10-2 0.67  
(0.39, 1.15) 
1.45×10-1 0.62  
(0.39, 0.98) 
4.17 ×10-2 0.74  
(0.33, 1.64) 
4.56 ×10-1 0.76  
(0.69, 0.85) 
1.45 ×10-6 0.79 
aMA, minor allele. 
bGWAS cohorts; SCES - Singapore Chinese Eye Study; SCORM - Singapore Cohort study of the Risk factors for Myopia;  SiMES - 
Singapore Malay Eye Study. 
cThe sample sizes for each study denote the number of high-myopia cases versus controls. For the Japan dataset 1, high myopia, AL ≥ 28mm 
for both eyes; controls,  general healthy population;  For the Japan dataset 2, SCES, and SiMES, high myopia, SE ≤ -9.0 D for either eye; 
controls, SE ≥ -3.0 D for both eyes; For SCORM children, high myopia, SE ≤ -6.0 D for either eye; controls, SE ≥ -1.0 D for both eyes.  
dOR, odds ratio per copy of minor allele.  











Figure 4. Principal component analysis (PCA) was performed in SiMES to 
assess the extent of population structure.  
Each figure represents a bivariate plot of two principal components from the 
PCA analysis of genetic diversity within SiMES. (A) 1st eigenvector against 
2nd eigenvector, (B) 2nd eigenvector against 3rd eigenvector, (C) 3rd 
eigenvector against 4th eigenvector and (D) 1nd eigenvector against 5th 
eigenvector . The first 5 principal components were used as covariates to 






Figure 5.  Principal Component Analysis (PCA) of discovery cohorts SCES, 
SCORM and SiMES with respect to the four population panels in phase 2 of 
the HapMap samples (CEU - European, YRI – African, CHB – Chinese, JPT – 
Japanese).   
( A) Principal components 1 versus 2; The principal components (PCs) were 
calculated with SCES, SCORM, SiMES and four HapMap panels on the 
thinned set of 102,122 SNPs (r2 <0.2). (B) Principal components 1 versus 2; 
(C) Principal components 1 versus 3; (D) Principal components 1 versus 4. 
For figure(B-D), The PCs were calculated with SCES, SCORM, SiMES and 










Figure 6.  Quantitle –Quantitle (Q-Q) plots of P-values for association between 
all SNPs and AL in the individual cohort (A) SCES,  (B) SCORM,(C) SiMES, and 










Figure 7. Manhattan plot of -log10(P) for the association on axial length from 
the meta-analysis in the combined cohorts of SCES, SCORM and SiMES.  






























Figure 8. The chromosome 1q41 region and its association with axial length 
in the Asian cohorts. A) Regional plots for AL from the meta-analysis of three 
Asian GWAS cohorts: SCES, SCORM and SiMES. The association signals in a 1 
megabase (Mb) region at chromosome 1q41 from 217,400 kb to 218,400 kb around 
the top SNP rs4373767 (red diamond) are plotted. The degree of pair-wise LD 
between the rs4373767 and any genotyped SNPs in this region is indicated by red 
shading, measured by r2. Superimposed on the plots are gene locations and 
recombination rates in HapMap Chinese and Japanese populations (blue lines).  B) 
LD plot showing pair-wise r2 for all the SNPs genotyped in HapMap database 
residing between rs4428898 and rs7544369, inclusively, at chromosome 1q41. The 
four identified top SNPs are in red rectangles. The LD plot is generated by 
Haploview using SNPs (MAF > 1%) genotyped on Han Chinese and Japanese 









Figure 9. mRNA expression of ZC3H11B, SLC30A10 and LYPLAL1 in human 
tissues .  
Expression of mRNA for the three genes was examined in human brain, 
placenta, neural retina (retina), retinal pigment epithelium (RPE) and sclera 
from adult tissues, and retina/RPE and sclera from 24-week gestation fetal 
tissues using reverse transcription polymerase chain reaction (RT-PCR). 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a housekeeping gene 
and was used as an internal control for the quantification of mRNA 
expression. NTC (No template control) served as a negative control with the 
















Figure 10. Transcription quantification of ZC3H11A, SLC30A10 and 
LYPLAL1 in mouse retina, retinal pigment epithelium and sclera in induced 
myopic eyes, fellow eyes and independent control eyes.  
Myopia was induced using -15 diopter negative lenses in the right eye of mice 
for 6 weeks. Uncovered left eyes were served as fellow eyes and age-matched 
naive mice eyes were controls. Quantification of mRNA expression in mice 
neural retina (retina), retinal pigment epithelium (RPE) and sclera using 
quantitative real-time PCR. The bar represents the fold changes of mRNA for 
each gene after normalization using GAPDH as reference. The mRNA levels 
of murine ZC3H11A, a gene that is conserved with respect to ZC3H11B in 
human, SLC30A10 and LYPLAL1 in myopic and fellow retina, RPE and sclera 
are compared with independent controls with P-values as follows:  ZC3H11A 
(retina/ RPE/sclera, P = 2.60 × 10-5, 2.62 × 10-6 and 1.08 × 10-4 respectively), 
SLC30A10 (P = 2.00 × 10-4, 2.00 × 10-4 and 4.02 × 10-4 respectively) and 









Figure 11.  Immunofluorescent labelling of (A) ZC3H11A (B) SLC30A10 and 
(C) LYPLAL1 in mouse retina, retinal pigment epithelium and sclera in 
induced myopic eyes, fellow eyes and independent control eyes. 
The neural retina (retina), retinal pigment epithelium (PRE) and scleral cells 
were immunolabeled with the polycolonal antibodies against ZC3H11A, 
SLC30A10 and LYPLAL1 and were co-labeled with 4',6-diamidino-2-
phenylindole (DAPI). Negative controls were devoid of a fluorescence signal, 
treated with the secondary antibody alone and DAPI. No immunostaining was 
observed in the negative controls. Scale bar represents 50µM and 
magnification is 200X. The florescence intensity labeled of the green color 
shows the localization of proteins and blue color indicates the nuclei that were 
stained with DAPI. Expression of the proteins had a trend in abundance 
similarly to that of their mRNA levels as depicted in Figure 10. Lower level 
of expression was determined for ZC3H11A in all tissues for myopic mice. 
Similarly significant reduction was shown in the expression of SLC30A10 in 
retina and RPE while higher level of expression was found in myopic sclera. 
LYPLAL1 showed higher level of expression in the retina and RPE tissue but 
reduced expression in the sclera in myopic mice. The following abbreviations 
represent the retinal layers: nerve fibre layer (NFL), ganglion cell layer 
(GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform 




4 Chapter 4   Genome-Wide Meta-Analysis of Five Asian 
Cohorts Identifies PDGFRA as a Susceptibility Locus for 
Corneal Astigmatism  
This Chapter is a slightly modified version of the paper published in PLoS Genet 
2011, 7(12):  e1002402. doi:10.1371/journal.pgen.1002402  
 
4.1 Abstract 
      Corneal astigmatism refers to refractive abnormalities and irregularities in the 
curvature of the cornea, and this interferes with light being accurately focused at a 
single point in the eye. This ametropic condition is highly prevalent, influences 
visual acuity and is a highly heritable trait. There is currently a paucity of research 
in the genetic aetiology of corneal astigmatism. Here we report the results from 
five genome-wide association studies of corneal astigmatism across three Asian 
populations, with case-control datasets of Chinese (1,991 cases /954 controls), 
Malays (1,018 cases /1,220 controls), Indians (825 cases /1,314 controls) and an 
independent 397 Chinese family trios. Variants in PDGFRA on chromosome 4q12 
(lead SNP: rs7677751, allelic odds ratio = 1.26 (95% CI: 1.16-1.36), Pmeta = 7.87 
× 10-9) were identified to be significantly associated with corneal astigmatism, 
exhibiting consistent effect sizes across all five cohorts. This highlights the 
potential role of variants in PDGFRA in the genetic aetiology of corneal 





      Astigmatism is a condition where light rays are prevented from focusing at a 
single point in the eye, resulting in blurred vision at any near or far distance. The 
reported age-adjusted prevalence of astigmatism was 37.8% for Chinese adults284, 
54.8% in rural Asian Indians334, 37% (≤ -0.75 D) for Caucasian in Australia335 
and 36.2% in the US336. The prevalence of astigmatism in children varies 
considerably across different studies and ethnic groups. For instance, the 
prevalence of astigmatism (≤ -0.75 D) in school-children ranges from 13.6% in 
Australia337, 20% in Northern Ireland338, 28.4% for Singapore school children122, 
to 42.7% for Chinese children in urban China339.  
      Although the precise cause of astigmatism is unknown, genetic factors have 
been implicated in the aetiology of corneal astigmatism. Studies have reported a 
higher risk of developing astigmatism in individuals whose sibling or parents 
have astigmatism125. However, only a few segregation analyses have been 
conducted for astigmatism. A study examined the mode of inheritance of 
astigmatism in 476 individuals from 125 nuclear familiars with probands affected 
by astigmatism340. The results suggested familial transformation existing for 
affected probands (≤ -0.75 D), and single-major-locus inheritance when the 
corneal astigmatism was coded as ordinal outcome by the severity degree. 
      Proportion of genetic contribution to astigmatism development is generally 
lower than that for spherical refractive error, with the estimated heritability, in 
general, ranging from 30% to 60%157,341-344. For instance, Hammond and 
colleagues157 investigated the inheritance of astigmatism for 226 monzygotic 
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(MZ) and 280 dizygotic (DZ) twins in the United Kingdom and found genetic 
effects accounted for 42% to 61% of the variation in corneal astigmatism. 
Similarly, heritability estimate was as high as 60% in 345 MZ and 267 DZ twin 
pairs in Austria in myopia (GEM) twin study341. While most of the twin studies 
have been conducted in Caucasian populations, a study on Chinese twins in 
Taiwan reported a heritability estimate of 46% for corneal astigmatism, 
suggesting that genetic factors account for a similar extent in the aetiology of 
astigmatism for Asian populations343.  However, in a recent study in 52 MZ and 
47 female twin pairs aged 66-79 years, the genetic contribution to the corneal 
astigmatism is not significant345; this may be due to the small samples size.  
      No genetic loci have been systematically and consistently identified to be 
implicated in the development of corneal astigmatism. Here we report the findings 
from the meta-analyses of five genome-wide association studies (GWAS) 
performed in 8,513 individuals from three Asian populations. The discovery 
phase of our study comprises 4,254 individuals from two population-based 
GWAS performed in adults of Chinese and Malay ethnicities from the Singapore 
Prospective Study Program (SP2) and the Singapore Malay Eye Study (SiMES) 
respectively. The replication phase comprises of data from three other genome-
wide surveys of: (i) 2,139 Indian adults from the Singapore Indian Eye Study 
(SINDI); (ii) 929 Chinese school children from the Singapore Cohort Study of the 
Risk Factors for Myopia (SCORM); and (iii) 397 Chinese trios of parents and 
astigmatic offsprings from the Singaporean Chinese in the Strabismus, Amblyopia 





4.3.1 Study cohorts 
      Singapore Prospective Study Program (SP2): Participants included in SP2 
were recruited from a revisit of four previously conducted population-based 
surveys in Singapore: Thyroid and Heart Study 1982-1984346, National Health 
Survey 1992347, National University of Singapore Heart Study 1993–1995348 and 
the National Health Survey 1998347-349. These studies comprise random samplings 
of individuals stratified by ethnicity from the entire Singapore population. From 
2003 to 2007, a total of 10,747 adults aged 40 years or older were invited in this 
follow-up survey of which 5,157 underwent a health examination and blood 
samples were drawn. The present genome-wide genotyping involved individuals 
of Chinese descent only (n = 2,867). Complete post-filtering data on corneal 
astigmatism for GWAS were available for 2,016 individuals.    
      Singapore Malay Eye Study (SiMES): SiMES is a population-based cross-
sectional survey on eye diseases for Malay adults aged 40 to 80 years living in 
Singapore. It was conducted between August of 2004 and June of 2006. The 
details of the study design and methods have been previously described291.  In 
brief, a total of 4,168 Malay residents in the Southwestern area of Singapore were 
identified and invited for a detailed ocular examination which 3,280 (78.7%) 
participated. Genome-wide genotyping was performed in 3,072 individuals26,29. 
Individuals with cataract surgery and missing corneal astigmatism measurements 
were excluded from the study. Complete post-filtering data on corneal 
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astigmatism for GWAS were available for 2,238 individuals.    
      Singapore Indian Eye Study (SINDI): SINDI is a population-based survey of 
major eye diseases288 in ethnic Indians aged 40 to 80 years living in the South-
Western part of Singapore and was conducted from August 2007 to December 
2009. In brief, 4,497 Indian adults were eligible and 3,400 participated. Genome-
wide genotyping was performed in 2,953 individuals26,29.  As in the discovery 
cohorts, participants were excluded from the study if they had cataract surgery 
and missing corneal astigmatism data. Complete post-filtering data on corneal 
astigmatism were available for 2,134 participants.  
      Singapore Cohort study of the Risk factors for Myopia (SCORM): A total of 
1,979 children in grades 1, 2, and 3 from three schools were recruited from 1999 
to 2001 with detailed information described elsewhere289.  The children were 
examined on the school premises annually by a team of eye care professionals. 
The GWAS was conducted in a subset of Chinese children of 1,116 subjects22. 
The phenotype used in this study was based on the corneal astigmatism measured 
on the 4th annual examination of the study (children at age 10 to 12 years). 
Complete post-filtering data on corneal astigmatism measurements and SNP data 
were available in 929 SCORM children.    
      Singaporean Chinese in the Strabismus, Amblyopia and Refractive Error 
Study (STARS): STARS is a population-based survey of Chinese families with 
children aged 6 to 72 months residing in the south-western and western region of 
Singapore. Disproportionate random sampling by 6-month age groups resulted in 
the recruitment and subsequent eye examination of 3,009 Chinese children 
108 
 
between May 2006 and November 2008. Details of the study design and 
methodology have been previously described350. A total of 1,451 samples from 
440 nuclear families were included for genome-wide genotyping. In all, 397 trio-
sets of parents and their offsprings with corneal astigmatism had complete post-
filtered genotype data. 
Measurements and definition of corneal astigmatism 
      All studies used a similar protocol to measure ocular phenotypes including 
corneal curvature, autorefraction and cylinder power by a team of eye care 
professionals. Participants in SP2, SIMES and SINDI underwent non-cycloplegic 
automated refractive assessments using the autorefractor (Canon RK-5, Tokyo, 
Japan). For SCORM and STARS, cycloplegic measurements (Canon RK-F1, 
Tokyo, Japan) were performed 30 minutes after three drops of 1% cyclopentolate 
which were administered 5 minutes apart.   
      Corneal curvature radii in the horizontal and vertical meridian were 
determined with keratometry in millimeters351. The keratometer measured the 
anterior corneal surface and used a refractive index of 1.3375 to account for the 
contribution from the posterior corneal surface to derive the corneal refractive 
power in diopters. Corneal cylinder power was calculated as the difference 
between the flattest and steepest meridian of the keratometry readings in diopters 
of power.  
      As the corneal cylinder power between the right and left eyes are strongly 
correlated across all five cohorts (Pearson’s correlation coefficient r ranging from 
0.51 to 0.79; P < 0.001), the mean corneal cylinder power over both eyes was 
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used to define corneal astigmatism.  Averaging ocular measurements between two 
eyes in genetic studies has been suggested to be statistically more powerful than 
using the information from only one eye36, and this approach has been 
consistently adopted in genome-wide studies of myopia34,35. As with previous 
studies337,340, we have defined individuals with average corneal cylinder power ≤ -
0.75 D as cases, and those with average corneal power between -0.75 D and 0 D 
as controls. 
 
4.3.2 Data quality control 
      For SP2, a total of 2,867 blood-derived DNA samples were genotyped using 
the Illumina Human610 Quad and 1Mduov3 Beadchips. For the samples that were 
genotyped on the two platforms, the genotypes from the denser platform were 
used in our study. For SiMES (n = 3,072), SINDI (n = 2,593) and STARS (n = 
1,451), the Illumina Human610 Quad Beadchips were used for genotyping all 
DNA samples. For the 1,116 SCORM children, DNA samples were genotyped on 
the Illumina HumanHap 550 Duo Beadchips®.  
      In brief, for case-control study design, QC criteria included a first round for 
autosomes SNP QC to obtain a cleaned set of genotypes for sample QC, by 
excluding SNPs with: (i) missingness (per-SNP call rate) > 5%; (ii) minor allele 
frequency (MAF) < 1%; and (iii) HWE p-value < 10-7. Using the subset of SNPs 
passing the first round QC, samples were then excluded based on the following 
conditions: (i) per-sample call rates of less than 95%; (ii) excessive 
heterozygosity (defined as the sample heterozygosity to be beyond 3 standard 
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deviations from the mean sample heterozygosity); (iii) cryptic relatedness; (iv) 
gender discrepancies; and (v) deviation in population membership from 
population structure analysis. A second round of SNP QC was then applied to the 
remaining samples passing quality checks. We excluded SNPs with missingness > 
5%, gross departure from HWE (P value < 10-6), MAF <1 % and low 
concordance between duplicate samples on different genotype platforms (relevant 
to SP2 samples only).  
      Population structure was ascertained using principal components analyses 
(PCA) with the EIGENSTRAT program7. Population substructure of SP2, 
SiMES, SINDI and SCORM was examined by PCA with respect to three 
population panels in the HapMap samples (Figure 12). Due to the presence of 
population structure within the Malay (Figure 4) and Indian samples (Figure 13), 
we adjusted for the top 5 principal components in the association analyses for the 
SiMES and SINDI datasets.  
      For the STARS trios, we additionally excluded samples and trio-sets on the 
basis of excessive Mendelian inconsistencies defined as having > 1% of the post-
QC SNPs exhibiting Mendelian errors. SNPs with more than 10% Mendelian 
errors are excluded from the association analyses, and the genotypes leading to 
Mendelian errors in all other remaining SNPs are coded as missing. As family 
trios are more robust to the presence of population structure, we did not exclude 
any samples due to population structure.   
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      Detailed data quality control (QC) procedures for each study are as follows 
(except the QC procedure for SCORM and SiMES are provided in Chapter 3 
Method Session):  
      SP2: Of the 2,867 blood-derived DNA samples, 392 samples were genotyped 
on the HumanHap 550v3, 1,459 samples on the 610-Quad, 817 samples on the 
1M-Duov3, 191 samples on both 550v3 and 1M-Duov3, and 8 samples on both 
610-Quad and 1M-Duov3. For the samples that were genotyped on two platforms, 
we used the genotypes from the denser platform in our study. We excluded 443 
individuals on the following conditions, sample call rates of less than 95%, 
excessive heterozygosity, cryptic relatedness by IBS, population structure 
ascertainment, and gender discrepancies as listed in the main text. This left 2,434 
post-QC SP2 samples. During the SNPs QC procedure, we excluded SNPs with 
low genotyping call rates (> 5% missingness) or monomorphic, with MAF < 1%, 
or with significant deviation from HWE (P< 10-6). This yielded a post-QC set of 
462,580 SNPs. As SP2 samples are genotyped on different platforms, the 
concordance of the duplicate samples plated on different Beadarrays chips was 
also examined as quality of genotyping. The average SNP concordance rate 
between chips for the post-QC duplicated samples was 0.995. We additionally 
assessed the SNPs that are present on different platforms for extreme variations in 
allele frequencies with a 2-degree of freedom chi-square test of proportions, 
removing 62 SNPs with P-values < 0.0001. We further excluded those with 
missing phenotype data on corneal astigmatism (n = 418). This yields a final set 
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of 462,518 SNPs that are common to all 2,016 SP2 samples (1231 cases, 785 
controls).   
       SiMES: Using the same quality control criteria, we omitted a total of 530 
individuals from the total of 3,280 samples in the study, including those of 
subpopulation structure (n = 170), cryptic relatedness (n = 279), excessive 
heterozygosity or high missingness rate > 5% (n = 37), and gender discrepancy (n 
= 44). After the removal of the samples, SNP QC was then applied on a total of 
579,999 autosomal SNPs for the 2,542 post-QC samples. SNPs were excluded 
based on (i) high rates of missingness (> 5%) (n = 26,343); (ii) monomorphic 
SNPs or MAF < 1% (n = 34,891); or (iii) genotype frequencies deviated from 
HWE (p < 1 × 10-6) (n = 3,053). This yielded 515,712 SNPs after the same SNP 
QC criteria. Those with missing data or having cataract surgery were further 
removed (n = 304).  Finally, 515,712 SNPs in 2,238 samples (1018 cases, 1220 
controls) were available for association analysis.  
      SINDI: We excluded 415 subjects from the total of 2,953 genotyped samples 
based on: excessive heterozygosity or high missingness rate > 5% (n = 34), 
cryptic relatedness (n = 326), issues with population structure ascertainment (n = 
39) and gender discrepancies (n = 16). This left a total of 2,538 individuals with 
579,999 autosomal SNPs. During SNP QC procedure, i) 17,923 SNPs were 
removed due to high rates of missingness (> 5%), ii) and 17,966 SNP that were 
monomorphic or had MAF < 1%, iii) and 2,958 SNPs out of HWE (p < 10-6). 
After SNP QC, 541,152 SNPs were available for analysis. We further excluded 
any individuals with missing data on corneal astigmatism measurements and 
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having history of cataract surgery (n = 399). This yielded a final dataset of 2,139 
individuals (825 cases, 1,314 controls) and 541,152 post-QC SNPs.    
      STARS: Of the total of 1,451 genotyping samples, the individuals were 
excluded based on gender discrepancy (n = 17), high missingness (> 5%), 
excessive heterozygosity (n = 11) and excessive Mendelian inconsistency 
(Mendelian error per family > 1%; n = 14). This left a set of 1,408 samples in 436 
families after quality control, of which 57 samples (from 29 families) were further 
excluded due to founder singleton, or non-founder without 2 parents, yielding 
1,351 individuals in 407 families. SNP QC was performed on the 576,979 
autosomal SNPs by excluding those with high missingness rate > 5% (n = 1,984), 
gross departure of HWE for parents (P < 10-8) (n = 908), monomorphic SNPs and 
SNPs with MAF <1% (n = 80,804), and SNPs exhibiting significant degree of 
Mendelian inconsistencies (> 10% of all the trios) (n = 7). This led to a final set of 
493,594 post-QC SNPs. We further restricted the family-based analyses to 1,191 
individuals in 397 parents-trios (317 nuclear families) having corneal astigmatic 
child. In all, 493,594 SNPs for 1,191 samples from 397 parent-trios were 
available for family GWAS on corneal astigmatism.        
 
4.3.3 Statistical methods 
      The genome-wide association tests were performed using PLlNK (version 
1.07; http://pngu.mgh.harvard.edu/~purcell/plink/) as the primary analysis tool. A 
logistic regression adjusted for age and gender is used to model the association of 
genetic markers with corneal astigmatism. For each of SiMES and SINDI, the top 
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5 principal components of genetic ancestry from the EIGENSTART PCA were 
also included as covariates to adjust for population stratification in these 
populations. We assumed an additive genetic model where the genotypes of each 
SNP is coded as 0, 1, and 2 for the number of minor alleles carried, in keeping 
with increments in allelic dosage. For family GWAS association tests in STARS, 
a transmission disequilibrium test (TDT) is used to measure significant distortions 
in transmission of an allele from heterozygous parents to the affected offspring 
under the condition of Mendel’s law352.  
      We also performed a quantitative trait analysis with the average corneal 
cylinder power as the outcome. This is performed in PLINK for the unrelated 
samples, and in FBAT (http://www.hsph.harvard.edu/~fbat/fbat.htm) for the 
family trios. As the distribution of the quantitative trait of corneal cylinder power 
is skewed, we performed a normal quantile transformation 353 prior to the 
association analysis for unrelated samples. For family-based data, no 
transformation was conducted since the FBAT does not require normal trait55 
      A meta-analysis of all five datasets is performed using weighted-inverse 
variance estimated from fixed-effect modelling in METAL 
(http://www.sph.umich.edu/csg/abecasis/metal/). We adopt the method by 
Kazeem and Farrall352 to pool the evidence from the case-control analyses and the 
family trio TDT. For the quantitative trait analysis, the overall z statistics is 
calculated as a weighted sum of the z-statistics from the linear regressions in the 
non-familial data and FBAT analysis for the family-based data, weighted by 
number of unrelated individuals or trios in the respective studies58.    
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      Genotyping quality of all reported SNPs in this paper have been visually 
assessed by checking the intensity clusterplots.    
4.4 Results  
4.4.1 Datasets after quality control 
      The characteristics of the post-QC samples from the five studies are 
summarised in Table 8. The post-QC SP2 dataset comprised 2,016 adults, of 
which 1,231 individuals had corneal astigmatism (≤ -0.75 D) and 785 subjects 
were defined as non-astigmatic controls. The post-QC datasets comprised 2,238 
adults (1,018 cases and 1,220 controls) in SiMES, 825 cases and 1,314 controls in 
SINID, and 760 cases and 169 controls in SCORM. 397 trio-sets of parents and 
their offsprings with corneal astigmatism passed sample QC (n = 1,191). In total, 
the genome-wide meta-analysis was conducted on 460,528 autosomal genotyped 
SNPs passed stringent quality control criteria present in all studies consisting of 
8,513 individuals.  
      There was no evidence of over-inflation of statistical significances due to 
population structure in either of the cohorts (SP2 λGC = 1.006, SiMES λGC = 
1.007, SINDI λGC = 1.009, SCORM λGC = 1.01, STARS λGC = 1.021 ) or in the 
meta-analysis of all studies (overall λGC = 1.002). Suggestive evidence of 
association (defined as 10-7 < P-value < 10-5) were seen in each of cohort 
(Figures 14A -E), as well as in the meta-analysis of five cohorts where a 
collection of SNPs deviated from their expected distributions in the quantile-
quantile plots of the P-values (Figure 14F).    
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4.4.2 Gene PDGFRA exhibiting genome-wide significance 
      Three SNPs (rs7677751, rs2307049 and rs7660560) in meta-analysis attained 
genome-wide significance of P-value < 5 × 10-8 and were found to cluster in the 
platelet-derived growth factor receptor alpha (PDGFRA) gene on chromosome 
4q12 (lowest P = 7.87  × 10-9 at rs7677751; Table 9; Figure 15). The direction 
and magnitude of the effect sizes at these SNPs in all five cohorts were highly 
similar. No significant evidence of effect size heterogeneity was detected across 
the SNPs (heterogeneity I2 P-value ≥ 0.246), and the minor allele frequencies of 
these SNPs are consistently similar across all five studies. Interestingly, these 
SNPs are located within the MYP9 region identified previously as a candidate 
locus for myopia through linkage scans 39.  
      At the most significant SNP rs7677751 in PDGFRA, the frequency of the risk 
T-allele ranged from 0.19  to 0.26 in the five cohorts and conferred a 26% higher 
risk of corneal astigmatism than the C allele (OR = 1.26, 95% CI = 1.16 – 1.36) in 
the meta-analysis across all five studies (Figure 16). This SNP alone explains 
0.41% of the variation in corneal cylinder power. In addition, a general genetic 
model identified that the 5.5% of the individuals in the combined cohorts that 
carry the TT genotype at rs7677751 had a 1.65-fold (95% CI = 1.33 – 2.06, P-
value = 6.23 ×  10-6) increase in the risk of developing corneal astigmatism 
compared to those that are not carrying any copies of the risk allele. All of the 
associated SNPs spanned 10kb within PDGFRA at 4q12, and a high degree of 
linkage disequilibrium is seen at this locus in all three Asian populations 




4.5  Discussion 
      We have performed a genome-wide survey for corneal astigmatism across 
8,513 individuals, combining the data from five GWAS performed in Chinese and 
Malay adults, Indian adults, Chinese children and family trios. We observed a 
strong and consistent association with the onset of corneal astigmatism at the 
PDGFRA gene locus on chromosome 4q12 across all five Asian cohorts, with 
three SNPs in this locus exhibiting evidence stronger than genome-wide 
significance in the meta-analysis. To the best of our knowledge, this is the first 
GWAS to investigate the genetic aetiology of corneal astigmatism in a genome-
wide fashion.  
      The PDGFRA gene spans 69kb with 23 coding exons and resides on 
chromosome 4q12. The receptor for platelet-derived growth factor (PDGF) 
contains two types of subunit, a- and β- PDGFRA, which are differentially 
expressed on the cell surface354. PDGFR-a binds to three forms of PDGF (PDGF-
AA, AB and BB) and mediates many biological process including embryonic 
development, angiogenesis, cell proliferation and differentiation. The role of 
PDGFRA in cellular growth and proliferation is underlined by its contribution to 
the pathogenesis of gastrointestinal stromal tumours355. A large body of evidence 
has shown that both PDGF and its receptors are expressed in corneal epithelium, 
stromal fibroblasts and endothelium356,357 as well as proliferative retinal tissues in 
eyes358-360. Along with other cytokines (epidermal growth factor, transforming 
growth factor-a,-β etc), studies have further suggested that PDGF and its 
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receptors can mediate corneal fibroblast migration, matrix remodelling and play 
an important role in corneal wound healing357,361-363. The corneal stroma 
comprises a large portion of the cornea; the sensitivity of stromal tissue to various 
growth factors is well described364. The administration of PDGF resulted in 
keratinocyte elongation using rabbit corneal stroma tissue365. In light of this, a 
role for PDGFRA in the regulation of ocular development and parameters cannot 
be excluded, and our study suggests that genetic polymorphisms within PDGFRA 
may be involved in the regulation of corneal biometrics resulting in the 
occurrence of corneal astigmatism. 
      In addition, Hammond and colleagues reported that 4q12 (MYP9; LOD 3.3) 
was significant linked with myopia from a genome-wide linkage study of 221 
dizygotic twin pairs39, and subsequent replication revealed nominal significance 
of 4q12 (P = 0.065) for refractive error in African-American families38. We thus 
undertook a candidate SNP approach with the identified SNPs to investigate the 
possible association between PDGFRA and (i) the onset of high myopia; (ii) the 
refractive error as a quantitative trait. We did not observe any striking association 
between the identified variants with either outcomes, suggesting that the 
association of PDGFRA with corneal astigmatism is probably not through any 
shared aetiology with myopia.   
      The most significant SNP in our analyses rs7677751 is located in the intron 1 
of PDGFRA. Interestingly, among the SNPs identified, rs2228230 is coding-
synonymous (valine:GTC > valine:GTT) and resides in exon 18, while rs3690 is 
within the untranslated-3’ region (Figure 17). These three SNPs (rs7677751, 
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rs2228230 and rs3690) are strongly correlated with each other (pair-wise Pearson 
correlation coefficient r ranging from 0.77 to 0.81), although the association 
evidence at the latter two SNPs did not reach genome-wide significance. As the 
next closest gene (GSX2) from the 5’ end of PDGFRA is 127kb away and is not 
within the LD block with our identified SNPs, it is unlikely that the signals 
observed in our study are attributed to functional variants located beyond 
PDGFRA.  
      Our group recently reported a strong association between variants in PDGFRA 
with corneal curvature366. Corneal curvature is an ocular dimension defined as the 
average of the radius of corneal curvature at the horizontal and vertical meridians. 
Myopic eyes have been found to have steeper corneas (reduced radius of 
curvature), but the significant correlation between corneal curvature and refractive 
error was not consistently observed331,367,368. Excessively flatter cornea is 
associated with cornea plana, producing high hyprotropia and likely resulting in 
angle-closure glaucoma33,369. On the other hand, corneal astigmatism is an eye-
disorder, where the cornea is more curved in one meridian direction compared to 
the other. This fragmentizes the light rays entering the eye, leading to the inability 
to focus onto a single point in the eye115. It is thus interesting that the same 
PDGFRA gene has been identified in two ocular outcomes that are biologically 
different, given the presence of a weak correlation between corneal astigmatism 
and corneal curvature (Spearman correlation coefficient r between 0.088 and 
0.192 in our cohorts), pointing to a possible pleiotropic contribution of PDGFRA. 
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      Our study has adopted a binary definition of corneal astigmatism (affected and 
unaffected) that is commonly adopted in clinical practice and eye-trait 
epidemiology337,340. One caveat of this definition is the potential for 
misclassifying the affected status, particularly for samples with cylinder power 
around the cutoff threshold of -0.75D. To evaluate the robustness of our findings 
to the choice of threshold used, we additionally performed the association analysis 
at the identified SNPs with four different combinations of the thresholds used to 
define cases and controls. We observed that the odds ratios were highly similar 
across all four scenarios, with the combined evidence at rs7677751 ranging from 
Pmeta of 1.5 × 10-4 to 6.7 × 10-8. Unsurprisingly, the association evidence was 
weakest in the scenario with the most stringent thresholding (≤ -1.5 for cases and 
> -0.5 for controls), given this stringency comes at the expense of decreasing the 
number of individuals in each study. We additionally performed a secondary 
analysis treating corneal cylinder power as a quantitative trait. Strong statistical 
evidence was consistently observed at the three leading SNPs (rs7677751, P = 
1.76 ×10-7; rs2307049, P = 3.41 × 10-7 and rs7660560, P = 4.41 × 10-7), indicating 
that our findings are robust to the definition of the phenotype.  
      Owing to the relatively small sample sizes within each of the five GWAS 
studies, we have chosen to priortise our survey to identify genetic variants that 
contribute to the aetiology of corneal astigmatism in multiple Asian populations. 
While Malays have been observed to be genetically closer to the Chinese, the 
Asian Indians tend to be genetically closer to the Caucasians100. Our discovery at 
PDGFRA thus suggests that part of the underlying biological pathway responsible 
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for astigmatism development is common to multiple populations, although there 
may be population-specific genetic variants that our current study is not 
sufficiently powered to identify.  
      Our study has included two pediatric Chinese populations (SCORM and 
STARS) with school or pre-school children who are still progressing to their final 
phenotype. It was documented that a high degree of astigmatism occurs during 
infancy and the early childhood 370. The prevalence rates remain stable during 
young adulthood (18 to 40 years), but increase consistently during late adulthood 
at aged 40 years or older115,284. Studies have also indicated that the age-related 
change in astigmatism is associated with meridians changes in the cornea125. 
Children and adolescents have a predominance of “within-the-rule” corneal 
astigmatism in general, where the vertical curve is greater than the horizontal 
(axis of 1° to 15°); while in older adults, it shifts to “against-the-rule” astigmatism 
(axis of 75° -105°)371,372. However, our study considers corneal astigmatism 
without reference to the axis nor the longitudinal changes from children to adults. 
Whether PDGFRA plays the same role in pediatric and adults populations will 









                                                                                              
 
Figure 12 Principal Component Analysis (PCA) of SP2, SiMES, SINDI, SCORM 
with respect to the population panels in phase 2 of the HapMap samples (CEU - 








Figure 13 Principal component analysis (PCA) was performed in SINDI to assess 
the extent of population structure.  Each figure represents a bivariate plot of two 
principal components from the PCA analysis of genetic diversity within SINDI. 
(A) 1st eigenvector against 2nd eigenvector, (B) 2nd eigenvector against 3rd 
eigenvector, (C) 3rd eigenvector against 4th eigenvector and (D) 1nd eigenvector 
against 5th eigenvector . The first 5 principal components were used as covariates 
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Figure 14 Quantile-Quantile (Q-Q) plots of P-values for association between all 
SNPs and corneal astigmatism in the combined meta-analysis of (A) individual 
cohort SP2, (B) SiMES, (C) SINID, (D) SCORM, (E) STARS and (F) SP2 + 







Figure 15 (A) Manhattan plot of log10(P-values) in the combined discovery 
cohort of SP2, SiMES, SINDI, SCORM and STARS. The blue horizontal line 
presents the threshold of suggestive significance (P = 1.00 x 10-5). (B) Regional 
plot of the association signals from the meta-analysis of the five GWAS cohorts 
around the PDGFRA gene locus. A region of 400kb around the lead SNP 
(rs7677751, red diamond) is shown. The LD between the lead SNP and the 
neighbouring SNPs is represented by the shading of the squares, with increasing 
shade of red indicating higher LD as measured by r2. The blue lines represent the 






Figure 16. Forest plot of the estimated allelic odds ratios for the lead SNP 
rs7677751. The allelic odd ratios for allele T of rs7677751 and 95% confidence 
intervals are presented for the five studies separately (black rectangles or green 








   
Figure 17 Linkage disequilibrium (LD) calculated in terms of r2 for Singapore 
Chinese samples from SP2 (A), Malays samples from SiMES (B) and Indians 
panels from SINID(C). Black squares show perfect LD whereas shades of grey 






Table 8. Characteristics of the participants in five studies 
Cohorts SP2 SIMES  SINDI  SCORM STARS 
Individuals genotyped  2687 3280 2953 1116 1451 (440 families) 
Individuals after QC 2434 2542 2538 1008 1351 (407 families) 
Individuals in GWAS 2016 2238 2139 929 1191 (397 parents-trios) 
Male (%) 45.8% 48.9% 51.2% 51.8% 52.3%
a 
Age (SD) 47.9 (11.2) 57.7 (10.7) 55.9 (8.9) 10.8 (0.8) 7.5 (3.8)
a 
Cases 1231 1018 825 760 NA 
Controls 785 1220 1314 169 NA 
Corneal cylinder powerb (SD)     
Cases -1.38 (0.73) -1.37 (0.94) -1.21 (0.58) -1.52 (0.68) 1.30 (0.78)* 
Controls -0.48 (0.15) -0.46 (0.15) -0.46 (0.16) -0.47 (0.14) NA 
aInformation of gender and age is based on data from the offsprings with corneal astigmatism in STARS family cohort.  
bAveraged across both eyes; NA, not available; Age is in years. 
SP2 - Singapore Prospective Study Program; SiMES - Singapore Malay Eye Study; SINDI - Singapore Indian Eye 
Study; SCORM - Singapore Cohort study of the Risk factors for Myopia; STARS - Singaporean Chinese in the 
Strabismus, Amblyopia and Refractive Error Study.
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Table 9 Top SNPs (P-value ≤ 5 x 10-6) identified from combined meta-analysis of five Asian population cohorts. 




 (n = 2,238)  
SINDI 
(n = 2,139)  
SCORM  
(n = 929)  
STARS 
(397 trios)   
Meta-analysis 
(n=8,513)  
SNP GENE CHR BPa Ab EAFc OR P OR P OR P OR P OR P OR s.e. P Pe 
rs7677751 PDGFRA 4 54819217 T 0.23 1.35 3.76E-04 1.27 6.26E-04 1.23 4.09E-03 1.22 2.00E-01 1.12 3.74E-01 1.30 0.05 7.87E-09 0.786 
rs7660560 PDGFRA 4 54829151 A 0.23 1.32 1.46E-03 1.28 5.34E-04 1.26 1.37E-03 1.13 4.22E-01 1.14 3.20E-01 1.29 0.05 1.15E-08 0.839 
rs2307049 PDGFRA 4 54824911 A 0.23 1.31 2.17E-03 1.26 7.55E-04 1.27 1.08E-03 1.14 4.03E-01 1.14 3.17E-01 1.28 0.05 1.58E-08 0.885 
rs10189905  2 199387355 G 0.12 0.72 2.56E-03 0.78 4.13E-03 0.83 1.09E-01 1.08 7.05E-01 0.61 5.70E-03 0.76 0.07 5.57E-07 0.508 
rs3690 PDGFRA 4 54856570 C 0.28 1.40 6.25E-04 1.29 1.53E-03 1.18 2.17E-02 1.03 8.58E-01 1.09 5.28E-01 1.33 0.06 7.77E-07 0.391 
rs4864872 PDGFRA 4 54847041 T 0.20 1.41 5.94E-04 1.26 3.19E-03 1.19 1.49E-02 1.05 7.69E-01 1.06 6.71E-01 1.32 0.06 1.24E-06 0.370 
rs2228230 PDGFRA 4 54846797 T 0.20 1.41 5.94E-04 1.26 3.19E-03 1.19 1.67E-02 1.05 7.69E-01 1.06 6.71E-01 1.32 0.06 1.43E-06 0.362 
rs10032688  4 54855415 A 0.19 1.39 8.28E-04 1.26 3.07E-03 1.20 1.39E-02 1.02 8.97E-01 1.11 4.80E-01 1.31 0.06 1.64E-06 0.470 
rs17084051  4 54782338 A 0.24 1.35 3.68E-04 1.26 1.08E-03 1.14 7.77E-02 1.23 1.68E-01 1.04 7.55E-01 1.29 0.05 2.16E-06 0.246 
rs6758183  2 226709230 A 0.16 1.37 2.36E-02 1.41 1.58E-03 1.21 1.10E-02 1.17 5.24E-01 1.33 1.78E-01 1.39 0.09 2.80E-06 0.772 
rs7676985  4 54759330 A 0.26 1.26 2.41E-03 1.19 1.10E-02 1.14 6.09E-02 1.36 3.82E-02 1.09 4.51E-01 1.22 0.05 2.98E-06 0.693 
rs1547904 PDGFRA 4 54841146 T 0.19 1.35 1.77E-03 1.24 6.10E-03 1.19 1.52E-02 1.09 6.19E-01 1.07 6.27E-01 1.28 0.06 4.41E-06 0.626 
rs6792584 SUCLG2 3 67614078 G 0.24 1.10 2.61E-01 1.36 8.33E-06 1.16 4.06E-02 1.02 8.72E-01 1.17 2.21E-01 1.24 0.05 4.72E-06 0.205 
rs2270676 KCNE3 11 73846059 G 0.20 0.74 1.89E-03 0.80 1.67E-03 0.90 1.76E-01 1.08 6.75E-01 0.80 1.18E-01 0.78 0.06 5.09E-06 0.392 
aBase pair positions are indicated according to the NCBI build 136 (hg18); bEffect allele;  cAverage effect allele frequency in the discovery 
cohort; s Standard error for odds ratios; eP-value for heterogeneity I2 between five study cohorts. 
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5 Chapter 5  Genome-Wide Comparison of Estimated 
Recombination Rates between Populations 
5.1 Study summary 
      Inter-population differences in recombination patterns yield important insights 
into recent human evolution and trans-ethnic fine-mapping. Although 
recombination profiles are largely conserved at a broad scale between 
populations, preliminary findings have suggested there are variations in fine-scale 
differences in recombination rates.  
      In this study, a signal-processing strategy (varRecM) is proposed to evaluate 
variations in inter-population recombination rates. Generally speaking, 
recombination rates estimated from two populations can differ in the following 
two aspects (see Figure 18): in (i) the kurtosis or ‘peakedness’ of the 
recombination profiles (e.g. Figure 18A to C); or in (ii) the level of coupling, or 
phase shifting, between the rates (e.g. Figure 18D to F). This method 
simultaneously quantifies the extent in the differential peakedness of the 
recombination profiles as well as the degree of phase shift, and adopts a sliding 
window approach to interrogate the whole genome for any variation in 
recombination patterns. For each sliding window, a numerical score (the varRecM 
score) that reflects the extent of recombination variation is assigned. A larger 
score represents greater evidence of variation in either the peakedness or the 
phase shift of the recombination rate profiles. Genomic regions harbouring 
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significant differences in recombination rate profiles are thus more likely to 
generate scores that lie in the right tail of the genome-wide distribution.  
      Using LD-based recombination rates that have been computed from the 
International HapMap Project (HapMap)5 and the Singapore Genome Variation 
Project (SGVP)100, we subsequently apply our varRecM method to compare the 
recombination rates between five population panels composed of European, East 
Asian, African, Singapore Chinese and Singapore Indian samples. This represents 
the first attempt to comprehensively catalogue recombination rate variations 
across different human populations on a genome-wide scale. While overall 
patterns of recombination were conserved between populations, several regions 
emerged with strong evidence of recombination rate variation that encompass 
genes exhibiting population-specific signatures of positive natural selection. 




5.2.1 Development of recombination variation score 
      We calculate the recombination rate differences between two populations with 
the varRecM score, which quantifies the extent in the differential peakedness and 
the degree of phase shift in the two recombination profiles from each of the two 
populations. The approach is implemented genome-wide by adopting a sliding 
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window of 50 kb throughout the whole genome where consecutive windows are 
shifted by one SNP. Assuming there are two recombination rate profiles estimated 
from the two populations across L SNPs within each genomic window, we define 
the varRecM score as  
𝑤 |  𝑔(1) − 𝑔(2)|
𝑔(1) + 𝑔(2)  
where g(1) and g(2)  denote the cumulative recombination measured in 
centimorgans (commonly defined as the genetic distance) within the window for 
population 1 and population 2 respectively and each metric is calculated as the 
area under the curve of the recombination rates across the window; and w denotes 
a composite weight metric. While we have taken the absolute value in the 
numerator, in practice we can identify which population spans a larger genetic 
distance for the same window (thus indicating a higher likelihood for 
recombination to take place) from the sign of g(1) – g(2). The weight metric w is 
defined as the product of two components wm and wcor, where: (i) wm effectively 
measures the kurtosis of the recombination peak (for the population that spans the 
larger genetic distance) relative to the averaged recombination in the window and 
is defined as 






with cl(k) denotes the recombination rate (in cM/Mb) between SNP l and SNP (l + 
1), k denotes the population that spans the larger genetic distance, and D defines 
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the physical distance of the window (in Mb); and (ii) wcor represents the extent of 
‘uncoupling’, or dissimilarity in correlation, between the two series of 
recombination rates across L SNPs in the two populations and is given as  
                                                   𝑤𝑐𝑜𝑟 = 1 − maxlag��𝑟lag�� ,  lag = 0, 1, 2, 3,… 
Here, rlag represents the lagged cross-correlation coefficient between the two 
recombination rate series and is defined as 
𝑟lag = ∑ �𝑐𝑙+𝑙𝑎𝑔(1) − 𝑐̅(1)� �𝑐𝑙(2) − 𝑐̅(2)�𝐿−lag𝑙=1
�∑ �𝑐𝑙+𝑙𝑎𝑔
(1) − 𝑐̅(1)�2 𝐿−lag𝑙=1  �∑ �𝑐𝑙(2) − 𝑐̅(2)�2𝐿−lag𝑙=1  
with 𝑐̅(𝑘) denoting the average recombination rate across the window for 
population k. 
      To provide a more robust assessment of the cross-correlation coefficient, 
particularly when a recombination peak occurs at the boundary of the window, the 
calculation of rlag is performed either with an additional buffer region of 4kb at 
each end of the window, or includes the recombination rates from two additional 
SNPs at each end, depending on which scheme includes more SNPs. The 
inclusion of the lag component explicitly allows for different SNP densities in the 
two populations. The use of the genetic distance also mitigates the need for the 
same SNPs to be present in the two populations.  
      The rationale behind the inclusion of the first component wm is to up-weigh 
the score of a window where there is a clear regional elevation of recombination 
rate beyond the averaged rate across the window (for example, a recombination 
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hotspot). Typically wm is between 0 and 2, except in the rare occasion that the 
maximum estimated recombination rate is at least 100 cM/Mb above the region-
averaged recombination rate. The intuition behind the second component wcor, 
bounded between 0 and 1 inclusive, is to down-weigh the scores where the cross-
correlation between the two series of recombination rates is high, since a high 
level of coupling between the two series of recombination rates suggests a smaller 
difference in recombination pattern between the two populations in this genomic 
window. 
5.2.2  Simulation   
Simulating recombination rates for two populations 
      For evaluating the performance of the method, we simulated recombination 
rates for two populations across a 200kb region spanning 401 evenly distributed 
SNPs. In population k (where k ∈ {1, 2}), we introduced a recombination hotspot 
starting at a physical position dk, with a width of wk (in kb) that is distributed as 
Normal (2, 0.52), and spans a genetic distance of gk (in cM). The assumed size of 
the hotspot is consistent with those observed in sperm typing78,373. The genetic 
distance here is equivalently the area under the recombination hotspot versus 
physical distance curve, or a measure of the cumulative peakedness of the 
recombination hotspot. The background recombination rate used in our simulation 
is assumed to follow an exponential distribution with a mean of 0.24cM/Mb. This 
is based on the observation that the average recombination rate is 1.2cM/Mb 
across the human genome, and yet only 20% of the recombination occurs outside 
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recombination hotspots374. In our simulations, we assume the presence of a 
recombination hotspot in each of the two populations, varying in intensity and 
location of the hotspots. The recombination rate for the hotspot in the first 
population g1 is distributed as Normal (µ, 0.52) with µ measured in cM/Mb. The 
recombination rate in the second population g2 is defined with respect to λ, which 
represents the ratio of g1 to g2 (or λ = g1/g2). Larger values of λ correspond to 
greater differences in the recombination profiles between the two populations.  
      For the assessment of the specificity of the varRecM metric, let ddiff denote the 
distance (in kb) between the starting locations of the two hotspots, assumed to be 
distributed as Normal (0, σd2) with σd ∈ {0, 0.5, 1, 2}. Varying σd2 thus controls 
the proximity of the hotspots in the two populations, and larger values of σd2 
effectively introduce greater differences in the simulated recombination profiles. 
In addition to adding moderate jitter in the starting positions of the recombination 
hotspots, we also evaluate the robustness of the varRecM metric in situations 
where moderate differences exist in the peakedness of the recombination hotspots 
between the two populations but not in the location of the hotspots. This is 
achieved by setting µ  as 25cM/Mb (for the first population) and λ ∈ {1, 5, 10}. 
We also evaluate the effect of varying the lag parameter in the metric across a 
range of values (0, 2, 4, 6, 8, 12 and 10 log10(L/2)), which broadly corresponds to 
lag distances of 0kb, 1kb, 2kb, 3kb, 4kb, 6kb and 5 log10(L/2)kb given a SNP 
density of 2 SNPs/kb.  
       Our assessment of the sensitivity of varRecM assumes the recombination 
hotspot for population 1 is located in the center of the simulated 200kb region, 
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while the hotspot for population 2 is randomly distributed between the 75kb and 
125kb mark in each window. Given that the size of each hotspot follows a Normal 
(2, 0.52) distribution, this simulates a high likelihood that the two hotspots are 
found in significantly different locations. In addition, we vary the relative 
intensities of the hotspots by setting µ ∈ {6, 25, 50} and allowing λ  to range 
from 1 (no difference in the peak intensities) to 50 (where the genetic distance 
from the recombination hotspot in population 1 is fifty times the genetic distance 
in population 2).  
      By performing 10,000 simulations under each of the different settings for σd,λ 
and µ, we count the frequencies where a large varRecM score than a pre-defined 
genome-wide threshold is obtained, since this represents stronger evidence of 
inter-population variation in recombination rates relative to the genome-wide 
distribution. The empirical distributions of the varRecM score from the pairwise 
genome-wide comparisons of the three HapMap populations displayed similar 
values for the top quantiles. We thus averaged the varRecM scores at the top 1% 
(and also the top 5% and top 0.1%) across the three pairs of comparisons , and 
used these values as thresholds in our calculation of statistical power and false 
positive rates. The power and false positive rates in our simulations are thus 
defined as the proportion of simulations out of 10,000 where obtained score 
exceeds the thresholds at the top 5%, 1% and 0.1% given the different 
combinations of σd ,λ and µ. In all likelihood, our choice of genome-wide 
thresholds will result in a marginal under-estimate of the statistical power and 




5.2.3 Estimation of recombination rates 
Data 
      Our genome-wide comparisons utilised recombination rates estimated from 
the genotypes of autosomal SNPs in the three population panels in Phase 2 of the 
HapMap5, as well as in the three Asian populations from the SGVP100. Phase 2 of 
HapMap surveyed around 2.8 million SNPs in each of the three panels, consisting 
of: (i) 60 unrelated individuals in Utah with European ancestry (CEU); (ii) 60 
unrelated Yoruba individuals sampled from the Ibadan region of Nigeria (YRI); 
(iii) 45 unrelated Han Chinese from Beijing (CHB) and 45 unrelated Japanese 
from Tokyo (JPT), which have been pooled as the East Asian panel (JPT+CHB). 
The SGVP surveyed around 1.6 million autosomal SNPs in three population 
groups, consisting of 96 Chinese (CHS), 89 Malays (MAS) and 83 Asian Indians 
(INS) in Singapore. Population-specific recombination rates for the SGVP 
samples are downloaded from the SGVP website (http://www.nus-
cme.org.sg/sgvp). To avoid any inadvertent confounding in our analyses that are 
solely attributed to the different SNP densities, we thinned the SNPs from the 
HapMap populations to a similar set of SNPs found in SGVP and re-estimated the 
recombination rates for each population panel separately.   
Recombination rate estimation 
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      Both the HapMap and SGVP used LDhat101 to calculate the recombination 
rates within each population, yielding an estimated rate in cM/Mb for each 
successive pair of SNPs. For the HapMap populations, per generation 
recombination rates c were obtained as the ratio of the estimated rate from LDhat 
to the effective population size, which have been estimated as 11,418 for CEU, 
17,469 for YRI and 14,269 for JPT+CHB60,375. For the SGVP populations, the 
effective population size of 14,269 was used for the Chinese and Malays, while 
the average of the effective population sizes for CEU and JPT+CHB (Ne = 
12,844) was used for the Singapore Indians.  
5.2.4 Simulation   
Simulating recombination rates for two populations 
      For evaluating the performance of the method, we simulated recombination 
rates for two populations across a 200kb region spanning 401 evenly distributed 
SNPs. In population k (where k ∈ {1, 2}), we introduced a recombination hotspot 
starting at a physical position dk, with a width of wk (in kb) that is distributed as 
Normal (2, 0.52), and spans a genetic distance of gk (in cM). The assumed size of 
the hotspot is consistent with those observed in sperm typing78,373. The genetic 
distance here is equivalently the area under the recombination hotspot versus 
physical distance curve, or a measure of the cumulative peakedness of the 
recombination hotspot. The background recombination rate used in our simulation 
is assumed to follow an exponential distribution with a mean of 0.24cM/Mb. This 
is based on the observation that the average recombination rate is 1.2cM/Mb 
139 
 
across the human genome, and yet only 20% of the recombination occurs outside 
recombination hotspots374. In our simulations, we assume the presence of a 
recombination hotspot in each of the two populations, varying in intensity and 
location of the hotspots. The recombination rate for the hotspot in the first 
population g1 is distributed as Normal (µ, 0.52) with µ measured in cM/Mb. The 
recombination rate in the second population g2 is defined with respect to λ, which 
represents the ratio of g1 to g2 (or λ = g1/g2). Larger values of λ correspond to 
greater differences in the recombination profiles between the two populations.  
      For the assessment of the false positive rate of the varRecM metric, let ddiff 
denote the distance (in kb) between the starting locations of the two hotspots, 
assumed to be distributed as Normal (0, σd2) with σd ∈ {0, 0.5, 1, 2}. Varying σd2 
thus controls the proximity of the hotspots in the two populations, and larger 
values of σd2 effectively introduce greater differences in the simulated 
recombination profiles. In addition to adding moderate jitter in the starting 
positions of the recombination hotspots, we also evaluate the robustness of the 
varRecM metric in situations where moderate differences exist in the peakedness 
of the recombination hotspots between the two populations but not in the location 
of the hotspots. This is achieved by setting µ  as 25cM/Mb (for the first 
population) and λ ∈ {1, 5, 10}. We also evaluate the effect of varying the lag 
parameter in the metric across a range of values (0, 2, 4, 6, 8, 12 and 10 
log10(L/2)), which broadly corresponds to lag distances of 0kb, 1kb, 2kb, 3kb, 
4kb, 6kb and 5 log10(L/2)kb given a SNP density of 2 SNPs/kb.  
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       Our assessment of the power of varRecM assumes the recombination hotspot 
for population 1 is located in the center of the simulated 200kb region, while the 
hotspot for population 2 is randomly distributed between the 75kb and 125kb 
mark in each window. Given that the size of each hotspot follows a Normal (2, 
0.52) distribution, this simulates a high likelihood that the two hotspots are found 
in significantly different locations. In addition, we vary the relative intensities of 
the hotspots by setting µ ∈ {6, 25, 50} and allowing λ  to range from 1 (no 
difference in the peak intensities) to 50 (where the genetic distance from the 
recombination hotspot in population 1 is fifty times the genetic distance in 
population 2).  
      By performing 10,000 simulations under each of the different settings for σd,λ 
and µ, we count the frequencies where a large varRecM score than a pre-defined 
genome-wide threshold is obtained, since this represents stronger evidence of 
inter-population variation in recombination rates relative to the genome-wide 
distribution. The empirical distributions of the varRecM score from the pairwise 
genome-wide comparisons of the three HapMap populations displayed similar 
values for the top quantiles. We thus averaged the varRecM scores at the top 1% 
(and also the top 5% and top 0.1%) across the three pairs of comparisons , and 
used these values as thresholds in our calculation of statistical power and false 
positive rates. The power and false positive rates in our simulations are thus 
defined as the proportion of simulations out of 10,000 where obtained score 
exceeds the thresholds at the top 5%, 1% and 0.1% given the different 
combinations of σd ,λ and µ. In all likelihood, our choice of genome-wide 
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thresholds will result in a marginal under-estimate of the statistical power and 
false positive rates. 
5.2.5 SNP annotation, copy number variation and FST calculation    
      Annotation information for all the SNPs was obtained from the PLINK 
retrieval interface (http://pngu.mgh.harvard.edu/~purcell/plink/psnp.shtml) which 
uses the TAMAL database 376 and maps to the information from the UCSC 
genome browser, HapMap and dbSNP build 126. We additionally classify each 
SNP as whether it is: (i) non-synonymous; (ii) synonymous; (iii) found within a 
gene; or (iv) not within a gene. We used Version 10 of the database for copy 
number variation from the Database of Genomic Variants (http://projects.tcag.ca).  
      For each SNP that is present in both populations, we calculated the FST using 
the Weir and Cockerham estimator377. This metric quantifies the difference in 
allele frequencies at a SNP between two populations. For each window in the 
calculation of the varRecM score, we adopt an established approach378 that uses 
the maximum FST across the SNPs to represent the regional differentiation 
between two populations. 
 
5.2.6 Quantification of variations in linkage disequilibrium 
      We used the varLD programme379 to assess the extent of LD variation 
between two populations across the genome, which considers sliding windows of 
50 SNPs with a 1-SNP shift. The position of each window is summarised as the 
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average physical position across the 50 SNPs. Further details of the varLD 
algorithm can be found in the original publication379. To evaluate the correlation 
between the varRecM and varLD scores calculated for each pair of populations, 
we calculated both the average and the maximum varLD scores across all varLD 
windows possessing averaged positions that fall within the start and end positions 
for each of the 50kb varRecM windows. We consider the varRecM windows with 
scores that are found in 15 bins, each spanning 0.1 quantile of the varRecM 
scores. The 15 quantile intervals considered are: 4.9th – 5th, 9.9th – 10th, 19.9th – 
20th, 29.9th – 30th, 39.9th – 40th, 49.9th – 50th, 59.9th – 60th, 69.9th – 70th, 79.9th – 
80th, 89.9th – 90th, 94.9th – 95th, 97.4th – 97.5th, 98.9th – 99th, 99.4th – 99.5th, 99.9th – 
100th. For example, the 94.9th – 95th quantile interval contains all the windows 
where the varRecM scores are found to be at least as large as 94.9% of the 
genome-wide distribution but less than the top 5% of the scores. We calculate the 
Pearson’s correlation coefficient between the varLD scores and the varRecM 
scores across the regions in these 15 bins. In addition, we also calculated the 
correlation between varLD and varRecM scores after adjusting for the effect of 
population differentiation as quantified by FST. This is achieved by regression the 





5.3 Results  
5.3.1 Simulation studies on power and false positive rates 
      Our formulation of the varRecM metric explicitly locates genomic regions 
where there is a significant deviation, such as a spike, in the recombination profile 
of one population that is not present in the second population. The varRecM score 
is negligible when the recombination profile is relatively flat across both 
populations. Thus, in assessing the power and false positive rates (FPRs) of 
varRecM, our simulations concentrated on situations where there is at least one 
spike in the recombination rates of each population, with varying degrees of 
peakedness and with different hotspot locations. We compared the varRecM score 
for each simulated window against three thresholds at the top 0.1%, 1% and 5% 
quantiles of the genome-wide distributions obtained from pairwise comparisons 
of the HapMap populations. This approach of prioritizing regions found in the 
extreme tails of the genome-wide distribution is similar to other population 
genetics strategies for highlighting unique features in the human genome, such as 
extreme evidence of LD variation379 and positive natural selection378,380-382.  
       We first evaluate the relevance of the lag component in the varRecM metric 
in minimizing the FPR. In addition to varying the relative intensities of the 
recombination profiles (quantified as λ ∈ {1, 5, 10}) in our simulations, we also 
allow minor variations in the hotspots locations in the two populations. This 
mimics the situation where the recombination rates in each population have been 
estimated with a slightly different set of SNPs due to the use of different 
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genotyping technology which can introduce minor deviations in the positions of 
the hotspots. When the simulated hotspots are located at exactly the same 
positions (corresponding to σd = 0), the FPR at the 1% threshold is almost entirely 
zero regardless of the relative intensities λ and the lag values used (Figure 19A). 
Unsurprisingly, as the positions of the hotspots start to vary (σd > 0), higher FPRs 
are observed although this can be controlled by increasing the lag value (Figure 
19B-D). Similar patterns are observed with the use of the 0.1% and 5% 
thresholds. However, increasing the lag reduces the power to detect genuine 
variations in recombination rates (Figure 20A) although this attenuation of power 
is marginal for moderately small lag values at the top 1% and 5% threshold (i.e. < 
6). Based on the SNP densities found in Phase 2 of the HapMap and SGVP, we 
calibrate the varRecM metric to adopt a lag distance equivalent to approximately 
4kb in all subsequent analyses.  
      To investigate the sensitivity of the varRecM metric to variations in 
recombination rates, we vary the ratios of hotspot intensities and the locations of 
the hotspots in the two populations (Figure 20B-D). Unsurprisingly, the power of 
varRecM is observed to increase with larger differences in the hotspot intensities 
(as λ increases from 1 to 50), particularly when the average intensity in the 
reference population is high (µ of 25 and 50 cM/Mb). The power is generally 
lower for detecting variations as a result of smaller spikes in recombination 




5.3.2 Application to HapMap and Singapore Genome Variation Project 
      Using the estimated recombination rates for HapMap and SGVP, five 
genome-wide scans of recombination rate variations are performed for the 
following population pairings: (i) CEU versus JPT+CHB; (ii) CEU versus YRI; 
(iii) JPT+CHB versus YRI; (iv) CHS versus INS; (v) CHS versus JPT+CHB. We 
adopt a sliding window approach where each window spans 50kb and consecutive 
windows are shifted by 1 SNP (see Subjects and methods).  Overlapping regions 
that emerged in the top 1% of each scan are merged to localize the start and end 
positions, and to avoid double-counting. In general, the genome-wide distribution 
of the varRecM statistics has a high kurtosis with long tails (Figure 21). Our 
survey of the two relatively homogeneous populations (CHS and JPT+CHB, 
median FST = 0.3%) revealed that the varRecM scores tend to be clustered around 
zero, with a median score of 0.0063, or approximately four-fold lower than the 
median scores from the comparison between YRI and non-YRI HapMap 
populations (Table 10). Using the associated varRecM score in the top 1% of the 
genome-wide distribution, we observed an apparent pattern in the spatial 
distribution of the population-specific recombination peak regions. From our 
pairwise comparisons between HapMap CEU and non-CEU samples (YRI , 
JPT+CHB), 114 regions exhibited strong evidence of CEU-specific 
recombination peaks across the autosomes (Figure 22). The same analyses 
comparing JPT+CHB against CEU and YRI identified 88 regions, while the 
corresponding number for YRI-specific recombination peaks is 294.  
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      Amongst the strongest twenty regions that emerged in the comparison 
between the HapMap Europeans (CEU) and East Asian (JPT+CHB), six regions 
harboured genetic evidence of population-specific positive selection (Table 11) 
such as the region on chromosome 15 that encompassed the SLC24A5 
pigmentation gene which is well-established to be positively selected in 
Europeans but not in other populations383. Recombination peaks spanning 0.12cM 
and 0.05cM are found adjacent to SLC24A5 in JPT+CHB (Figure 23A ) and YRI 
respectively, and this is notably absent in CEU.  Another region encapsulated the 
LPP gene on chromosome 3q28. The region spans a 100kb window where a 
significant spike in the recombination rates was observed in CEU, but not in 
JPT+CHB (Figure 23B). Intriguingly the recombination hotspot was also present 
in CHS, and this window emerged with strong evidence of recombination 
variation in our analysis between CHS and HapMap JPT+CHB (Table 12). The 
LPP gene has previously been reported as a strong candidate for recent positive 
selection in the HapMap East Asians382, and subsequent studies have suggested 
that this selection signal is present only in northern Chinese populations but not in 
southern Chinese populations384. It is however not necessarily true that a selection 
sweep appears to coincide with a region of low recombination, as we observed 
spikes in recombination in regions reported to be undergoing positive selection. 
One example is at the region encompassing PHACTR1, which is a candidate gene 
for positive selection in HapMap East Asian381 but yet exhibits evidence of 
significant recombination in JPT+CHB (Figure 23C).  
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      For the comparisons between YRI and the non-African populations (CEU, 
CHB+JPT), only two top regions contain population-specific selection (Table 
11). The first is in the region around the SLC24A5 gene in the comparison 
between CEU and YRI; the second is an extended region surrounding GRP85 on 
chromosome 7 which has been identified to be positive selected in East Asians380-
382 (Figure 23D). In addition, although recombination hotspots are thought to be 
highly active in YRI populations, strong population-specific recombination peaks 
are also observed for CEU (10 of 20 top regions) and CHB + JPT (6 of 20) in the 
comparison to YRI (Table 12). 
      In addition to locating candidates of positive selection, there are other regions 
that emerged with strong evidence of inter-population differences in 
recombination rates (Table 11 & Table 12, Figure 24 - 28). Several genes are 
related with severe genetic syndromes. For example, the region encompassing 
SPINK5 (associated with Netherton syndrome) on chromosome 5q32 was 
consistently identified among the top signals in the comparisons between YRI and 
non-Africans (CEU, JPT+CHB); PLCE1 on chromosome 10q23, which is 
associated with diffuse mesangial sclerosis (DMS), has two strong hotspots in the 
gene for JPT+CHB populations but a significantly weaker recombination profile 
in YRI; and SLC2A2 on chromosome 3q26, which is a major genetic factor for 
Fancoin-Bickel syndrome, has a hotspot that is present only in CEU but not in 




5.3.3 Recombination variation and Linkage disequilibrium variation highly 
correlated 
      To examine the relationship between inter-population variations in 
recombination rates and LD patterns, we measured the average and maximum 
varLD scores for each window used in the varRecM score calculation. We 
observed strong correlations between the varRecM and averaged varLD metrics in 
all of our comparisons (Pearson’s correlation coefficient r ranging from 0.873 to 
0.965 with corresponding p-values ranging from 2.10 × 10-5 to 6.38 × 10-9, see 
Figure 29), except in the comparison between the two East Asian panels (CHS 
versus JPT+CHB, r = -0.039, P-value = 0.889). Similar patterns were observed 
when we use the maximum varLD scores. The strongest correlation between 
inter-population LD variation and recombination differences was observed in the 
comparison between JPT+CHB and YRI. To address whether this strong 
relationship is driven by the differences in allele frequency spectrum between the 
populations which may inadvertently bias both the LD calculations and the 
recombination rate estimation, we calculated the FST for every SNP that is found 
in both populations and calculated the maximum FST across the SNPs in each 
window. Similar correlation patterns between the varRecM and varLD scores 
remained after accounting for the FST within a regression framework, while no 




5.3.4 Regions with largest recombination variation less frequent in genes  
      We observed there was an enrichment of windows exhibiting high varRecM 
scores in non-gene regions (P-values < 10-7, Figure 30), except in the comparison 
between CHS and JPT+CHB (P-value = 0.614). In the comparison between CEU 
and JPT+CHB, high varRecM scores (defined as in the top 1% of the genome-
wide distribution) were 1.11 times (95% CI: 1.07 – 1.15, P-value = 1.23 × 10-9) 
more likely to be found in nongenic regions as compared to varRecM scores 
below the top percentile. Similar odds ratios were observed in the comparisons 
between CEU and YRI (OR = 1.23, 95% CI: 1.19 – 1.27, P-value = 8.66 × 10-24); 
JPT+CHB and YRI (OR = 1.16, 95% CI: 1.12 – 1.20, P-value = 1.76 × 10-18); 
CHS and INS (OR =1.10, 95% CI: 1.06 – 1.17, P-value =5.67 × 10-8). This 
suggests that extreme inter-population variations in recombination rates are 
generally less likely to happen in gene regions, which concurs with previous 




      We have introduced a quantitative approach to evaluate fine-scale inter-
population variation in recombination rates across the whole genome based on the 
high-resolution recombination maps. This method is especially powerful for 
locating genomic regions where a recombination spike exists in one population 
but not in another population. By introducing a lag component in the formula, our 
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metric is robust to small shifts in the relative positions of recombination hotspots 
that are found in both populations. We adopted the same approach as most 
population genetics strategies for LD variations379 and positive selection379-381 by 
prioritizing genomic regions with extreme evidence when benchmarked against 
the rest of the genome. We applied our method to pairs of populations from 
HapMap and SGVP, observing significant fine-scale differences in the 
recombination profiles of Europeans, Africans and East Asians. The number of 
regions in the top 1% exhibiting strong evidence of YRI-specific recombination 
peaks is at least twice the number of population-specific recombination peaks for 
CEU or JPT+CHB. Seven of the top twenty regions that emerged with the 
strongest evidence of recombination differences between HapMap CEU and JPT+ 
CHB coincide with genomic regions exhibiting strong signatures of population-
specific positive selection, while a few of the top regions contain genomic 
signatures of positive selection from the comparisons between African and non-
African populations. In addition, multiple top regions encompass genes associated 
with the severe genetic syndromes. Large inter-population variation in 
recombination is also less frequent in genes, and unsurprisingly we detected a 
strong correlation between variations in recombination rates and LD patterns.  
      Overall the varRecM score in each window indicates the extent of 
recombination rate variation between the two populations in consideration, with 
larger values corresponding to higher amount of differences in the recombination 
rate profiles in the two populations. These differences can be due to differential 
peakedness in the recombination rates, phase shifting, or both. As with most 
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population genetic metrics, it is difficult to interpret the statistical significance of 
each varRecM score and instead we consider the overall distribution of the 
varRecM scores across the entire human genome. This allows us to identify 
specific genomic regions which exhibit the strongest evidence of recombination 
rate variation between the populations. For example, a varRecM score that falls in 
the top 0.1% of the genome-wide distribution suggests that the difference in the 
recombination rates in this particular window is more pronounced than 99.9% of 
the genome. We emphasize that this does not necessarily indicate the biological 
relevance or significance of this genomic window, other than to highlight the 
region as potentially interesting given the evidence of significant diversity in 
recombination patterns. To the best of our knowledge, there is currently no formal 
statistical metric for defining recombination rate variation without first defining 
the presence or absence of recombination hotspots. The varRecM score is thus the 
first metric that performs an agnostic survey of recombination rate differences 
with the rates directly.   
      One of the challenges we encounter in formulating a metric for evaluating 
inter-population variation in recombination rates is justifying the sensitivity of the 
method – how do we know that the regions we identified truly concur with 
genuine differences in recombination? There are two aspects to this question: (i) 
that there are genuine differences in the biological mechanisms between different 
populations that resulted in recombination preferentially occurring in one 
population but not in the other; (ii) that methods used to estimate recombination 
rates are biased by inherent artifacts in the data used, such as erroneous genotype 
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calls, loss of heterozygosity due to copy numbers or positive selection. We have 
used recombination rates that were fundamentally estimated via the coalescence 
of haplotype data385,386. This inference of historical recombination can be 
distorted locally by positive selection, since the time tracing back to the most 
recent common ancestor (MRCA) in a coalescent based-model is underestimated 
when local genetic diversity is low or reaches fixation387,388. Thus, the 
concordance between the regions of suppressed recombination we identified with 
known signatures of intensive positive selection (i.e. SLC24A5) is reassuring, 
providing the means for bench-marking the performance of the method as well. 
      Conversely, it has been suggested, perhaps surprisingly, that selective sweeps 
could also decrease or even eliminate LD on the selected loci, but such LD 
reduction has the potential to create false evidence of recombination 
hotspots103,389,390. The top regions identified in our study with the strongest 
evidence of elevated rates of recombination at well-established selection loci thus 
warrants further investigation for such scenarios.  
      Our study has approached recombination rate differences at the population 
level. However accumulating evidence suggests that differential hotspot presence 
across individuals or between males and females may be in part attributed to 
germline genetic differences. Several studies have suggested that recombination 
may be activated by: (i) a single base change at certain SNPs84,373,391; (ii) the 
presence of a certain haplotype392; or (iii) the presence of a specific 13-mer motif 
of binding site for the zinc finger104. Recent studies have also discovered the 
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coding zinc-finger protein PRDM9 gene can influence both allelic and non-allelic 
recombination and can account for up to 18% of hotspot variance in humans105,393-
395. It has been shown through pedigree analyses393 and sperm typing394 that 
individuals carrying the PRDM9 variants lacking the motif-recognizing alleles 
exhibited dramatically lower genome-wide hotspot usage. Substantial allele 
frequency differences in PRDM9 between populations have been suggested to 
result in potential shifts in recombination hotspots98. The results from our study 
are consistent with the findings that recombination hotspots can be polymorphic 
among human populations. Our approach thus serves to identify genomic regions 
that may be investigated further for association with PRDM9 variants across 
different populations.  
      Recombination is one of the key forces that breakdowns LD, and the rate of 
recombination has been widely used in SNP imputation algorithms60. Our 
genome-wide surveys identified a close relationship between the evidence of LD 
variation and recombination rate variation.  This observation is important in trans-
ethnic experiments that aim to fine-map the functional polymorphisms by 
leveraging on the genomic diversity of different populations396,397, as it highlights 
the use of population-specific recombination rates for carrying out the fine-
mapping. Since regions priortised for trans-ethnic fine-mapping tend to be 
disease-associated regions that exhibited variable LD patterns between 
populations, using recombination rates that are averaged across multiple 
populations (such as those available on the HapMap resource) may not accurately 
define the haplotype breakpoints in the different populations. We did not observe 
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any correlation between the recombination and LD differences in two closely-
related populations: CHS and JPT+CHB, likely because one or both of the 
varRecM and varLD statistics will be highly skewed in such comparisons and 
scores at the tail end of the genome-wide distribution may not effectively 
differentiate the degree of inter-population recombination variation.  
       Recently, Wegmann and colleagues have found that regions at a broad scale 
of 1Mb showing the strongest differences in recombination are disrupted by 
common structural variation (inversions) in the comparison between admixture 
American Africans and Europeans95. Some regions exhibiting largest 
recombination differences in our study also harboured copy number variation, 
especially in the comparisons between Africans and non-Africans. However, in 
contrast to the previous study, these structural variants were generally very rare 
(frequency less than 0.05) and therefore less likely to distort the local 
recombination rate estimation within these top identified regions.   
      Our findings of genomic regions that exhibit population-specific 
recombination hotspots illustrate that there can be variations in fine-scale 
recombination profiles between populations. The regions with the largest 
recombination difference residing in the population-specific sites of positive 
selection may reflect artifacts that are introduced due to a suppression of 
heterozygosity in the genotype data as a result of the positive selection signatures, 
which inadvertently affect the estimation of recombination rates. The fine-scale 
comparison of recombination profiles will priortise genomic regions for further 
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studies into the biological basis of heterogeneous recombination across different 





Figure 18. Illustration of ranking the recombination differences from two 
populations. Suppose there are two recombination rate profiles estimated from 
different populations, population 1 (yellow line) and population 2 (blue line), 
while the genetic distance (the area under the curve) for population 1 is assumed 
larger than that for population 2 in a fixed window. We rank the recombination 
differences between population 1 and 2 as depicted by the red arrow. For the 
upper panel, the region with the extent variation in the magnitude of the 
recombination peaks between these two populations is greatest in C) where high 
peak in population 1 and depleted recombination in population 2. For the lower 
panel, the recombination difference is incremental from D) to E), which is 






Figure 19. Evaluation of false positive rates (FPR) of varRecM method.  
The false positive rate of the varRecM approach is evaluated for the two 
recombination hotspots which are at the same or close proximity location with 
varying intensity. The distance between the starting positions of two hotspots is 
distributed as Normal (0, σd 2), where A) σd =0 kb, B) σd = 0.5 kb, C) σd = 1.0 kb 
and D) σd =2.0 kb.  The recombination rate for the hotspot in the first population 
g1 is distributed as Normal (25, 0.52). The recombination rate in the second 
population g2 is defined with respect to λ, where λ ∈ {1, 5, 10},*, which 
represents the recombination hotspot intensity ratio of g1 to g2. The lag parameter 
is varying across a range of values (0, 2, 4, 6, 8, 12 and 10 log10(L/2)) where L 
=100, the total SNP in the 50 kb of the window in the simulation study. Give a 
SNP density of 2 SNPs/kb in the simulated data, the lag values corresponds to lag 
distances of 0kb, 1kb, 2kb, 3kb, 4kb, 6kb and 5 log10(L/2)kb. Threshold in the 







Figure 20. Power performance of varRecM method. The power of the varRecM 
metric is evaluated using the simulated data with varying intensity and phase 
shifting of the recombination hotspots between two populations. Recombination 
hotspot for population g1 is located at the center of the simulated 50kb window, 
where the hotspot rate is distributed as Normal (µ, 0.52) and µ  is set as A) 25 
cM/Mb, B) 6 cM/Mb, C) 25 cM/Mb, and D) 50 cM/Mb. The hotspot for 
population g2 is randomly distributed within each window of 50kb, and the rate is 
determined by λ, intensity ratio of g1 to g2. For A), λ is fixed at 10; For B), C) and  
D), λ ranges from 1 (no difference in hotspot intensity) to 50 (where the hotspot 
intensity in population g1 is fifty times the hotspot intensity in population g2). The 







Figure 21. Accumulative density plots of varRecM scores from five pair 
comparisons between HapMap and SGVP populations. CEU - JPT + CHB: 
comparisons between HapMap Europeans (CEU) and East Asians (JPT+CHB) 
(black line); CEU - YRI: comparisons between HapMap European (CEU) and 
Africans (YRI) (red line); JPT + CHB - YRI: comparisons between HapMap East 
Asians (JPT + CHB) and Africans (YRI) (green line); CHS - INS: comparisons 
between SGVP Chinese (CHS) and Indian (INS) (blue line); CHS - JPT + CHB: 
comparisons between SGVP Chinese (CHS) and HapMap East Asians (JPT + 






Figure 22. Distribution of population-specific recombination peak regions in the 
top 1% of the varRecM scores. We identified those population-specific 
recombination peak regions that contained signals in the top 1% of the genome-
wide distributions in two specific population-pair comparisons (say between 
population A and population B, and between population A and population C) but 
not in the top 5% of the distribution in the third population-pair (between 
population B and population C). These regions are indicative that the signals are 
driven mainly by one population (population A in our example here). The number 






Figure 23. Top regions of largest varRecM scores with overlapping signals of 
positive selection. The top regions illustrated are from the comparisons between 
HapMap Europeans (CEU) and East Asians (JPT+CHB) (Fig. 23A-C), and 
HapMap JPT+ CHB versus Africans (YRI) (Fig. 23D). The varRecM scores are 
depicted as dark blue points.   Recombination rates for CEU (orange line), 
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in JPT+CHB but suppressed in CEU at 46.3 Mb on chromosome 15. The deficit 
of rates in CEU is within the extended selection region at gene SLC24A5. The 
horizontal grey bar near the x-axis denotes the position undergoing selection for 
CEU and the red bar below indicates the position of the gene SLC24A5. B) Strong 
recombination rate is within LPP (red bar) at 190.0 Mb on chromosome 3 in CEU 
with the selection signals for JPT+CHB (grey bar), while the rate is depleted for 
JPT+CHB at the same location. C) Recombination peaks at 12.9 Mb on 
chromosome 6 in JPT+CHB, but absent in CEU. High recombination in 
PHACTR1 genes in JPT+CHB coincides with selection reported in the Chinese 
population. D) High recombination peak in JPT+CHB but suppressed in YRI at 
112.5Mb on chromosome 7, corresponding to a selection region in JPT+CHB 








Figure 24. Plots of the top 20 regions of the varRecM scores for the comparison 
between samples of HapMap CEU and JPT+CHB.  Recombination rates of CEU 















Figure 25. Plots of the top 20 regions of the varRecM scores for the comparison 
between samples of HapMap CEU and YRI. Recombination rates of CEU (black 







Figure 26. Plots of the top 20 regions of the varRecM scores for the comparison 
between samples of HapMap JPT+CHB and YRI. Recombination rates of 









Figure 27. Plots of the top 20 regions of the varRecM scores for the comparison 
between samples of SGVP CHS and INS. Recombination rates of CHS (black 











Figure 28. Plots of the top 20 regions of the varRecM scores for the comparison 
between samples of SGVP CHS and HapMap JPT+CHB.  Recombination rates of 







Figure 29. Scatter plot of varLD score versus varRecM score among HapMap 
and SGVP populations. A) CEU - JPT+CHB (Pearson correlation coefficient r = 
0.873; p = 2.10 × 10-5 ), B) CEU- YRI (r = 0.897; p = 5.72 × 10-6 ), C) JPT+ CHB 
– YRI (r = 0.965; p = 6.38 × 10-9), D) CHS-INS (r = 0.893; p = 7.49 × 10-6 ), E) 
CHS - JPT+CHB (r = -0.039; p = 0.889). Fitted line is predicated from the linear 









Figure 30. Odds ratio of extreme varRecM scores presenting in intergenic versus 
gene regions. 
 CEU –JPT + CHB: comparisons between HapMap Europeans (CEU) and East 
Asians (JPT+CHB); CEU - YRI: HapMap European (CEU) and Africans (YRI); 
JPT + CHB - YRI: HapMap East Asians (JPT + CHB) and Africans (YRI); CHS - 
INS: SGVP Chinese (CHS) and Indian (INS); CHS - JPT + CHB: SGVP Chinese 
(CHS) and HapMap East Asians (JPT + CHB). For all the comparisons, regions 
with extreme varRecM scores are defined as > top 1% in the distribution and non-
extreme scores at ≤ top 1%, except for comparison between SGVP CHS and 
HapMap JPT +CHS; for CHS and JPT +CHB, regions with extreme varRecM 
scores are defined as exceeding top 0.1%. Y error bar represents 95% CI of the 

























Table 10. varRecM scores at top percentiles for pair-wise comparisons of the 
three HapMap populations between CEU and JPT + CHB, CEU and YRI, YRI 
and JPT + CHB  
Percentage\populations 
CEU - 
JPT+CHB  CEU -YRI 
YRI - 
JPT+CHB Mean SE 
top 5% 0.216 0.265 0.246 0.242 0.014 
top 1 % 0.447 0.475 0.443 0.455 0.010 
top 0.5% 0.552 0.565 0.537 0.551 0.008 




Table 11. The 20 strongest signals of varRecM scores in comparisons of HapMap 
populations. 














CEU – JPT +CHB 
1 192.78 – 192.88 CEU ( 28.2)     
2 35.15 – 35.24 JPT + CHB (30.5 ) 
 
 
   Copy number difference 
in HapMap samples398 
3 172.22 – 172.35 CEU (20.2) SLC2A2, 
TNIK  
   
3 189.93 – 190.03 CEU (52.1) LPP JPT + CHB382,399  189.73 – 190.42   
4 148.40 – 148.50 CEU (42.5)      
4 149.00 – 149.10 CEU (23.2) ARHGAP10 CEU381,400 148.74 – 149.14  
4 161.91 – 162.00 JPT + CHB (39.5)     Copy number loss in 
Caucasians or African-
Americans 401 / copy 




5 43.85 –  43.95 CEU (46.9)      
5 151.85  – 151.92 JPT + CHB (61.3)      
6 12.88 – 13.02 JPT + CHB (17.8) PHACTR1 JPT+CHB381,403/ 
Chinese399 
12.62 – 13.20   
7 92.16 – 92.26 CEU (22.3) CDK6 CEU381,403  92.12  –  92.22  
7 135.72 – 135.81 CEU (81.0)      
8 136.27 – 136.36 CEU (54.0)      
10 126.92 – 127.01 JPT + CHB (28.6)   JPT + CHB380,404 126.90  – 127.00  
11 71.46 – 71.52 CEU (18.5) LRRC51, 
NUMA1, 
FOLR3 
   
13 31.56 – 31.66 JPT + CHB (57.9) FRY    
15 34.04 – 34.12 CEU (44.4)      
15 46.26 – 46.36 JPT + CHB (47.8) SLC24A5, 
SLC12A,MY
EF2 
CEU381,382,399,403 45.94 – 46.80  
17 71.01 – 71.11 CEU (35.4) CASKIN2, 
LLGL2, 
TSEN54 
  Copy number loss in 
Caucasian/African-
American, HGDP, 
Japanese 401,405,406 /gain 
in HGDP405 
18 63.70 – 63.77  CEU (14.1)      
CEU - YRI 
1 98.02 – 98.12 CEU (82.1) DPYD    





2 8.24 – 8.35 YRI (34.1)     Copy number gain in 
Caucasian individuals 
407  
2 151.09 – 151.19 CEU (88.6)      
2 226.52 – 226.62 CEU (32.7)      
3 179.54 – 179.64 CEU (59.9)      
4 42.42 – 42.52 CEU (99.1)      
4 54.43 – 54.52 CEU (70.4)      
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5 147.45 – 147.55 YRI (40.4) SPINK5, 
SPINK5L2 
   
7 139.56- 139.62  CEU (44.0)      
9 119.25 – 119.35 CEU (42.0)      
10 2.24 – 2.34 YRI (36.6)      
10 5.37 – 5.46 CEU (44.8) NET1,UCN3
, TUBAL3 
   
10 122.83 – 122.93 YRI (51.5)     Copy number 
differences in HapMap 
samples398 
11 15.75 – 15.83 YRI (37.2)      
11 18.99 – 19.08 YRI (64.6) MRGPRX2,
ZDHHC13 
  Copy number 
differences in HapMap 
samples398  
12 2.79 – 2.88 CEU (42.0) TULP3,NRI
P2,ITFG2,F
KBP4, 
  Copy number loss in 
CEPH diverse 
population 409  
15 46.26 – 46.36 YRI (34.5) SLC12A1, 
SLC24A5, 
MYEF2 
CEU381,382,399,403 45.94 – 46.80  
18 57.80 – 57.89 YRI (55.8) PIGN   Copy number difference 
in CEPH diverse 
population 409 
20 12.34 – 12.40 YRI (35.8)    Copy number 
differences in HapMap 
samples398 
JPT + CHB - YRI 
3 82.53 – 82.59 YRI (28.8)     Copy number gain in 
HapMap samples398 
4 12.84 – 12.93 YRI (31.0)     Copy number loss in 
CEPH diverse 
population 409  
5 51.19 – 51.30 JPT + CHB (34.8)      
5 58.32 – 58.42 YRI (22.5) PDE4D    
5 147.45 – 147.55 YRI (40.4) SPINK5, 
SPINK5L2 
   
5 151.85 – 151.95 JPT + CHB (61.3)      
6 67.91 – 67.99 YRI (21.7)      
7 112.43 – 112.54 JPT + CHB (40.4) GPR85 JPT + CHB380-382 111.87 – 112.59 Copy number difference 
in HapMap samples398  
7 135.72 – 138.81 YRI (36.1)      
10 95.89 – 96.01 JPT + CHB (57.9) PLCE1    
11 91.13 – 91.27 YRI (27.7)      
11 100.81 – 100.91 JPT + CHB (38.8) TRPC6    
12 65.73 – 65.83 YRI (30.0)      
15 34.83 – 34.95 YRI (28.8) C15orf41    
15 63.24 – 63.33 YRI (57.8) CLPX,CILP,
PARP16 
   
16 75.38 – 75.47 YRI (32.2)     Copy number loss in 
Caucasians407 
17 22.53 – 22.61 JPT + CHB (36.1)      
18 63.72 – 63.77 YRI (20.7)      
20 12.33 – 12.43 YRI (35.8)      
21 22.72 – 22.80 YRI (26.0)     Copy number loss in 
Caucasian/African-
American 401 
a Peak rate is the estimated recombination rate in cM/Mb for the population-
specific recombination peak present in each top region.  
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b Region undergoing selection is the stretch spanning a maximum length and 
collapsed from all the overlap regions reported from studies410.  
c Copy number variations have to be at least 10 kb to be included and overlap with 
the peak rate regions. The frequency of the copy number difference is rare ( < 
0.05) in the source populations unless otherwise specified in the table. 
 CEU -JPT+CHB: comparisons between HapMap Europeans (CEU) and East 
Asians (JPT+CHB); CEU - YRI: comparisons between HapMap European (CEU) 
and Africans (YRI); JPT + CHB - YRI: comparisons between HapMap East 







Table 12. The 20 strongest signals of varRecM score in comparison of 
populations of SGVP Chinese and Indians, and Chinese and HapMap East Asians. 













Structure variation c 
CHS -INS 
1 214.96 – 215.06 INS (72.3) ESRRG    
1 215,07 – 215.20 INS (49.6) ESRRG    
1 230.65 – 230.75 INS (38.7) SIPA1L2    
2 25.06 – 25.15 CHS (19.9) EFR3B    
2 209.42 – 209.50 CHS (25.7)     Copy number difference 
in Indian411  
3 164.98 – 165.07 INS (38.7)      
4 29.80  –  29.89 INS (29.5)      
4 72.07 – 72.16 INS (53.0) DCK,MOB
KL1A 
CEU403,412 72.04  – 72.41 
  
4 73.90 – 73.95 INS (16.3)      
4 135.62 – 135.72 INS (24.5)   CEU400,404,413  135.10  – 135.64 Common copy number 
loss in Indian411 
5 66.21 – 66.30 INS (28.0) MAST4    
7 122.16 – 122.22 INS (19.0) CADPS2    
8 127.38 – 127.46 CHS (51.1)      
9 24.10 – 24.19 CHS (73.2)      




12 70.85 – 70.92 INS (34.7)      
12 124.77 – 124.85 INS (65.4)      
18 74.82 – 74.91 INS (28.5) SALL3   Copy number loss in 
Indian and Singapore 
Chinese411 
20 52.60 – 52.73 INS (39.3) DOK5 JPT+CHB404,412 52.43  – 52.75  
21 18.34 – 18.40 CHS (66.8)     Copy number loss  in 
Singapore Chinese411 
CHS – JPT + CHB 




1 214.95 – 215.06 JPT + CHB (66.8) ESRRG    
1 215.08 – 215.20 JPT + CHB (44.9) ESRRG    
3 189.93 – 190.03 CHS (41.4) LPP JPT + 
CHB382,399  
189.73 – 190.42   
4 123.05 – 123.14 CHS (37.2) TRPC3    
4 142.23 – 142.33 JPT + CHB (41.6) RNF150    
5 153.38- 153.44 JPT + CHB (39.5) MFAP3, 
FAM114A2 
   
6 67.91 – 68.02 CHS (18.4)      
8 57.00 – 57.10 JPT + CHB (29.3) LYN JPT + 
CHB403,412 
56.96 – 57.18 
 
8 111.71 – 111.81 CHS (20.5)   JPT+CHB381,404 111.41 – 111.86  
9 119.53 – 119.62 JPT + CHB (47.1) TLR4    
10 107.85 – 107.94 JPT + CHB (42.1)      
11 100.50 – 100.60 JPT + CHB (17.0) PGR JPT + CHB404 100.49 – 100.60  
11 100.81 – 100.91 JPT + CHB (38.8) TRPC6     
12 70.85 – 70.93 JPT + CHB (40.9)      
15 43.97 – 44.07 JPT + CHB (27.2)   JPT+CHB404/As
ian American399  
43.92 – 44.33 
  
18 30.71 – 30.82 CHS (14.5) DTNA     
21 18.35 – 18.40 CHS (66.8)      
180 
 
21 18.93 – 18.99 CHS (75.1)     Copy number gain  in 
Singapore Chinese411 





a Peak rate is the estimated recombination rate in cM/Mb for the population-
specific recombination peak present in each top region.  
b Region undergoing selection is the stretch spanning a maximum length and 
collapsed from all the overlap regions reported from studies 410.  
c Copy number variations have to be at least 10 kb to be included and overlap with 
the peak rate regions. The frequency of the copy number difference is rare ( < 
0.05) in the source populations unless otherwise specified in the table. 
CHS - INS: comparisons between SGVP Chinese (CHS) and Indian (INS); CHS - 
JPT + CHB: comparisons between SGVP Chinese (CHS) and HapMap East 






6 Chapter 6  Conclusion 
      This dissertation is comprised of three studies (Study 1, 2 and 3). Since each 
study has its own discussion, in this final chapter, I will only summarise the key 
results and major implications, and suggest areas for further research.  
 
6.1 Identified genetic variants associated with refractive errors  
      In Study 1 (Chapter 3), the genetic locus on chromosome 1q41 containing 
zinc-finger pseudogene ZC3H11B was found to associate with AL through a 
meta-analysis of three GWAS in Chinese and Malays. This is the first genome-
wide association scan, to best of our knowledge, to explore the genetic association 
for AL. The discovery of chromosome 1q41 as a locus for high myopia in our 
data was further supported by validation in two independent Japanese cohorts. 
Similar genetic effects at 1q41 for high myopia in Chinese, Malays and Japanese 
were observed, suggesting that underlying biological mechanisms of the genetic 
variation are likely to be conserved across these three Asian populations. Our 
GWAS results herein highlight AL QTLs relevant for high myopia predisposition, 
which advances our understanding of the genetic aetiology of common and high 
myopia.  
      In Study 2 (Chapter 4), our genome-wide meta-analysis across five genome-
wide surveys from three genetically diverse populations in Asia revealed that 
genetic variants in the PDGFRA gene on chromosome 4q12 are significantly 
associated with corneal astigmatism. We observed a strong and consistent 
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association with the onset of corneal astigmatism at the PDGFRA gene locus on 
chromosome 4q12 across Chinese, Malays and Indians. 
      Due to the nature of the GWAS design of ‘indirect mapping’, the identified 
SNPs at locus chromosome 1q41 or within gene PDGFRA are probably not the 
casual variants, but are likely to be in LD with the causal SNPs. Further strategies 
to pinpoint the causal mutation including fine mapping and deep-sequencing on 
this genomic region in different population will be required.   
 
6.2 Transferability of the genetic variants for refractive errors across 
populations  
      The international Consortium for Refractive Error and Myopia (CREAM) has 
recently been launched, representing the largest genome-wide scan on AL in 
about 23,000 individuals from 18 cohorts in Europe, United States, Australia and 
Asia. Meta-analysis on 2.5 million autosomal SNPs by whole-genome imputation 
using HapMap 2 reference panels reveals the most significant association for AL 
on chromosome 1q41 in the proximity of pseudogene ZC3H11B ( meta-P = 9.6 × 
10-12 ), along with genetic locus on chromosome 15q14 and seven novel loci (data 
not published). In a parallel genome-wide meta-analysis of GWAS in 27 
Caucasian populations from the CREAM Consortium, use of spherical equivalent 
as a continuous phenotype has identified 24 distinct genetic regions, while 13 loci 
show significant evidence of replication in the Asian populations.    
      Chromosome 4q12, harbouring the gene PDGFRA, is a previously reported 
myopia loci (MYP9). Interestingly, our group also found a strong association 
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between variants in PDGFRA with corneal curvature in Asians414, where corneal 
curvature is one of the underlying ocular parameters of refractive error, pointing 
to a possible pleiotropic contribution of PDGFRA on corneal astigmatism and 
corneal curvature. Recent GWAS in Australian of northern European ancestry 
confirmed the important role of the PDGFRA gene in controlling the corneal 
curvature415. Significant associations of PDGFRA to corneal curvature and 
corneal astigmatism were also found in UK European Children (data not shown). 
These outcomes, along with finding from the CREAM Consortium, provide 
evidence for substantial overlap in genetic aetiology of refractive error between 
Caucasians and Asians.  
      The transferability of the genetic variants for refractive errors across different 
ethnic groups will have important implication for preventive or therapeutic 
intervention for myopia in the future. The discovery of common risk loci in 
GWAS raises the possibility of using these variants for risk predication in a 
clinical setting. Assuming that the genetic variants for myopia are shared across 
different population, a generic risk predication model will be used to classify 
individuals into high or low risk for myopia onset and enable targeted preventive 
treatment. A good genetic prediction model has been built up for age-related 
macular degeneration, utilizing multiple large-effect genetic variants in addition 
to epidemiological risk factors416. Limited predicative value, however, is noted for 
most common diseases so far417. Substantial improvements will only be expected, 
as the field of genomics is progressing, to better characterise genetic variation via 
184 
 
fine-mapping, whole-genome sequencing as well as functional testing, and assess 
gene-environment interactions.  
  
6.3 Statistical meta-analysis of GWAS in diverse populations  
      The use of diverse populations will be an essential component of the next 
phase of GWAS. Meta-analysis combining many studies as possible provides the 
opportunity to scrutinise less significant SNPs embedded in the individual GWAS 
that may reflect the genuine association at larger sample sizes. In Study 2, the 
existing inter-population variation of LD (i.e. Indians versus Chinese) may 
diminish the statistical power to detect genetic loci at these regions with different 
LD patterns across ethnic groups, although the false-positive rate generally is not 
affected. Such inter-population LD variation could yield different effect sizes of 
the association (or even opposite direction in the association) at the genotyped 
SNP, while the underlying genetic effect of the casual variant is the same72. 
Rather than combining test statistic of the same SNP, regional-based meta-
analysis method is useful in trans-ethnic studies for assessing regional evidence of 
phenotypic association, while accommodating different patterns of LD and the 
presence of allelic heterogeneity68.     
      In addition, the assumption of fixed-effect model adopted in the current meta-
analysis model does not account for the scenario where the effect sizes of genetic 
variants can vary across studies. Interestingly, the conventional random-effect 
model yields less significant p-values than the fixed-effect model in the presence 
of inter-study heterogeneity 418. There are future opportunities to perform more 
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advanced statistical analyses to accommodate this issue in the trans-ethnic 
mapping. For example, Han and Eskin have proposed a revised random-effect 
model that relaxed the conservative assumption of null-hypothesis, showing 
significantly improved power in comparison with the traditional random-effect 
model66. By accounting for similarity in allelic effects between genetically close-
related populations but allowing heterogeneity between more diverse ethnic 
groups, Morris has demonstrated that such an approach significantly increased the 
power compared to the uniform fixed- or random-effect models67.  
 
6.4 Missing heritability of myopia  
      In Study 1, the effect sizes of the observed association for AL were modest, 
and the proportion of variance explained was about 1% for AL. The odds ratio of 
the risk allele (major allele) at the implicated SNP (rs4373767) for high myopia 
was below 1.35, similarly to other implicated loci reported in previous 
GWAS22,265,266.  
     There are many possible reasons for such ‘missing heritability’ of ocular traits, 
considering the heritability estimate as high as 88% for quantitative refraction. 
One is the gene-environmental interaction. There is abundant evidence for 
environmental impacts on the development of myopia. The importance of the 
environmental influence on the development of myopia is strongly supported in 
experimental animal models, which show that changes in visual experience can 
generate signals that promote eye growth, leading to myopia 126. In humans, the 
continuously increased prevalence of myopia globally, especially in urban East 
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Asia in the last several decades, has suggested the roles of environmental factors, 
such as levels of educational attainment, the extent of near work, and outdoor 
activities110. The lifestyle changes may alter the distribution of genetic effects in 
some subgroups as well109. However, unless there is a priori knowledge that 
particular environmental factors or genes interplay with each other and reasonable 
fraction of individuals experience the adverse exposure, a direct search for pairs 
of interacting loci and/or interaction with environmental factors can be difficult.  
      Another possibility is that large-effect rare variants may contribute to the 
genetic and phenotypic variation419. Rare variants (MAF <5%) are generally 
omitted in GWAS due to a lack of power. The presence of allelic heterogeneity 
poses a challenge for rare variants in exome sequencing studies, as it is expected 
that, in the same functional unit, different causal mutations of extremely low 
frequencies could be carried by different individuals. The statistical analysis of 
rare variants is fundamentally different from association statistics used for testing 
common variants. The challenges arise in several aspects including extremely low 
power in the single-marker test, allelic heterogeneity, effect heterogeneity of the 
variants within the same region (gene), etc.420. Developing practical computer 
software to prioritise promising rare variants for further functional assay is 
currently an active research area for statistical geneticists. 
      Genome-wide scans for refractive errors on structure variations, such as copy 
number variations (CNVs) referring to the chromosomal deletions or duplications, 
are lag behind many complex diseases. Different computational algorithms have 
been developed to generate CNV calls based on the current available SNP chips 
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from GWAS, however large variation of copy number detection among different 
programs is noted421. With the availability of genome-wide sequencing data in the 
near future, it is expected that studies on genome-wide CNVs for myopia will be 
reported.  
 
6.5  Recombination variations and implications in genetic association studies  
      In Study 3 (Chapter 5), a signal processing approach (varRecM) was 
introduced to evaluate differences in two estimated recombination rate profiles. 
To the best of our knowledge, there is currently no formal statistical metric for 
defining recombination rate variation without first defining the presence or 
absence of recombination hotspots.  
      Applying the metric to genome-wide recombination rates estimated from 
HapMap and SGVP suggests that significant fine-scale differences exist in the 
recombination profiles of Europeans, Africans and East Asians. This observation 
is important in trans-ethnic studies, as it provides the insight into the fine-
mapping of the functional polymorphisms in diverse populations. Assuming that a 
functional variant of the similar effect size and the same direction is present 
across multiple populations, whether this association is detectable largely depends 
on the pattern of LD in the region. Recombination is one of the key forces that 
breakdowns LD, and the rate of recombination has been widely used as a 
surrogate measure for LD in genetic association studies, for instance, SNP 
imputation algorithms60.  Therefore, comparison of inter-population 
recombination variation at fine scale, which is relevant to the extent of LD 
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variation in the same region, is of great value to studies that aim to identify the 
genetic associations transferable across different populations. Top regions 
exhibiting large recombination variations will be studied further for the relevance 
to the disease-associated regions and subsequently the transferability of genetic 
associations at these regions.    
       Until very recently two largest meta-analyses of GWAS ever have uncovered 
a total of 39 genetic loci implicated with myopia 422,423. The association signals 
from both studies are primarily discovered from the samples of Caucasian 
descent. In the CREAM GWAS on spherical equivalent, a number of these loci 
have been successfully replicated in Asian populations comprising Chinese, 
Malays and Indians, whereas others have failed. Since the causal variants are 
highly likely to be in LD with these associated SNPs, the variation of LD patterns 
can challenge replication studies across populations. Further evaluation of inter-
population differences in the patterns of recombination (varRecM scores), or 
similarly the extent of LD, will facilitate our understanding of the transferability 
of theses ‘myopia’ genetic loci in multiple populations.   
      This analysis also shows that the large variations in recombination profiles are 
generally found in non-gene regions, an observation that appears to be concordant 
with previous reports that recombination tends to be suppressed in genes93 even 
though the biological mechanisms for this are still poorly understood424. An 
interesting question remaining is why some hotspots are less likely to be shared 
between different human populations? Our findings prioritise genomic regions for 
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further studies to provide insight into the biological basis of heterogeneous 
recombination in different populations.   
     In summary, this dissertation demonstrates the value of integrating population 
genomics and medical genetics to carry out large-scale genetic association studies 
in multiple populations in elucidation of the genetic architecture of refractive 
errors. The disease-predisposing genetic variation identified in this dissertation 
will shed light on the complete picture of the genetic pathways involved in the 
occurrence and development of refractive errors and further characterisation of 
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